- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID Caco-2-RCAr clone 2
AC CVCL_HA82
RX PubMed=10393089;
CC Selected for resistance to: UniProtKB; P02879; Ricinus communis Ricin.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0025 ! Caco-2
SX Male
CA Cancer cell line
//
ID Caco-2/15
AC CVCL_0232
SY Caco2/15
DR BTO; BTO:0005279
DR MCCL; MCC:0000121
RX PubMed=1764023;
RX PubMed=9827699;
RX PubMed=14599474;
RX PubMed=15868485;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0025 ! Caco-2
SX Male
CA Cancer cell line
//
ID Caco-2/3
AC CVCL_Z578
RX PubMed=1764023;
RX PubMed=15868485;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0025 ! Caco-2
SX Male
CA Cancer cell line
//
ID Caco-2/AQ
AC CVCL_Z585
SY Caco2/AQ
DR BTO; BTO:0005666
RX PubMed=9486194;
RX PubMed=14599474;
RX PubMed=15868485;
RX PubMed=18205904;
RX PubMed=22940288;
RX PubMed=24176760;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0232 ! Caco-2/15
SX Male
CA Cancer cell line
//
ID Caco-2/PD-10
AC CVCL_Z579
SY Caco-2/PD10; Caco2/PD10; PD-10; PD10
RX PubMed=8175910;
RX PubMed=15868485;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0025 ! Caco-2
SX Male
CA Cancer cell line
//
ID Caco-2/PD-7
AC CVCL_Z580
SY Caco-2/PD7; Caco2/PD7; PD-7; PD7
RX DOI=10.1016/0378-5173(94)00280-I;
RX PubMed=8175910;
RX PubMed=15868485;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0025 ! Caco-2
SX Male
CA Cancer cell line
//
ID Caco-2/PF-11
AC CVCL_Z581
SY Caco-2/PF11; Caco2/PF11; PF-11; PF11
RX DOI=10.1016/0378-5173(94)00280-I;
RX PubMed=8175910;
RX PubMed=15868485;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0025 ! Caco-2
SX Male
CA Cancer cell line
//
ID Caco-2/TC-7
AC CVCL_0233
SY Caco-2/TC7; Caco2/TC7; TC-7; TC7
DR BTO; BTO:0002571
DR EFO; EFO_0002817
DR MCCL; MCC:0000122
DR Lonza; 1105
RX DOI=10.1016/0378-5173(94)00280-I;
RX PubMed=8175910;
RX PubMed=14599474;
RX PubMed=15868485;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0025 ! Caco-2
SX Male
CA Cancer cell line
//
ID CAD
AC CVCL_0199
SY Cath-A-Differentiated
DR BTO; BTO:0003695
DR MCCL; MCC:0000090
DR ECACC; 08100805
RX PubMed=9006967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0204 ! CATH.a
SX Male
CA Transformed cell line
//
ID CAD,KR
AC CVCL_E513
SY CAD, KR
DR dbMHC; 48528
DR ECACC; 94092209
DR IHW; IHW9110
DR IMGT/HLA; 11655
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl110.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CaD2
AC CVCL_5714
DR CLS; 400138/p468_CaD2
CC Breed/subspecies: C3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID CADO LC1
AC CVCL_Z047
RX PubMed=7690355;
CC Derived from metastatic site: Brain.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC10
AC CVCL_Z054
RX PubMed=7690355;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC11
AC CVCL_Z055
RX PubMed=7690355;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC15
AC CVCL_Z056
RX PubMed=7690355;
CC Derived from metastatic site: Brain.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC17
AC CVCL_Z057
RX PubMed=7690355;
CC Caution: Indicated incorrectly in Table 1 of PubMed=7690355 as being a SCLC cell line.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC20
AC CVCL_Z058
RX PubMed=7690355;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC21
AC CVCL_Z059
RX PubMed=7690355;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC22
AC CVCL_Z060
RX PubMed=7690355;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC24
AC CVCL_Z061
RX PubMed=7690355;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC26
AC CVCL_Z062
RX PubMed=7690355;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC3
AC CVCL_Z048
SY CADO-LC3
RX PubMed=7690355;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC41
AC CVCL_Z063
RX PubMed=7690355;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC5
AC CVCL_Z049
RX PubMed=7690355;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC6
AC CVCL_Z050
RX PubMed=7690355;
RX PubMed=12569360;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC7
AC CVCL_Z051
RX PubMed=7690355;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC8
AC CVCL_Z052
RX PubMed=7690355;
CC Derived from metastatic site: Liver.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO LC9
AC CVCL_Z053
RX PubMed=7690355;
RX PubMed=12569360;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CADO-ES1
AC CVCL_1103
SY CADO ES1; CADO-ES-1; CADOES1; CADO-ES; ESCADO1
DR CLO; CLO_0002173
DR EFO; EFO_0002818
DR BioSample; SAMN03473333
DR CCLE; CADOES1_BONE
DR CLS; 300127/p767_CADO-ES1
DR Cosmic; 753539
DR Cosmic; 1718434
DR Cosmic; 2294581
DR Cosmic-CLP; 753539
DR DSMZ; ACC-255
DR GDSC; 753539
DR GEO; GSM510004
DR GEO; GSM886901
DR GEO; GSM887966
DR GEO; GSM1669643
RX PubMed=1756482;
RX PubMed=19787792;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 48 hours (PubMed=25984343); ~35 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): CLS; Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,13
ST D16S539: 9,11
ST D18S51: 15,20
ST D21S11: 31,32.2
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 12,15
ST FGA: 21,22
ST Penta D: 13
ST Penta E: 12,19
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAEP
AC CVCL_4670
SY Carassius Auratus ErythroPhoroma
DR CLO; CLO_0051591
DR RCB; RCB0185
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Cancer cell line
//
ID CAF
AC CVCL_R883
SY Carassius Auratus Fin
DR CLO; CLO_0051593
DR RCB; RCB0186
RX CelloPub=CLPUB00025;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Caf 10
AC CVCL_1H12
SY caf 10; Caf10; CAF10
RX Patent=US6358511;
RX PubMed=11192295;
RX PubMed=11752148;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CaF-2
AC CVCL_W100
SY Ca F-2; Carp Fin-2
RX CelloPub=CLPUB00303;
CC Group: Fish cell line.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CAF-Clan I
AC CVCL_AV11
RX PubMed=19343458;
CC Group: Insect cell line.
OX NCBI_TaxID=499538; ! Clostera anachoreta
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CAF-Clan II
AC CVCL_AV12
RX PubMed=19343458;
CC Group: Insect cell line.
OX NCBI_TaxID=499538; ! Clostera anachoreta
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CAF-MM1
AC CVCL_R884
RX PubMed=6408467;
RX PubMed=7063616;
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
HI CVCL_R883 ! CAF
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CAG
AC CVCL_D569
DR BTO; BTO:0005277
RX PubMed=11001907;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CAK
AC CVCL_HE49
RX PubMed=4138999;
CC Breed/subspecies: AKR/J x C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID CAK-A32-G11
AC CVCL_HE50
RX PubMed=4138999;
CC Breed/subspecies: AKR/J x C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HE49 ! CAK
SX Female
CA Spontaneously immortalized cell line
//
ID CAK-B3
AC CVCL_HE51
SY CAK-A32-G11-D9-B3
RX PubMed=6940188;
CC Breed/subspecies: AKR/J x C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HE50 ! CAK-A32-G11
SX Female
CA Spontaneously immortalized cell line
//
ID CAK-B3-Toyr13
AC CVCL_HE52
RX PubMed=6581543;
RX PubMed=6940188;
CC Selected for resistance to: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC Selected for resistance to: ChEBI; CHEBI:134606; Toyocamycin.
CC Breed/subspecies: AKR/J x C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HE51 ! CAK-B3
SX Female
CA Spontaneously immortalized cell line
//
ID CAK-TK-
AC CVCL_HE53
CC Breed/subspecies: AKR/J x C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HE49 ! CAK
SX Female
CA Spontaneously immortalized cell line
//
ID Caki-1
AC CVCL_0234
SY CAKI-1; CaKi-1; caki-1; CAKI.1; CAKI 1; CAKI1; Caki1
DR BTO; BTO:0003204
DR CLO; CLO_0002175
DR CLO; CLO_0002176
DR EFO; EFO_0002149
DR MCCL; MCC:0000123
DR CLDB; cl623
DR CLDB; cl5175
DR ATCC; HTB-46
DR BioSample; SAMN01821541
DR BioSample; SAMN01821674
DR BioSample; SAMN03473223
DR CCLE; CAKI1_KIDNEY
DR CCRID; 3111C0001CCC000244
DR CCRID; 3131C0001000700135
DR ChEMBL-Cells; CHEMBL3307522
DR ChEMBL-Targets; CHEMBL614067
DR CLS; 300149/p748_Caki-1
DR Cosmic; 687940
DR Cosmic; 801356
DR Cosmic; 849379
DR Cosmic; 874611
DR Cosmic; 875871
DR Cosmic; 897463
DR Cosmic; 905963
DR Cosmic; 974303
DR Cosmic; 979705
DR Cosmic; 1044261
DR Cosmic; 1092594
DR Cosmic; 1305375
DR Cosmic; 1312363
DR Cosmic; 1998436
DR Cosmic; 2036675
DR Cosmic; 2301558
DR Cosmic; 2520632
DR Cosmic-CLP; 905963
DR DSMZ; ACC-142
DR DSMZ; ACC-731
DR GDSC; 905963
DR GEO; GSM50229
DR GEO; GSM50293
DR GEO; GSM750816
DR GEO; GSM799374
DR GEO; GSM799437
DR GEO; GSM846288
DR GEO; GSM886902
DR GEO; GSM887967
DR GEO; GSM1153447
DR GEO; GSM1181288
DR GEO; GSM1181368
DR GEO; GSM1669644
DR IGRhCellID; Caki1
DR IMGT/HLA; 13865
DR IZSLER; BS TCL 108
DR JCRB; JCRB0801
DR KCB; KCB 200850YJ
DR KCLB; 30046
DR PRIDE; PXD003105
DR RCB; RCB1985
DR SKY/M-FISH/CGH; 2790
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=2041050;
RX PubMed=6244232;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=9290701;
RX PubMed=10723130;
RX PubMed=11146448;
RX PubMed=15604581;
RX PubMed=17088437;
RX PubMed=17804913;
RX PubMed=19372543;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=27993170;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=38
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/caki-1-human-renal-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-534.
CC Doubling time: 36 hours (PubMed=25984343); 39 hours (DTP); ~40-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: DSMZ; ACC-142; true.
CC Discontinued: RCB; RCB1985; true.
CC Derived from metastatic site: Skin.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=19372543; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 9.1,14 (CLS)
ST D18S51: 14 (PubMed=19372543; PubMed=25877200)
ST D19S433: 14
ST D21S11: 28,30
ST D2S1338: 17
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 12 (PubMed=19372543)
ST D7S820: 8,12 (ATCC; CLS; Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=25877200; RCB)
ST D8S1179: 12,14
ST FGA: 26
ST Penta D: 11,12
ST Penta E: 22,23
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Caki-1-Luc
AC CVCL_J247
DR JCRB; JCRB1400
DR JCRB; NIHS0653
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0653; true.
CC Derived from metastatic site: Skin.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0234 ! Caki-1
SX Male
CA Cancer cell line
//
ID Caki-2
AC CVCL_0235
SY CAKI-2; CaKi-2; CAKI 2; Caki 2; Caki2; CAKI2
DR CLO; CLO_0002177
DR EFO; EFO_0002150
DR MCCL; MCC:0000124
DR CLDB; cl625
DR CLDB; cl626
DR CLDB; cl627
DR CLDB; cl629
DR ATCC; HTB-47
DR BioSample; SAMN01821542
DR BioSample; SAMN01821619
DR BioSample; SAMN03471873
DR CCLE; CAKI2_KIDNEY
DR CCRID; 3111C0001CCC000337
DR ChEMBL-Cells; CHEMBL3308071
DR ChEMBL-Targets; CHEMBL613852
DR CLS; 300140/p524_Caki-2
DR Cosmic; 687941
DR Cosmic; 874612
DR Cosmic; 877458
DR Cosmic; 979706
DR Cosmic; 982278
DR Cosmic; 1152536
DR Cosmic; 2520633
DR DSMZ; ACC-54
DR ECACC; 93120819
DR ENCODE; ENCBS461KDA
DR ENCODE; ENCBS768KGZ
DR GEO; GSM374478
DR GEO; GSM886903
DR GEO; GSM887968
DR ICLC; HTL95029
DR IGRhCellID; Caki2
DR IZSLER; BS TCL 8
DR KCLB; 30047
DR PRIDE; PXD000335
DR PRIDE; PXD003105
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6244232;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=10723130;
RX PubMed=17409424;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27993170;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/caki-2-human-renal-cell-line
WW http://tcpaportal.org/mclp/
CC Problematic cell line: Misidentified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424, PubMed=27993170).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2010-068.
CC Doubling time: ~30-40 hours (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; COG; DSMZ; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 9,13
ST D18S51: 17
ST D19S433: 13,14
ST D21S11: 27,31
ST D2S1338: 17,20
ST D3S1358: 14
ST D5S818: 11
ST D7S820: 12
ST D8S1179: 10
ST FGA: 22
ST Penta D: 10,13
ST Penta E: 7,17
ST TH01: 6
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Caki-dTub
AC CVCL_0B30
DR BTO; BTO:0005559
RX CelloPub=CLPUB00226;
RX PubMed=17009030;
CC Selected for resistance to: ChEBI; CHEBI:88246; 2'-deoxytubercidin.
CC Derived from metastatic site: Skin.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0234 ! Caki-1
SX Male
CA Cancer cell line
//
ID CAL
AC CVCL_E514
SY TER101; TER249; TER309
DR IMGT/HLA; 10376
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CAL-1 [Human melanoma]
AC CVCL_G085
SY CAL 1
RX PubMed=2145926;
RX PubMed=2440566;
RX PubMed=6873970;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-1 [Human plasmacytoid dendritic]
AC CVCL_5G46
RX PubMed=15765784;
WW http://www.clg.niigata-u.ac.jp/~matak/eng/resmat12.pdf
DI NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAL-120
AC CVCL_1104
SY CAL 120; CAL120
DR CLO; CLO_0002179
DR EFO; EFO_0005356
DR BioSample; SAMN03472991
DR BioSample; SAMN03473555
DR CCLE; CAL120_BREAST
DR ChEMBL-Cells; CHEMBL3308577
DR ChEMBL-Targets; CHEMBL1075405
DR Cosmic; 906826
DR Cosmic; 1995355
DR Cosmic; 2164984
DR Cosmic-CLP; 906826
DR DSMZ; ACC-459
DR GDSC; 906826
DR GEO; GSM344361
DR GEO; GSM344411
DR GEO; GSM783963
DR GEO; GSM827160
DR GEO; GSM847210
DR GEO; GSM847455
DR GEO; GSM843483
DR GEO; GSM886904
DR GEO; GSM887969
DR GEO; GSM1669645
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 45 hours (PubMed=25984343); ~50-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 12
ST D21S11: 30
ST D3S1358: 18
ST D5S818: 13
ST D7S820: 12
ST D8S1179: 12,13
ST FGA: 21
ST Penta D: 13
ST Penta E: 11
ST TH01: 6
ST TPOX: 8,9 (Cosmic-CLP; DSMZ)
ST TPOX: 9 (PubMed=25877200)
ST vWA: 18
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-12T
AC CVCL_1105
SY Cal-12T; CAL 12T; CAL12T; CAL 12
DR CLO; CLO_0002180
DR EFO; EFO_0006547
DR BioSample; SAMN03473097
DR CCLE; CAL12T_LUNG
DR ChEMBL-Cells; CHEMBL3308132
DR ChEMBL-Targets; CHEMBL1075406
DR Cosmic; 753540
DR Cosmic; 1995356
DR Cosmic-CLP; 753540
DR DSMZ; ACC-443
DR GDSC; 753540
DR GEO; GSM784241
DR GEO; GSM827248
DR GEO; GSM886905
DR GEO; GSM887970
DR GEO; GSM1669646
RX PubMed=2145926;
RX PubMed=2440566;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 10
ST D18S51: 15
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 15
ST FGA: 23,24
ST Penta D: 12,13
ST Penta E: 11,13
ST TH01: 6
ST TPOX: 8
ST vWA: 16
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAL-148
AC CVCL_1106
SY CAL 148; CAL148
DR CLO; CLO_0002181
DR EFO; EFO_0005357
DR BioSample; SAMN03471761
DR CCLE; CAL148_BREAST
DR ChEMBL-Cells; CHEMBL3308794
DR ChEMBL-Targets; CHEMBL1075407
DR Cosmic; 924106
DR Cosmic; 1603194
DR Cosmic; 2164985
DR Cosmic-CLP; 924106
DR DSMZ; ACC-460
DR GDSC; 924106
DR GEO; GSM344383
DR GEO; GSM344433
DR GEO; GSM783978
DR GEO; GSM827186
DR GEO; GSM886906
DR GEO; GSM887971
DR GEO; GSM1669647
RX PubMed=7531416;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~30-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13,14
ST D16S539: 12
ST D18S51: 17,18
ST D21S11: 28,31.2
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 14
ST FGA: 18,23
ST Penta D: 11,14
ST Penta E: 5,11
ST TH01: 7
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-185
AC CVCL_G081
SY CAL 185
RX PubMed=11720483;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAL-18A
AC CVCL_G083
SY CAL 18A; CAL 18 A
RX PubMed=2440566;
RX PubMed=2982486;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_G084 ! CAL-18B
SX Female
CA Cancer cell line
//
ID CAL-18B
AC CVCL_G084
SY CAL 18B; CAL 18 B
RX PubMed=2440566;
RX PubMed=2982486;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_G083 ! CAL-18A
SX Female
CA Cancer cell line
//
ID CAL-2
AC CVCL_5V17
SY CAL 2
RX PubMed=2145926;
RX PubMed=2440566;
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-23
AC CVCL_5V13
SY CAL 23; Cal 23
RX PubMed=2145926;
RX PubMed=2440566;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CAL-24
AC CVCL_5V14
SY CAL 24; Cal 24
RX PubMed=2145926;
RX PubMed=2440566;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CAL-26
AC CVCL_X042
SY CAL 26; Cal 26
RX PubMed=2440566;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CAL-27
AC CVCL_1107
SY Cal-27; CAL 27; CAL27; Cal27
DR BTO; BTO:0000921
DR CLO; CLO_0002178
DR CLO; CLO_0002182
DR EFO; EFO_0006366
DR ATCC; CRL-2095
DR BCRJ; 0326
DR BioSample; SAMN03471886
DR CCLE; CAL27_UPPER_AERODIGESTIVE_TRACT
DR CCRID; 3111C0001CCC000338
DR ChEMBL-Cells; CHEMBL3308098
DR ChEMBL-Targets; CHEMBL1075408
DR Cosmic; 686972
DR Cosmic; 910916
DR Cosmic; 1006469
DR Cosmic; 1017793
DR Cosmic; 1041674
DR Cosmic; 1339913
DR Cosmic; 1466800
DR Cosmic; 1530734
DR Cosmic; 1752762
DR Cosmic; 2043896
DR Cosmic; 2131842
DR Cosmic; 2296292
DR Cosmic-CLP; 910916
DR DSMZ; ACC-446
DR GDSC; 910916
DR GEO; GSM422868
DR GEO; GSM886907
DR GEO; GSM887972
DR GEO; GSM1374427
DR GEO; GSM1374428
DR GEO; GSM1519074
DR GEO; GSM1519075
DR GEO; GSM1519076
DR GEO; GSM1669648
DR IGRhCellID; CAL27%20GSE9585
RX PubMed=2145926;
RX PubMed=2440566;
RX PubMed=3181269;
RX PubMed=21868764;
RX PubMed=22460905;
RX PubMed=25275298;
RX PubMed=25485619;
RX PubMed=25888065;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Doubling time: ~20-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=21868764; PubMed=25275298; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 11,12
ST D18S51: 13
ST D21S11: 28,29
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 13,15
ST FGA: 25
ST Penta D: 9,10
ST Penta E: 7
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAL-27 TPFR
AC CVCL_GY99
RX PubMed=25962396;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1107 ! CAL-27
SX Male
CA Cancer cell line
//
ID CAL-29
AC CVCL_1808
SY CAL 29; CAL29
DR BioSample; SAMN03473515
DR CCLE; CAL29_URINARY_TRACT
DR Cosmic; 1285115
DR Cosmic; 1995357
DR Cosmic; 2050440
DR Cosmic; 2057444
DR Cosmic; 2444248
DR Cosmic-CLP; 1290730
DR DSMZ; ACC-515
DR GDSC; 1290730
DR GEO; GSM827161
DR GEO; GSM886908
DR GEO; GSM887973
DR GEO; GSM1669649
RX PubMed=2440566;
RX PubMed=11720483;
RX PubMed=22460905;
RX PubMed=24367658;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 8
ST vWA: 16
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-32
AC CVCL_X043
SY CAL 32; Cal 32
RX PubMed=2145926;
RX PubMed=2440566;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CAL-33
AC CVCL_1108
SY CAL 33; CAL33
DR BTO; BTO:0000941
DR CLO; CLO_0002183
DR BioSample; SAMN03473547
DR CCLE; CAL33_UPPER_AERODIGESTIVE_TRACT
DR ChEMBL-Cells; CHEMBL3308715
DR ChEMBL-Targets; CHEMBL1075409
DR Cosmic; 753541
DR Cosmic; 2296293
DR Cosmic-CLP; 753541
DR DSMZ; ACC-447
DR GDSC; 753541
DR GEO; GSM887974
DR GEO; GSM1669650
RX PubMed=2145926;
RX PubMed=2440566;
RX PubMed=3181269;
RX PubMed=22460905;
RX PubMed=25275298;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Doubling time: ~30-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25275298
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 11
ST D18S51: 14
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 21,22
ST Penta D: 12,13
ST Penta E: 7,15
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAL-39
AC CVCL_1109
SY CAL 39; CAL39
DR CLO; CLO_0002184
DR CLDB; cl630
DR BioSample; SAMN03473368
DR ChEMBL-Cells; CHEMBL3308716
DR ChEMBL-Targets; CHEMBL1075410
DR Cosmic; 924107
DR Cosmic; 1995358
DR Cosmic-CLP; 924107
DR DSMZ; ACC-187
DR GDSC; 924107
DR GEO; GSM1669651
RX PubMed=21573363;
RX PubMed=27397505;
CC Doubling time: ~50-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 8
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-4
AC CVCL_G086
SY CAL 4; Cal 4
RX PubMed=2145926;
RX PubMed=2440566;
RX PubMed=6873970;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAL-41
AC CVCL_5V16
SY CAL 41
RX PubMed=2145926;
RX PubMed=2440566;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CAL-43
AC CVCL_X044
SY CAL 43; CAL43
RX PubMed=2440566;
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-44
AC CVCL_G082
SY CAL 44; CAL44
RX PubMed=2440566;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-51
AC CVCL_1110
SY CAL 51; CAL51; Cal51
DR BTO; BTO:0000945
DR CLO; CLO_0002185
DR EFO; EFO_0005358
DR BioSample; SAMN03473159
DR CCLE; CAL51_BREAST
DR ChEMBL-Cells; CHEMBL3308717
DR ChEMBL-Targets; CHEMBL1075411
DR Cosmic; 687467
DR Cosmic; 910927
DR Cosmic; 1057761
DR Cosmic; 2164986
DR Cosmic-CLP; 910927
DR DSMZ; ACC-302
DR GDSC; 910927
DR GEO; GSM115099
DR GEO; GSM217567
DR GEO; GSM344362
DR GEO; GSM344412
DR GEO; GSM350521
DR GEO; GSM459702
DR GEO; GSM783973
DR GEO; GSM827162
DR GEO; GSM847246
DR GEO; GSM847456
DR GEO; GSM886909
DR GEO; GSM887975
DR GEO; GSM1374429
DR GEO; GSM1664565
DR GEO; GSM1669652
DR IGRhCellID; CAL51
DR LINCS; 50008
DR Lonza; 1002
RX PubMed=2390488;
RX PubMed=11044355;
RX PubMed=12661003;
RX PubMed=12800145;
RX PubMed=15677628;
RX PubMed=19582160;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/CAL51.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=CAL-51
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 24 hours (PubMed=25984343); ~50-60 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (PubMed=12661003; PubMed=15677628; Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'Ca151' in Cosmic 1057761.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 11,13
ST D18S51: 15,17
ST D21S11: 31,32
ST D3S1358: 16,17
ST D5S818: 12,13
ST D7S820: 7,12
ST D8S1179: 14
ST FGA: 22,23
ST Penta D: 10,14
ST Penta E: 7,12
ST TH01: 7
ST TPOX: 8,9
ST vWA: 18
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-54
AC CVCL_1111
SY CAL 54; CAL54
DR CLO; CLO_0002186
DR EFO; EFO_0002125
DR BioSample; SAMN03473166
DR CCLE; CAL54_KIDNEY
DR ChEMBL-Cells; CHEMBL3308346
DR ChEMBL-Targets; CHEMBL1075412
DR Cosmic; 910952
DR Cosmic-CLP; 910952
DR DSMZ; ACC-365
DR GDSC; 910952
DR GEO; GSM886910
DR GEO; GSM887976
DR GEO; GSM1669653
DR IGRhCellID; CAL54
RX PubMed=8868943;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~72 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13,14
ST D16S539: 13
ST D18S51: 13,14
ST D21S11: 30.2
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 9,12
ST FGA: 22,23
ST Penta D: 10,13
ST Penta E: 7,19
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAL-62
AC CVCL_1112
SY Cal-62; CAL 62; CAL62
DR BTO; BTO:0002146
DR CLO; CLO_0002187
DR EFO; EFO_0002126
DR BioSample; SAMN03473548
DR CCLE; CAL62_THYROID
DR ChEMBL-Cells; CHEMBL3308099
DR ChEMBL-Targets; CHEMBL1075413
DR Cosmic; 891257
DR Cosmic; 906828
DR Cosmic; 1152118
DR Cosmic; 1162838
DR Cosmic; 1239974
DR Cosmic; 2054116
DR Cosmic-CLP; 906828
DR DSMZ; ACC-448
DR GDSC; 906828
DR GEO; GSM886911
DR GEO; GSM887977
DR GEO; GSM1669654
DR IGRhCellID; CAL62
RX PubMed=1369551;
RX PubMed=18713817;
RX PubMed=22460905;
RX PubMed=23833040;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~24 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=18713817
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 16
ST D21S11: 32.2
ST D3S1358: 16
ST D5S818: 9,12
ST D7S820: 10
ST D8S1179: 13
ST FGA: 19
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-7
AC CVCL_G087
SY CAL 7
RX PubMed=2145926;
RX PubMed=6873970;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-72
AC CVCL_1113
SY CAL 72; CAL72
DR BTO; BTO:0002089
DR CLO; CLO_0002188
DR BioSample; SAMN03473545
DR ChEMBL-Cells; CHEMBL3308718
DR ChEMBL-Targets; CHEMBL1075414
DR Cosmic; 906827
DR Cosmic; 1074399
DR Cosmic-CLP; 906827
DR DSMZ; ACC-439
DR GDSC; 906827
DR GEO; GSM320825
DR GEO; GSM1669655
RX PubMed=10389764;
RX PubMed=12631258;
RX PubMed=27397505;
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 10
ST D5S818: 13
ST D7S820: 11
ST TH01: 8
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAL-78
AC CVCL_1809
SY CAL 78; CAL78
DR CLO; CLO_0002189
DR BioSample; SAMN03473549
DR CCLE; CAL78_BONE
DR Cosmic; 1995359
DR Cosmic-CLP; 1290765
DR DSMZ; ACC-449
DR GDSC; 1290765
DR GEO; GSM886912
DR GEO; GSM887978
DR GEO; GSM1669656
RX PubMed=21590123;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~240 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 8,11
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 6
ST TPOX: 8
ST vWA: 16
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAL-85-1
AC CVCL_1114
SY Cal-85-1; CAL 85-1; CAL85-1; CAL851
DR CLO; CLO_0002190
DR EFO; EFO_0005359
DR BioSample; SAMN03473094
DR CCLE; CAL851_BREAST
DR ChEMBL-Cells; CHEMBL3308700
DR ChEMBL-Targets; CHEMBL1075415
DR Cosmic; 910852
DR Cosmic; 2164987
DR Cosmic-CLP; 910852
DR DSMZ; ACC-440
DR GDSC; 910852
DR GEO; GSM344363
DR GEO; GSM344413
DR GEO; GSM827163
DR GEO; GSM847247
DR GEO; GSM847457
DR GEO; GSM843484
DR GEO; GSM843485
DR GEO; GSM886913
DR GEO; GSM887979
DR GEO; GSM1669657
DR Lonza; 1212
RX PubMed=7531416;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11,13
ST D18S51: 14
ST D21S11: 30.2,32.2
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 15
ST FGA: 24
ST Penta D: 9
ST Penta E: 11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAL-9
AC CVCL_5V15
SY CAL 9
RX PubMed=2145926;
RX PubMed=2440566;
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Calg-ARLC
AC CVCL_6F05
RX PubMed=4817948;
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Female
CA Spontaneously immortalized cell line
//
ID CALM KO MEF
AC CVCL_6D16
DR RCB; RCB4594
RX PubMed=22363754;
CC Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CALM WT MEF
AC CVCL_6D17
DR RCB; RCB4593
RX PubMed=22363754;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CaLo
AC CVCL_5121
SY CALO
DR BTO; BTO:0003110
DR GEO; GSM723051
DR GEO; GSM723052
DR SKY/M-FISH/CGH; 2648
RX CelloPub=CLPUB00348;
RX PubMed=12659655;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CALOGERO
AC CVCL_E515
DR CLDB; cl7224
DR dbMHC; 48529
DR ECACC; 94070703
DR ICLC; HTL14001
DR IHW; IHW9084
DR IMGT/HLA; 10377
WW http://bioinformatics.hsanmartino.it/ecbr/cl84.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Calu-1
AC CVCL_0608
SY CaLu-1; CALU-1; CALU 1; Calu 1; CALU1; Calu1
DR BTO; BTO:0002940
DR CLO; CLO_0002191
DR EFO; EFO_0002151
DR CLDB; cl631
DR CLDB; cl632
DR CLDB; cl633
DR ATCC; HTB-54
DR BioSample; SAMN03471732
DR CCLE; CALU1_LUNG
DR ChEMBL-Cells; CHEMBL3308031
DR ChEMBL-Targets; CHEMBL613505
DR CLS; 300141/p1546_Calu-1
DR Cosmic; 724858
DR Cosmic; 755615
DR Cosmic; 929968
DR Cosmic; 933574
DR Cosmic; 934465
DR Cosmic; 934541
DR Cosmic; 1089224
DR Cosmic; 1146872
DR Cosmic; 1188586
DR Cosmic; 1434968
DR Cosmic; 2060525
DR Cosmic; 2125218
DR ECACC; 93120818
DR GDSC; 724858
DR GEO; GSM206451
DR GEO; GSM253387
DR GEO; GSM434324
DR GEO; GSM784250
DR GEO; GSM794261
DR GEO; GSM843486
DR GEO; GSM886914
DR GEO; GSM887980
DR GEO; GSM1374430
DR GEO; GSM1374431
DR GEO; GSM1374432
DR ICLC; HTL95002
DR IGRhCellID; Calu1
DR IZSLER; BS TCL 76
DR LINCS; 50009
DR PRIDE; PXD002556
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=7736387;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26361996;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/calu-1-human-lung-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 784.
CC Doubling time: 37 hours (PubMed=25984343).
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'CALV1' in Cosmic 1434968.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 14,17
ST D21S11: 28
ST D3S1358: 17
ST D5S818: 10,12
ST D7S820: 9,10
ST D8S1179: 10
ST FGA: 20,21
ST Penta D: 9
ST Penta E: 11
ST TH01: 9,9.3 (ATCC; CLS; PubMed=25877200)
ST TH01: 9.3 (ECACC)
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Calu-2
AC CVCL_1E46
RX PubMed=833871;
RX PubMed=6935474;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Calu-3
AC CVCL_0609
SY CaLu-3; CALU-3; Calu3; CALU3
DR BTO; BTO:0002750
DR CLO; CLO_0002192
DR EFO; EFO_0002819
DR CLDB; cl634
DR CLDB; cl635
DR CLDB; cl5176
DR ATCC; HTB-55
DR BCRJ; 0264
DR BioSample; SAMN03471552
DR CCLE; CALU3_LUNG
DR CCRID; 3111C0001CCC000032
DR CCRID; 3111C0001CCC000329
DR CCRID; 3131C0001000700067
DR CCRID; 3131C0001000700157
DR ChEMBL-Cells; CHEMBL3307390
DR ChEMBL-Targets; CHEMBL614534
DR Cosmic; 687777
DR Cosmic; 910562
DR Cosmic; 933578
DR Cosmic; 945227
DR Cosmic; 961842
DR Cosmic; 1006532
DR Cosmic; 1028940
DR Cosmic; 1146873
DR Cosmic; 1219068
DR Cosmic; 1239869
DR Cosmic; 1434969
DR Cosmic; 1802295
DR Cosmic; 2125219
DR Cosmic-CLP; 687777
DR GDSC; 687777
DR GEO; GSM159355
DR GEO; GSM159356
DR GEO; GSM159357
DR GEO; GSM159358
DR GEO; GSM253347
DR GEO; GSM353233
DR GEO; GSM434276
DR GEO; GSM513948
DR GEO; GSM514318
DR GEO; GSM784249
DR GEO; GSM794262
DR GEO; GSM827549
DR GEO; GSM886915
DR GEO; GSM887981
DR GEO; GSM1374433
DR GEO; GSM1374434
DR GEO; GSM1669658
DR IGRhCellID; Calu3
DR IZSLER; BS TCL 103
DR KCLB; 30055
DR LINCS; 50010
DR Lonza; 342
DR PRIDE; PXD000589
DR PRIDE; PRD000594
DR TOKU-E; 768
RX PubMed=327080;
RX PubMed=7459858;
RX PubMed=7515578;
RX PubMed=10523844;
RX PubMed=11064206;
RX PubMed=15463957;
RX PubMed=17483357;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=24207061;
RX PubMed=25485619;
RX PubMed=25555374;
RX PubMed=25894527;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=30
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-604.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/calu-3-human-lung-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-533.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Cell surface proteome.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'CALV3' in Cosmic 1434969.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): AddexBio; ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12,14
ST D18S51: 14,17
ST D21S11: 28,30
ST D3S1358: 15,18
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 11,15
ST FGA: 25
ST Penta D: 9,16
ST Penta E: 5,21
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Calu-5
AC CVCL_U901
SY CALU-5
RX PubMed=9636188;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Calu-6
AC CVCL_0236
SY CaLu-6; CALU-6; Calu6; CALU6
DR BTO; BTO:0002235
DR CLO; CLO_0002193
DR EFO; EFO_0002152
DR MCCL; MCC:0000125
DR CLDB; cl636
DR CLDB; cl638
DR ATCC; HTB-56
DR BioSample; SAMN03473148
DR CCLE; CALU6_LUNG
DR CCRID; 3131C0001000700144
DR ChEMBL-Cells; CHEMBL3307639
DR ChEMBL-Targets; CHEMBL614535
DR CLS; 300135/p2096_Calu-6
DR Cosmic; 724859
DR Cosmic; 929969
DR Cosmic; 933575
DR Cosmic; 934466
DR Cosmic; 934542
DR Cosmic; 1071885
DR Cosmic; 1089230
DR Cosmic; 1146874
DR Cosmic; 1176611
DR Cosmic; 1434959
DR Cosmic; 1995360
DR Cosmic-CLP; 724859
DR DSMZ; ACC-734
DR GDSC; 724859
DR GEO; GSM253341
DR GEO; GSM434325
DR GEO; GSM513938
DR GEO; GSM514319
DR GEO; GSM794263
DR GEO; GSM843487
DR GEO; GSM886916
DR GEO; GSM887982
DR GEO; GSM1374435
DR GEO; GSM1374436
DR GEO; GSM1669659
DR ICLC; HTL97003
DR IGRhCellID; Calu6
DR KCLB; 30056
DR Lonza; 1139
DR NCBI_Iran; C431
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-473.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Doubling time: ~72 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 13
ST D18S51: 12,16
ST D21S11: 31
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 10,14
ST FGA: 22
ST Penta D: 13
ST Penta E: 5,14
ST TH01: 9
ST TPOX: 8
ST vWA: 17
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Calu3-GemR
AC CVCL_EQ19
DR GEO; GSM159359
DR GEO; GSM159360
DR GEO; GSM159361
DR GEO; GSM159362
DR GEO; GSM159363
DR GEO; GSM159364
DR GEO; GSM159365
DR GEO; GSM159366
DR GEO; GSM159367
DR GEO; GSM159368
DR GEO; GSM159369
DR GEO; GSM159370
DR GEO; GSM159371
DR GEO; GSM159372
DR GEO; GSM159373
DR GEO; GSM159374
RX PubMed=17483357;
CC Selected for resistance to: ChEBI; CHEBI:175901; Gemcitabine (Gemzar).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0609 ! Calu-3
SX Male
CA Cancer cell line
//
ID CAM020
AC CVCL_E516
DR dbMHC; 48530
DR ECACC; 94050334
DR IHW; IHW9256
DR IMGT/HLA; 10378
WW http://bioinformatics.hsanmartino.it/ecbr/cl256.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CAM191
AC CVCL_BS93
DR KCB; KCB 200539YJ
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CaMa clone 15
AC CVCL_1T14
SY CaMa (clone 15); Cancer Mammae
DR BioSample; SAMN03152002
RX PubMed=6451928;
RX PubMed=14071827;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of human origin but found to be from both mouse and hamster (PubMed=6451928, PubMed=20143388). Originally thought to originate from a breast carcinoma.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID CAMA-1
AC CVCL_1115
SY Cama-1; CAMA1; CAMA
DR BTO; BTO:0005022
DR CLO; CLO_0002194
DR EFO; EFO_0001100
DR ATCC; HTB-21
DR BioSample; SAMN03472698
DR CCLE; CAMA1_BREAST
DR ChEMBL-Cells; CHEMBL3308719
DR ChEMBL-Targets; CHEMBL1075416
DR Cosmic; 687468
DR Cosmic; 871153
DR Cosmic; 904354
DR Cosmic; 946382
DR Cosmic; 997930
DR Cosmic; 1000130
DR Cosmic; 1046925
DR Cosmic; 1047717
DR Cosmic; 1136349
DR Cosmic; 1287905
DR Cosmic; 1289386
DR Cosmic; 1603195
DR Cosmic; 1995361
DR Cosmic; 2165018
DR Cosmic-CLP; 946382
DR GDSC; 946382
DR GEO; GSM344344
DR GEO; GSM344394
DR GEO; GSM378143
DR GEO; GSM783930
DR GEO; GSM827295
DR GEO; GSM847248
DR GEO; GSM847458
DR GEO; GSM843488
DR GEO; GSM843489
DR GEO; GSM886917
DR GEO; GSM887983
DR GEO; GSM1008894
DR GEO; GSM1215264
DR GEO; GSM1374437
DR GEO; GSM1661977
DR GEO; GSM1669660
DR LINCS; 50131
DR Lonza; 1251
DR PRIDE; PXD002486
RX PubMed=833871;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=10862037;
RX PubMed=12353263;
RX PubMed=12661003;
RX PubMed=12800145;
RX PubMed=17157791;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=CAMA-1
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-breast-cell-line-cama-1
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 926.
CC Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 14,15
ST D21S11: 32.2
ST D3S1358: 18
ST D5S818: 12,13
ST D7S820: 8,11
ST D8S1179: 12,13
ST FGA: 19,25
ST Penta D: 10,11
ST Penta E: 12,14
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 15
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CAMe001-A
AC CVCL_9R98
SY HNES-1; HNES1
DR hPSCreg; CAMe001-A
CC From: University of Cambridge; Cambridge; UK.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC15-15.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CAMe002-A
AC CVCL_9R99
SY HNES-3; HNES3
DR hPSCreg; CAMe002-A
CC From: University of Cambridge; Cambridge; UK.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC15-16.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CAMi001-A
AC CVCL_2Z89
SY KiPS C1
DR hPSCreg; CAMi001-A
CC From: University of Cambridge; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID CAMi002-A
AC CVCL_2Z90
SY FiPS 2a
DR hPSCreg; CAMi002-A
CC From: University of Cambridge; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z91 ! CAMi002-B
OI CVCL_2Z92 ! CAMi002-C
SX Female
CA Induced pluripotent stem cell
//
ID CAMi002-B
AC CVCL_2Z91
SY FiPS 2b
DR hPSCreg; CAMi002-B
CC From: University of Cambridge; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z90 ! CAMi002-A
OI CVCL_2Z92 ! CAMi002-C
SX Female
CA Induced pluripotent stem cell
//
ID CAMi002-C
AC CVCL_2Z92
SY FiPS 2C
DR hPSCreg; CAMi002-C
CC From: University of Cambridge; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2Z90 ! CAMi002-A
OI CVCL_2Z91 ! CAMi002-B
SX Female
CA Induced pluripotent stem cell
//
ID CAMi004-A
AC CVCL_2Z93
SY AdiPS 1
DR hPSCreg; CAMi004-A
CC From: University of Cambridge; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID CAMi005-A
AC CVCL_9S01
SY hIPS-O27-Tat; O27Tat
DR hPSCreg; CAMi005-A
CC From: University of Cambridge; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9S02 ! CAMi005-B
SX Female
CA Induced pluripotent stem cell
//
ID CAMi005-B
AC CVCL_9S02
SY 2F8
DR hPSCreg; CAMi005-B
CC From: University of Cambridge; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9S01 ! CAMi005-A
SX Female
CA Induced pluripotent stem cell
//
ID CaOs-1
AC CVCL_H746
SY CaOs1
DR ChEMBL-Cells; CHEMBL3307926
DR ChEMBL-Targets; CHEMBL614378
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID CaOV
AC CVCL_M091
DR BioSample; SAMN03151670
RX PubMed=1246601;
RX PubMed=4472134;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=4472134, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID Caov-1
AC CVCL_0200
SY CaOV-1; CAOV-1; CaOv1; CAOV1
DR MCCL; MCC:0000091
DR GEO; GSM784570
RX DOI=10.1007/978-1-4757-1647-4_5;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Omentum.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Caov-2
AC CVCL_6861
SY CaOV-2; CAOV-2; CAOV2
DR BioSample; SAMN03151863
DR GEO; GSM851912
RX PubMed=22710073;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OVCAR-2 derivative (PubMed=22710073).
CC Omics: Transcriptome analysis.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3941 ! OVCAR-2
SX Female
CA Cancer cell line
//
ID Caov-3
AC CVCL_0201
AS CVCL_0231
SY CaOv-3; CaOV-3; CAOV-3; CAOV3; CaOV3; CaOv3; Caov3; CA-OV-3
DR BTO; BTO:0000814
DR CLO; CLO_0002195
DR EFO; EFO_0002148
DR MCCL; MCC:0000119
DR ATCC; HTB-75
DR BioSample; SAMN03472624
DR CCLE; CAOV3_OVARY
DR CCRID; 3111C0001CCC000339
DR CCRID; 3142C0001000000121
DR ChEMBL-Cells; CHEMBL3307927
DR ChEMBL-Targets; CHEMBL614379
DR Cosmic; 687927
DR Cosmic; 688092
DR Cosmic; 809114
DR Cosmic; 844349
DR Cosmic; 906579
DR Cosmic; 906825
DR Cosmic; 924149
DR Cosmic; 949225
DR Cosmic; 1102821
DR Cosmic; 1139227
DR Cosmic; 1305310
DR Cosmic; 1312190
DR Cosmic; 1707569
DR Cosmic; 1709259
DR Cosmic; 2186585
DR Cosmic; 2301585
DR Cosmic-CLP; 906825
DR GDSC; 906825
DR GEO; GSM184398
DR GEO; GSM184399
DR GEO; GSM313711
DR GEO; GSM459740
DR GEO; GSM659371
DR GEO; GSM784569
DR GEO; GSM851913
DR GEO; GSM886918
DR GEO; GSM887984
DR GEO; GSM1001485
DR GEO; GSM1669661
DR IGRhCellID; CaOv3
DR IZSLER; BS TCL 165
DR KCB; KCB 2013041YJ
RX PubMed=4016745;
RX PubMed=12080474;
RX PubMed=18560578;
RX PubMed=22328975;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=24023729;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=27561551;
RX PubMed=28196595;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/caov-3-human-ovarian-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2010-069.
CC Doubling time: 68 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Secretome proteome analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'CaCOV3'.
CC Misspelling: Occasionally 'CACOV-3'.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 12
ST D16S539: 9
ST D18S51: 18
ST D19S433: 14,17
ST D21S11: 30
ST D2S1338: 16,17
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 9,14
ST FGA: 24
ST Penta D: 12
ST Penta E: 11,15
ST TH01: 7
ST TPOX: 8,10
ST vWA: 16,18
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Caov-4
AC CVCL_0202
SY CaOv-4; CaOV-4; CAOV-4; CAOV4; Caov4
DR CLO; CLO_0002196
DR ATCC; HTB-76
DR BioSample; SAMN03472755
DR BioSample; SAMN03472784
DR CCLE; CAOV4_OVARY
DR CCRID; 3111C0001CCC000367
DR ChEMBL-Cells; CHEMBL3308232
DR ChEMBL-Targets; CHEMBL2366249
DR Cosmic; 688093
DR Cosmic; 809112
DR Cosmic; 844350
DR Cosmic; 849610
DR Cosmic; 948287
DR Cosmic; 949090
DR Cosmic; 949226
DR Cosmic; 1305321
DR Cosmic-CLP; 949090
DR GDSC; 949090
DR GEO; GSM784562
DR GEO; GSM886919
DR GEO; GSM887985
DR GEO; GSM1001487
DR GEO; GSM1669662
DR IGRhCellID; Caov4
DR IZSLER; BS TCL 183
DR KCLB; 30076
DR NCBI_Iran; C595
RX PubMed=6935474;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25230021;
RX PubMed=25984343;
RX PubMed=27235858;
RX PubMed=27397505;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/caov-4-human-ovarian-cell-line
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: OCCP ovarian cancer cell line panel.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2010-070.
CC Doubling time: >120 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subserosa of fallopian tube.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11 (ATCC)
ST CSF1PO: 10 (Cosmic-CLP; KCLB; PubMed=25230021; PubMed=25877200)
ST D13S317: 12,14
ST D16S539: 9,11
ST D18S51: 21
ST D21S11: 28,33.2
ST D3S1358: 16
ST D5S818: 11,13 (ATCC)
ST D5S818: 11 (Cosmic-CLP; KCLB; PubMed=25230021; PubMed=25877200)
ST D7S820: 8,10
ST D8S1179: 12
ST FGA: 22
ST Penta D: 9,10
ST Penta E: 12,13
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CaPa
AC CVCL_1U09
RX PubMed=14071827;
CC Derived from metastatic site: Abdominal cavity.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CaPA-4
AC CVCL_V028
RX PubMed=8760589;
DI NCIt; C5977; Submandibular gland carcinoma ex pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Capan-1
AC CVCL_0237
SY CaPan-1; CAPAN-1; CAPAN 1; CAPAN1; Capan1
DR BTO; BTO:0002744
DR CLO; CLO_0002197
DR EFO; EFO_0002153
DR MCCL; MCC:0000126
DR CLDB; cl639
DR CLDB; cl640
DR ATCC; HTB-79
DR BCRJ; 0265
DR BioSample; SAMN01821543
DR BioSample; SAMN01821620
DR BioSample; SAMN03471999
DR CCLE; CAPAN1_PANCREAS
DR CGH-DB; 162-1
DR CGH-DB; 9269-4
DR ChEMBL-Cells; CHEMBL3307640
DR ChEMBL-Targets; CHEMBL614536
DR CLS; 300143/p663_Capan-1
DR Cosmic; 724646
DR Cosmic; 736270
DR Cosmic; 753624
DR Cosmic; 755302
DR Cosmic; 808173
DR Cosmic; 872997
DR Cosmic; 913302
DR Cosmic; 922252
DR Cosmic; 923166
DR Cosmic; 932516
DR Cosmic; 933521
DR Cosmic; 947395
DR Cosmic; 948374
DR Cosmic; 948726
DR Cosmic; 949231
DR Cosmic; 1006365
DR Cosmic; 1090399
DR Cosmic; 1108338
DR Cosmic; 1122342
DR Cosmic; 1198205
DR Cosmic; 1299296
DR Cosmic; 1320462
DR Cosmic; 1534317
DR Cosmic; 1571774
DR Cosmic; 1761694
DR Cosmic; 1995362
DR Cosmic; 2434105
DR Cosmic-CLP; 753624
DR DSMZ; ACC-244
DR GDSC; 753624
DR GEO; GSM206452
DR GEO; GSM621902
DR GEO; GSM784706
DR GEO; GSM886920
DR GEO; GSM887986
DR GEO; GSM1024398
DR GEO; GSM1374438
DR GEO; GSM1374439
DR GEO; GSM1669663
DR IGRhCellID; Capan1
DR IZSLER; BS TCL 9
DR KCLB; 30079
DR Lonza; 1011
DR PRIDE; PXD003198
DR SKY/M-FISH/CGH; 1999
DR TOKU-E; 773
RX DOI=10.4172/jpb.1000057;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6278935;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=10027410;
RX PubMed=11169957;
RX PubMed=12692724;
RX PubMed=14695172;
RX PubMed=18380791;
RX PubMed=20418756;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27259358;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/capan-1.html
WW http://www.addexbio.com/productdetail?pid=31
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/capan-1-human-pancreatic-adenocarcinoma-cell-line
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 923.
CC Doubling time: ~50-100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'CANPAN-1' in Cosmic 2434105.
CC Derived from metastatic site: Liver.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 13,14
ST D18S51: 12
ST D21S11: 28,30
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 14,16
ST FGA: 24
ST Penta D: 9,13
ST Penta E: 10,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Capan-1 SimpleCell O-GalNAc
AC CVCL_S022
SY Capan-1 SimpleCell; Capan-1 SC
RX PubMed=21983924;
RX PubMed=23399548;
RX PubMed=23584533;
CC Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC Knockout cell: Method=ZFN; HGNC; 24338; C1GALT1C1.
CC Derived from metastatic site: Liver.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0237 ! Capan-1
SX Male
CA Cancer cell line
//
ID Capan-2
AC CVCL_0026
SY CaPan-2; CAPAN-2; CAPAN 2; CAPAN2; Capan2
DR BTO; BTO:0002745
DR CLO; CLO_0002198
DR EFO; EFO_0002154
DR MCCL; MCC:0000127
DR CLDB; cl642
DR CLDB; cl643
DR CLDB; cl644
DR ATCC; HTB-80
DR BCRJ; 0060
DR BioSample; SAMN03472025
DR BioSample; SAMN03473387
DR CCLE; CAPAN2_PANCREAS
DR CGH-DB; 163-1
DR CGH-DB; 9270-4
DR ChEMBL-Cells; CHEMBL3308720
DR ChEMBL-Targets; CHEMBL1075417
DR CLS; 300144/p660_Capan-2
DR Cosmic; 730527
DR Cosmic; 736271
DR Cosmic; 755303
DR Cosmic; 808163
DR Cosmic; 868246
DR Cosmic; 910915
DR Cosmic; 913303
DR Cosmic; 922256
DR Cosmic; 923167
DR Cosmic; 932517
DR Cosmic; 932987
DR Cosmic; 933522
DR Cosmic; 934554
DR Cosmic; 947396
DR Cosmic; 948727
DR Cosmic; 949232
DR Cosmic; 1006366
DR Cosmic; 1108339
DR Cosmic; 1299297
DR Cosmic; 1320463
DR Cosmic; 1366277
DR Cosmic; 1571775
DR Cosmic; 1995363
DR Cosmic; 2009527
DR Cosmic; 2046535
DR Cosmic; 2434087
DR Cosmic-CLP; 910915
DR DSMZ; ACC-245
DR GDSC; 910915
DR GEO; GSM206453
DR GEO; GSM621896
DR GEO; GSM784710
DR GEO; GSM886921
DR GEO; GSM887987
DR GEO; GSM1024399
DR GEO; GSM1374440
DR GEO; GSM1669664
DR IGRhCellID; Capan2
DR IZSLER; BS TCL 10
DR KCLB; 30080
DR Lonza; 1464
DR PRIDE; PXD003198
DR SKY/M-FISH/CGH; 1993
RX DOI=10.4172/jpb.1000057;
RX PubMed=3019537;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=10027410;
RX PubMed=11169957;
RX PubMed=11169959;
RX PubMed=12692724;
RX PubMed=12800145;
RX PubMed=14695172;
RX PubMed=15126341;
RX PubMed=15688027;
RX PubMed=18380791;
RX PubMed=20418756;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27259358;
RX PubMed=27397505;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/capan-2.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Capan-2
WW http://www.proteinatlas.org/learn/cellines
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-178.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/capan-2-human-pancreatic-adenocarcinoma-cell-line
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2000-049.
CC Doubling time: ~50-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'CANPAN-2' in Cosmic 2434087.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12 (ATCC; CLS; Cosmic-CLP; KCLB; PubMed=25877200)
ST D13S317: 11,12,13 (DSMZ)
ST D16S539: 9,13
ST D18S51: 13
ST D21S11: 31
ST D3S1358: 17,18
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 12,13
ST FGA: 21,24
ST Penta D: 13,15
ST Penta E: 11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17 (ATCC; CLS; Cosmic-CLP; PubMed=25877200)
ST vWA: 16,17 (DSMZ)
ST vWA: 17,19 (KCLB)
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Capan1M9
AC CVCL_0A59
RX PubMed=22109279;
CC Derived from metastatic site: Liver.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0237 ! Capan-1
SX Male
CA Cancer cell line
//
ID CAPE
AC CVCL_0203
DR MCCL; MCC:0000092
RX PubMed=6285321;
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Finite cell line
//
ID CaPi
AC CVCL_0I81
SY Ca-Pi; Carp Pituitary
RX PubMed=6675352;
CC Group: Fish cell line.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CAR
AC CVCL_4140
SY Car
DR CLO; CLO_0002199
DR CLDB; cl646
DR CLDB; cl647
DR ATCC; CCL-71
DR ECACC; 89072611
DR IZSLER; BS CL 12
CC Group: Fish cell line.
OX NCBI_TaxID=7957; ! Carassius auratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CAR #1
AC CVCL_IV96
RX PubMed=994214;
CC Doubling time: 43 hours, at 16th passage (PubMed=994214).
CC Derived from metastatic site: Inguinal lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Car Bur
AC CVCL_U771
DR ATCC; CRL-1142
CC Discontinued: ATCC; CRL-1142; true.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CaR-1
AC CVCL_1116
SY CaR1; CAR1
DR BTO; BTO:0003131
DR EFO; EFO_0006548
DR BioSample; SAMN03472863
DR ChEMBL-Cells; CHEMBL3308100
DR ChEMBL-Targets; CHEMBL1075418
DR Cosmic; 873697
DR Cosmic; 924108
DR Cosmic; 1122321
DR Cosmic; 1184086
DR Cosmic; 1187300
DR Cosmic-CLP; 924108
DR GDSC; 924108
DR GEO; GSM827225
DR GEO; GSM1374441
DR GEO; GSM1448170
DR GEO; GSM1669665
DR JCRB; JCRB0207
RX CelloPub=CLPUB00026;
RX PubMed=9290701;
RX PubMed=20606684;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,12
ST D16S539: 9
ST D18S51: 14,20
ST D19S433: 13
ST D21S11: 32.2
ST D2S1338: 19,20
ST D3S1358: 17
ST D5S818: 10
ST D7S820: 8,12
ST D8S1179: 13,15
ST FGA: 23,25
ST Penta D: 9,11
ST Penta E: 11
ST TH01: 6
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CAR-2/3F4
AC CVCL_L833
SY 2/3 F4; 2/3F4
DR ECACC; 97011602
CC Monoclonal antibody target: UniProtKB; P10599; Human TXN.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CAR-XP10
AC CVCL_L834
SY XP10
DR ECACC; 97011601
CC Monoclonal antibody target: UniProtKB; P10599; Human TXN.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CAR,ML
AC CVCL_E517
SY CAR, ML
DR dbMHC; 48531
DR ECACC; 94082207
DR IHW; IHW9108
DR IMGT/HLA; 11653
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl108.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CAR47
AC CVCL_S899
DR ATCC; CRL-3235
RX PubMed=18056771;
RX PubMed=21924324;
RX PubMed=22266826;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12,14
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4705; Carney complex
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CarB
AC CVCL_5715
SY Carcinoma B; carB
DR BTO; BTO:0003896
RX PubMed=1855225;
RX PubMed=1918152;
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
DI NCIt; C21609; Mouse squamous cell carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID CarC
AC CVCL_5716
SY Carcinoma C; carC
RX PubMed=1855225;
RX PubMed=1918152;
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
DI NCIt; C21609; Mouse squamous cell carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Carl
AC CVCL_0E92
SY CARL
DR ATCC; CRL-1857
RX PubMed=1690682;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-1857; true.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Transformed cell line
//
ID CARM-L1 TG3
AC CVCL_G349
SY CARM-line 1
DR ECACC; 11120835
RX PubMed=2981541;
CC Breed/subspecies: PVG/c.
DI NCIt; C60453; Rat malignant mesothelioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_G354 ! Me9-TG3
CA Cancer cell line
//
ID CARM-L11 TG3
AC CVCL_G355
SY CARM-line 11
RX PubMed=2981541;
CC Breed/subspecies: PVG/c.
DI NCIt; C60453; Rat malignant mesothelioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_G354 ! Me9-TG3
CA Cancer cell line
//
ID CARM-L12 TG3
AC CVCL_G350
SY CARM-line 12
DR ECACC; 11120833
RX PubMed=2981541;
CC Breed/subspecies: PVG/c.
DI NCIt; C60453; Rat malignant mesothelioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_G354 ! Me9-TG3
CA Cancer cell line
//
ID CARNAVAL
AC CVCL_D330
DR DSMZ; ACC-724
CC Doubling time: ~40-50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 13
ST D5S818: 10
ST D7S820: 10
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CAS-1
AC CVCL_1117
SY CAS1
DR CLO; CLO_0002200
DR CLDB; cl4963
DR CCLE; CAS1_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3308187
DR ChEMBL-Targets; CHEMBL2366100
DR Cosmic; 910943
DR Cosmic; 2367510
DR Cosmic; 2516014
DR Cosmic-CLP; 910943
DR GDSC; 910943
DR GEO; GSM886922
DR GEO; GSM887988
DR GEO; GSM1669666
DR ICLC; HTL97009
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 60 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,10
ST D16S539: 9,14
ST D5S818: 13
ST D7S820: 8,12
ST TH01: 6,9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAS-9
AC CVCL_8537
DR JCRB; JCRB1385
RX PubMed=8660794;
CC Monoclonal antibody target: UniProtKB; Q00651; Mouse Itga4/Cd49d.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID Casa-1
AC CVCL_1E91
RX DOI=10.1007/978-1-4757-1647-4_5;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Derived from metastatic site: Lung.
DI NCIt; C5977; Submandibular gland carcinoma ex pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CAT-13.0B10
AC CVCL_1972
DR CLO; CLO_0002202
DR DSMZ; ACC-472
CC Doubling time: ~25 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P49961; Human ENTPD1/CD39.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CAT-13.1E10
AC CVCL_1973
DR CLO; CLO_0002203
DR DSMZ; ACC-473
CC Doubling time: ~30-40 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD19.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CAT-13.6E12
AC CVCL_U079
DR CLO; CLO_0002204
DR DSMZ; ACC-474
CC Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC Discontinued: DSMZ; ACC-474; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CAT-13.9C1
AC CVCL_1974
DR CLO; CLO_0002205
DR DSMZ; ACC-475
CC Doubling time: ~48 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P06734; Human FCER2/CD23.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CAT-MT
AC CVCL_T987
SY JM
DR ECACC; 12122001
RX PubMed=3906801;
OX NCBI_TaxID=9685; ! Felis catus
SX Female
CA Cancer cell line
//
ID CAT(Wil)
AC CVCL_W772
SY CAT; Wil
RX PubMed=1828972;
RX PubMed=8512807;
RX PubMed=12127398;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Cates-1B
AC CVCL_3296
DR CLO; CLO_0002206
DR ATCC; HTB-104
DR BioSample; SAMN03471090
RX PubMed=833871;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 12,13
ST D7S820: 7,12
ST TH01: 6
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CATH.a
AC CVCL_0204
SY CATH-a; CATHa; Central Adrenergic TH-expressing a
DR BTO; BTO:0005820
DR CLO; CLO_0002207
DR MCCL; MCC:0000093
DR ATCC; CRL-11179
DR KCB; KCB 2014010YJ
RX Patent=US5591626;
RX PubMed=7680068;
RX PubMed=9006967;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-118.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID CaVe
AC CVCL_8444
SY Cancer Ventriculi
DR BioSample; SAMN03151671
RX PubMed=58478;
RX PubMed=6451928;
RX PubMed=14071827;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=58478, PubMed=6451928, PubMed=20143388). Originally thought to originate from a gastric carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID CAVEOC-2
AC CVCL_D308
RX PubMed=8615606;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CB [Catla]
AC CVCL_U262
SY Catla Brain
RX PubMed=19236559;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=20
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC020.
OX NCBI_TaxID=72446; ! Gibelion catla
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CB [Cobia]
AC CVCL_6F69
SY Cobia Brain
RX PubMed=19925591;
CC Group: Fish cell line.
OX NCBI_TaxID=141264; ! Rachycentron canadum
OI CVCL_6F70 ! CF [Cobia]
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CB [Human B-cell]
AC CVCL_E518
DR dbMHC; 48532
DR ECACC; 94050344
DR IHW; IHW9311
DR IMGT/HLA; 10394
WW http://bioinformatics.hsanmartino.it/ecbr/cl311.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CB-16
AC CVCL_CW56
SY CB16
DR NCBI_Iran; H171
RX PubMed=3412357;
WW http://www.bioprobe.s5.com/cb_16.html
CC Monoclonal antibody target: UniProtKB; P08637; Human FCGR3A/CD16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID CB-3512
AC CVCL_7175
DR CLO; CLO_0050474
DR BioSample; SAMN03471919
DR RCB; RCB2531
DR TKG; TKG 0305
RX PubMed=6175525;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB; TKG
ST Amelogenin: X (RCB)
ST Amelogenin: X,Y (TKG)
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 9,14
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,17 (RCB)
ST vWA: 16,17,18 (TKG)
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Cb-E1A
AC CVCL_HB81
RX PubMed=8865201;
WW https://www.kerafast.com/product/3025/rat-cerebellar-granule-cell-line-cb-e1a
CC Characteristics: Can be used as a model system for differentiated cerebellar granule neurons.
CC Doubling time: 24 hours (Kerafast).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5 [E1A; rv12S].
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID CB-F7
AC CVCL_9V08
RX PubMed=2828478;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybrid cell line
//
ID CB-HIV1
AC CVCL_9V09
SY CB HIV1
RX PubMed=2828478;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9V08 ! CB-F7
CA Hybridoma
//
ID CB-HIV2
AC CVCL_9V10
RX PubMed=2828478;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9V08 ! CB-F7
CA Hybridoma
//
ID CB-NJR
AC CVCL_Y580
RX PubMed=2302710;
RX PubMed=23882450;
CC From: Reynolds C.P.; Children's Hospital of Los Angeles; Los Angeles; USA.
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CB0001
AC CVCL_8T97
DR ECACC; 93012701
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C118434; Albright's hereditary osteodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CB0051
AC CVCL_8T98
DR ECACC; 93111608
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CB0054
AC CVCL_8T99
DR ECACC; 93111919
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CB1
AC CVCL_U652
RX Patent=US6156307;
RX PubMed=8245771;
CC Transfected with: UniProtKB; P0C0N9; Avian retrovirus MH2 v-Myc.
CC Transformant: v-Myc.
CC Breed/subspecies: DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CB23
AC CVCL_E421
RX PubMed=1325212;
RX PubMed=3491677;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CB33
AC CVCL_E422
SY CB-33; LCL-CB33
DR BTO; BTO:0004407
RX PubMed=1325212;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CB34
AC CVCL_0I94
RX PubMed=1325212;
RX PubMed=3491677;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CB57/C91PL
AC CVCL_0I93
DR CLO; CLO_0002208
RX PubMed=3020320;
CC Characteristics: HTLV-1 producing cell line.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0197 ! C91/PL
CA Transformed cell line
//
ID CB58/MT2
AC CVCL_0D79
DR CLO; CLO_0002209
RX PubMed=1696163;
RX PubMed=3020320;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2631 ! MT-2
SX Male
CA Transformed cell line
//
ID CB59/MT2
AC CVCL_0D80
DR CLO; CLO_0002210
RX PubMed=1696163;
RX PubMed=3020320;
CC Characteristics: HTLV-1 producing cell line.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2631 ! MT-2
SX Male
CA Transformed cell line
//
ID CB660
AC CVCL_L184
DR PRIDE; PXD002322
RX PubMed=18450476;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/cb660.aspx
CC From: University of Cambridge; Cambridge; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-08-035, Steering comm. appl. SCSC08-25.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID CB6B
AC CVCL_E519
DR dbMHC; 48533
DR ECACC; 88052060
DR IHW; IHW9060
DR IMGT/HLA; 10397
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl60.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID cBAL111
AC CVCL_S904
RX PubMed=18093687;
RX PubMed=19845959;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID CBiPS 2F-1c
AC CVCL_9S23
SY CBiPS c; ESi041-A
DR hPSCreg; ESi041-A
RX PubMed=24311783;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_2015/Documento_Deposito_Linea_CBiPS_2F-1c.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9S25 ! CBiPS 4F-3a
OI CVCL_9S24 ! CBiPS 4F-10b
SX Female
CA Induced pluripotent stem cell
//
ID CBiPS 4F-10b
AC CVCL_9S24
SY CBiPS 4F 10b; CBiPS 4F-10; CBiPS c; ESi041-C
DR hPSCreg; ESi041-C
RX PubMed=24311783;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_2015/Documento_Deposito_CBiPS_4F-10.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9S23 ! CBiPS 2F-1c
OI CVCL_9S25 ! CBiPS 4F-3a
SX Female
CA Induced pluripotent stem cell
//
ID CBiPS 4F-3a
AC CVCL_9S25
SY CBiPS a; ESi041-B
DR hPSCreg; ESi041-B
RX PubMed=24311783;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_2015/Documento_Deposito_CBiPS_4F-3a.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9S23 ! CBiPS 2F-1c
OI CVCL_9S24 ! CBiPS 4F-10b
SX Female
CA Induced pluripotent stem cell
//
ID CBiPS1sv-4F-40
AC CVCL_V189
SY ESi007-A
DR BioSamples; SAMEA3303231
DR hPSCreg; ESi007-A
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/CBiPS1sv-4F-40.pdf
CC From: Inbiomed; Gipuzkoa; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V190 ! CBiPS1sv-4F-5
SX Female
CA Induced pluripotent stem cell
//
ID CBiPS1sv-4F-5
AC CVCL_V190
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/CBiPS1sv-4F-5.pdf
CC From: Inbiomed; Gipuzkoa; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V189 ! CBiPS1sv-4F-40
SX Female
CA Induced pluripotent stem cell
//
ID CBiPS30-4F-3
AC CVCL_C744
SY CBiPS 4F-3; ESi034-A
DR hPSCreg; ESi034-A
RX PubMed=19796614;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/CBiPS30-4F-3.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C745 ! CBiPS30-4F-5
SX Male
CA Induced pluripotent stem cell
//
ID CBiPS30-4F-5
AC CVCL_C745
SY CBiPS 4F-5; ESi034-B
DR hPSCreg; ESi034-B
RX PubMed=19796614;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/CBiPS30-4F-5.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C744 ! CBiPS30-4F-3
SX Male
CA Induced pluripotent stem cell
//
ID CBiPS32-2F-2
AC CVCL_V180
SY ESi038-A
DR hPSCreg; ESi038-A
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud_Deposito_Linea_CBiPS32-2F-2.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V177 ! CBiPS32-3F-10
OI CVCL_V178 ! CBiPS32-3F-12
SX Female
CA Induced pluripotent stem cell
//
ID CBiPS32-3F-10
AC CVCL_V177
SY CBiPS 3F-10; ESi038-B
DR hPSCreg; ESi038-B
RX PubMed=19796614;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Linea_CBiPS32-3F-10.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V180 ! CBiPS32-2F-2
OI CVCL_V178 ! CBiPS32-3F-12
SX Female
CA Induced pluripotent stem cell
//
ID CBiPS32-3F-12
AC CVCL_V178
SY CBiPS 3F-12; CBiPS3F-12; ESi038-C
DR hPSCreg; ESi038-C
RX PubMed=19796614;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_Lineas_CBiPS30-3F-12.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V180 ! CBiPS32-2F-2
OI CVCL_V177 ! CBiPS32-3F-10
SX Female
CA Induced pluripotent stem cell
//
ID CBiPS6-2F-1
AC CVCL_V179
SY CBiPS 2F-1; CBiPS2F-1
RX PubMed=19796614;
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C746 ! CBiPS6-2F-4
SX Male
CA Induced pluripotent stem cell
//
ID CBiPS6-2F-4
AC CVCL_C746
SY CBiPS 2F-4; ESi033-A
DR BioSamples; SAMEA104009426
DR hPSCreg; ESi033-A
RX PubMed=19796614;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/CBiPS6-2F-4.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V179 ! CBiPS6-2F-1
SX Male
CA Induced pluripotent stem cell
//
ID CBL-1
AC CVCL_K136
SY CBL1
DR CLO; CLO_0002213
DR ATCC; HB-8214
RX Patent=US5330896;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CBL63
AC CVCL_GS35
RX PubMed=3143916;
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID CBM1-Ral-Sto
AC CVCL_IS07
SY CB-M1-Ral-Sto; CBM1
RX PubMed=2479717;
RX PubMed=9685479;
CC Characteristics: Transformed by the EBV strain from the Rael-BL (CVCL_7208) cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID cbMSC-hTERT
AC CVCL_GT25
SY hTERT-cbMSC
DR BCRC; 60604
RX PubMed=20230225;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID cbMSC-hTERT-RFP
AC CVCL_GT26
SY hTERT/RFP-cbMSC
DR BCRC; 60605
RX PubMed=20230225;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; Q9U6Y8; RFP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_GT25 ! cbMSC-hTERT
SX Female
CA Telomerase immortalized cell line
//
ID CBRA59109884011
AC CVCL_9T60
DR IMGT/HLA; 25497
RX PubMed=22077627;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CBRM1/1
AC CVCL_0F21
DR ATCC; CRL-2859
RX PubMed=7679388;
CC Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CBRM1/10
AC CVCL_0F23
DR ATCC; CRL-2861
RX PubMed=7679388;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CBRM1/23
AC CVCL_0F24
DR ATCC; CRL-2862
RX PubMed=7679388;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CBRM1/30
AC CVCL_0F25
DR ATCC; CRL-2863
RX PubMed=7679388;
CC Discontinued: ATCC; CRL-2863; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CBRM1/32
AC CVCL_0F26
DR ATCC; CRL-2864
RX PubMed=7679388;
CC Discontinued: ATCC; CRL-2864; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CBRN1/6
AC CVCL_0F22
DR ATCC; CRL-2860
RX PubMed=9614126;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CBRH-7919
AC CVCL_7176
SY CBRH7919
DR BTO; BTO:0005317
DR CCRID; 3131C0001001000002
RX CelloPub=CLPUB00284;
CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC Breed/subspecies: Wistar.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID CBS
AC CVCL_D298
SY HCT-CBS
DR Cosmic; 887231
DR Cosmic; 1131686
RX PubMed=3349466;
RX PubMed=6437669;
RX PubMed=7329817;
RX PubMed=7761852;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=17363507;
CC Microsatellite instability: Stable (MSS) (PubMed=9000147).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CBS-R
AC CVCL_0I68
SY CBS
DR CCLV; CCLV-RIE 0266
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID CC
AC CVCL_E520
DR dbMHC; 48534
DR ECACC; 94050336
DR IHW; IHW9259
DR IMGT/HLA; 10399
WW http://bioinformatics.hsanmartino.it/ecbr/cl259.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CC 11
AC CVCL_K137
SY CC-11; CC11
DR ATCC; CRL-9455
DR ATCC; HB-9455
RX Patent=US5512443;
CC Discontinued: ATCC; CRL-9455; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC 15
AC CVCL_K138
SY CC-15; CC15
DR ATCC; CRL-9460
DR ATCC; HB-9460
RX Patent=US5512443;
CC Discontinued: ATCC; CRL-9460; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC 30
AC CVCL_K139
SY CC-30; CC30
DR ATCC; CRL-9457
DR ATCC; HB-9457
RX Patent=US5512443;
CC Discontinued: ATCC; CRL-9457; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC 46
AC CVCL_K140
SY CC-46; CC46
DR ATCC; CRL-9458
DR ATCC; HB-9458
RX Patent=US5512443;
CC Discontinued: ATCC; CRL-9458; probable.
CC Discontinued: ATCC; HB-9458; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC 49
AC CVCL_K141
SY CC-49; CC49
DR CLO; CLO_0002214
DR ATCC; CRL-9459
DR ATCC; HB-9459
RX Patent=US5512443;
CC Characteristics: Produces the monoclonal antibody Minretumomab which has been used in phase 1 clinical trials for the treatment of various cancers.
CC Monoclonal antibody target: Human tumor associated glycoprotein 72 (TAG-72).
CC Discontinued: ATCC; CRL-9459; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC 83
AC CVCL_K142
SY CC-83; CC83
DR ATCC; CRL-9453
DR ATCC; HB-9453
RX Patent=US5512443;
CC Discontinued: ATCC; CRL-9453; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC 92
AC CVCL_K143
SY CC-92; CC92
DR ATCC; CRL-9454
DR ATCC; HB-9454
RX Patent=US5512443;
CC Discontinued: ATCC; CRL-9454; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC-1
AC CVCL_4141
DR CLO; CLO_0002215
DR CLDB; cl651
DR ChEMBL-Cells; CHEMBL3307391
DR ChEMBL-Targets; CHEMBL614537
DR ECACC; 93070901
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID CC-10A
AC CVCL_DF79
SY CC10A
DR GEO; GSM226733
DR GEO; GSM226869
RX PubMed=10554043;
RX PubMed=17311676;
CC Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DF80 ! CC-10B
SX Female
CA Cancer cell line
//
ID CC-10B
AC CVCL_DF80
SY CC10B
DR GEO; GSM226741
DR GEO; GSM226870
RX PubMed=10554043;
RX PubMed=17311676;
CC Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DF79 ! CC-10A
SX Female
CA Cancer cell line
//
ID CC-11
AC CVCL_DF81
SY CC11
RX PubMed=10554043;
CC Transformant: NCBI_TaxID; 37120; Human papillomavirus type 67 (HPV67).
DI NCIt; C4519; Cervical adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CC-11+
AC CVCL_DF82
SY CC11+
DR GEO; GSM226736
DR GEO; GSM226872
RX PubMed=17311676;
CC Transformant: NCBI_TaxID; 37120; Human papillomavirus type 67 (HPV67).
DI NCIt; C4519; Cervical adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DF81 ! CC-11
SX Female
CA Cancer cell line
//
ID CC-11-
AC CVCL_DF83
SY CC11-
DR GEO; GSM226735
DR GEO; GSM226871
RX PubMed=17311676;
CC Transformant: NCBI_TaxID; 37120; Human papillomavirus type 67 (HPV67).
DI NCIt; C4519; Cervical adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DF81 ! CC-11
SX Female
CA Cancer cell line
//
ID CC-135-VGH
AC CVCL_GT23
DR BCRC; 60597
RX CelloPub=CLPUB00353;
CC Doubling time: 44 hours (BCRC).
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CC-62
AC CVCL_M274
RX PubMed=11249201;
CC Breed/subspecies: Wistar.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID CC-8
AC CVCL_DF78
SY CC8
DR GEO; GSM226734
DR GEO; GSM226868
RX PubMed=10554043;
RX PubMed=17311676;
CC Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C4519; Cervical adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CC-CL-1
AC CVCL_M733
DR Cosmic; 927190
RX PubMed=11802210;
CC Miscellaneous: Only mentioned as a cholangiocarcinoma cell line in PubMed=11802210.
CC Misspelling: 'CC-LC-1' in Cosmic 927190.
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CC-LP-1
AC CVCL_0205
SY CC-LP-I; CCLP-1; CCLP1
DR BTO; BTO:0002933
DR MCCL; MCC:0000094
DR Cosmic; 927189
DR TOKU-E; 4041
RX CelloPub=CLPUB00275;
RX PubMed=1355757;
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CC-M1
AC CVCL_Y096
DR BCRC; 60448
ST Source(s): BCRC
ST Amelogenin: X
ST CSF1PO: 7,10
ST D13S317: 10,12,13
ST D16S539: 10,11,12,13
ST D5S818: 10,11,12
ST D7S820: 11,12,13
ST TH01: 8,9
ST TPOX: 8,9
ST vWA: 16,22
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CC-M2
AC CVCL_Y097
RX PubMed=1696674;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CC-M2MN
AC CVCL_Y098
RX PubMed=1696674;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y097 ! CC-M2
SX Male
CA Cancer cell line
//
ID CC-M3
AC CVCL_Y099
RX PubMed=1696674;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CC-M4
AC CVCL_Y100
RX PubMed=1696674;
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CC-ML3
AC CVCL_F654
RX PubMed=2036925;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID CC-SW-1
AC CVCL_A429
SY CC-SW-I; CCSW-1; CCSW1
DR Cosmic; 927188
RX CelloPub=CLPUB00275;
RX PubMed=1355757;
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CC1 [Human ESC]
AC CVCL_C638
DR ISCR; 1638
RX PubMed=20555390;
CC From: University of Calgary; Calgary; Canada.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-01.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CC1 [Mouse hybridoma]
AC CVCL_M062
SY AFRC IAH-CC1
DR ECACC; 95072101
CC Monoclonal antibody target: UniProtKB; F1MJS9; Bovine PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC1-PI 19
AC CVCL_9V76
DR NCBI_Iran; C216
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CC101
AC CVCL_U062
SY AFRC IAH-CC101
DR ECACC; 99011338
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC104
AC CVCL_M047
SY AFRC IAH-CC104
DR ECACC; 95072105
CC Monoclonal antibody target: UniProtKB; Q24LN2; Bovine ITGAM/CD11b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC13
AC CVCL_G098
SY AFRC IAH-CC13
DR ECACC; 88022403
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC14
AC CVCL_G099
SY AFRC IAH-CC14
DR ECACC; 88022404
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC15
AC CVCL_G100
SY AFRC IAH-CC15
DR CLO; CLO_0002216
DR ATCC; HB-265
DR ECACC; 88022410
CC Monoclonal antibody target: UniProtKB; P30205; Bovine WC1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC17
AC CVCL_G101
SY AFRC IAH-CC17
DR CLO; CLO_0002217
DR ATCC; HB-281
DR ECACC; 88022406
CC Monoclonal antibody target: UniProtKB; P19238; Bovine CD5.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC171
AC CVCL_U063
SY AFRC IAH-CC171
DR ECACC; 99011340
CC Monoclonal antibody target: UniProtKB; F1MJS9; Bovine PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC20 [Human colon adenocarcinoma]
AC CVCL_2H54
DR GEO; GSM1374442
RX PubMed=2994902;
RX PubMed=20606684;
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2H55 ! CC21 [Human colon adenocarcinoma]
OI CVCL_2H56 ! CC22
CA Cancer cell line
//
ID CC20 [Mouse hybridoma]
AC CVCL_G102
SY AFRC IAH-CC20
DR CLO; CLO_0002218
DR ATCC; HB-267
DR ECACC; 91080605
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC21 [Human colon adenocarcinoma]
AC CVCL_2H55
RX PubMed=2994902;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2H54 ! CC20 [Human colon adenocarcinoma]
OI CVCL_2H56 ! CC22
CA Cancer cell line
//
ID CC21 [Mouse hybridoma]
AC CVCL_G103
SY AFRC IAH-CC21
DR CLO; CLO_0002219
DR ATCC; HB-288
DR ECACC; 88022411
RX PubMed=2021068;
CC Monoclonal antibody target: UniProtKB; C9EGT0; Bovine CR2/CD21 (BoWC3).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC22
AC CVCL_2H56
RX PubMed=2994902;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2H54 ! CC20 [Human colon adenocarcinoma]
OI CVCL_2H55 ! CC21 [Human colon adenocarcinoma]
CA Cancer cell line
//
ID CC29
AC CVCL_G104
SY AFRC IAH-CC29
DR CLO; CLO_0002220
DR ATCC; HB-269
DR ECACC; 88022407
CC Monoclonal antibody target: UniProtKB; P19238; Bovine CD5.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC3
AC CVCL_C639
DR ISCR; 1639
RX PubMed=20555390;
CC From: University of Calgary; Calgary; Canada.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-01.
CC Misspelling: 'CC2' in ISCR 1639.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CC3/CUHK3
AC CVCL_S964
SY cc3/CUHK3
RX PubMed=2166463;
RX PubMed=2334130;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CC30
AC CVCL_G105
SY AFRC IAH-CC30
DR CLO; CLO_0002221
DR ATCC; HB-270
DR ECACC; 88022412
CC Monoclonal antibody target: UniProtKB; I0J0K0; Bovine CD4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC32
AC CVCL_M048
SY AFRC IAH-CC32
DR ECACC; 95072102
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC37
AC CVCL_G106
SY AFRC IAH-CC37
DR ECACC; 92021415
RX PubMed=2021068;
CC Monoclonal antibody target: UniProtKB; C9EGT0; Bovine CR2/CD21 (BoWC3).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC38
AC CVCL_G107
SY AFRC IAH-CC38
DR CLO; CLO_0002222
DR ATCC; HB-266
DR ECACC; 88022413
CC Monoclonal antibody target: UniProtKB; F1MU15; Bovine CD6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC39
AC CVCL_G108
SY AFRC IAH-CC39
DR CLO; CLO_0002223
DR ATCC; HB-274
DR ECACC; 91080607
CC Monoclonal antibody target: UniProtKB; P30205; Bovine WC1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC42
AC CVCL_G109
SY AFRC IAH-CC42
DR CLO; CLO_0002224
DR ATCC; HB-272
DR ECACC; 88022408
CC Monoclonal antibody target: UniProtKB; Q148M9; Bovine CD2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC51
AC CVCL_G110
SY AFRC IAH-CC51
DR CLO; CLO_0002225
DR ATCC; HB-271
DR ECACC; 88022414
RX PubMed=2021068;
CC Monoclonal antibody target: UniProtKB; C9EGT0; Bovine CR2/CD21 (BoWC3).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC531
AC CVCL_0206
SY CC-531
DR EFO; EFO_0001101
DR MCCL; MCC:0000095
DR CLS; 500387/p813_CC531
RX PubMed=8225852;
CC Breed/subspecies: WAG/Rij.
DI NCIt; C63866; Adenocarcinoma of the rat colon
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID CC55
AC CVCL_G111
SY AFRC IAH-CC55
DR CLO; CLO_0002226
DR ATCC; HB-282
DR ECACC; 91080604
RX PubMed=2021068;
CC Monoclonal antibody target: Bovine WC4 antigen (BoWC4).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC56
AC CVCL_G112
SY AFRC IAH-CC56
DR CLO; CLO_0002227
DR ATCC; HB-273
DR ECACC; 91080609
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC57
AC CVCL_G113
SY AFRC IAH-CC57
DR CLO; CLO_0002228
DR ATCC; HB-268
DR ECACC; 91080608
RX PubMed=2021068;
CC Monoclonal antibody target: Bovine WC4 antigen (BoWC4).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC58
AC CVCL_G114
SY AFRC IAH-CC58
DR CLO; CLO_0002229
DR ATCC; HB-275
DR ECACC; 91080606
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC62
AC CVCL_U061
SY AFRC IAH-CC62
DR ECACC; 99011334
CC Monoclonal antibody target: UniProtKB; P81425; Bovine DPP4/CD26.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC63
AC CVCL_G115
SY AFRC IAH-CC63
DR CLO; CLO_0002230
DR ATCC; HB-264
DR ECACC; 91080603
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC76A
AC CVCL_M050
SY AFRC IAH-CC76A
DR ECACC; 95072103
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC7T/VGH
AC CVCL_K269
SY CC7T; CC-7T
DR BCRC; 60195
RX CelloPub=CLPUB00027;
RX PubMed=2536104;
ST Source(s): BCRC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 9,11
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C9039; Cervical carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CC8
AC CVCL_G116
SY AFRC IAH-CC8
DR CLO; CLO_0002231
DR ATCC; HB-280
DR ECACC; 88022405
CC Monoclonal antibody target: UniProtKB; I0J0K0; Bovine CD4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC94
AC CVCL_M049
SY AFRC IAH-CC94
DR ECACC; 95072104
CC Monoclonal antibody target: UniProtKB; Q24LN2; Bovine ITGAM/CD11b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC98
AC CVCL_U060
SY AFRC IAH-CC98
DR ECACC; 99011337
CC Monoclonal antibody target: UniProtKB; Q6WY07; Bovine LY75/CD205 (BoWC6).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CC9C10
AC CVCL_G643
DR CLO; CLO_0002239
DR ATCC; HB-123
RX PubMed=6193965;
CC Monoclonal antibody target: UniProtKB; P01317; Bovine INS (also reacts with other species including human).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID CCa
AC CVCL_Z821
DR DGRC; 175
WW http://flybase.org/reports/FBrf0205934.html
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Female
CA Spontaneously immortalized cell line
//
ID CCA
AC CVCL_N717
DR Cosmic; 687947
DR Cosmic; 1082512
RX PubMed=2065319;
RX PubMed=8617485;
RX PubMed=23882450;
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CCALD iPSC-10
AC CVCL_B939
DR ISCR; 1803
RX PubMed=21721033;
CC From: Yonsei University College of Medicine; Seoul; South Korea.
DI NCIt; C61252; Adrenoleukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID CCALD iPSC-2
AC CVCL_B940
DR ISCR; 1804
RX PubMed=21721033;
CC From: Yonsei University College of Medicine; Seoul; South Korea.
DI NCIt; C61252; Adrenoleukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID CCB
AC CVCL_W096
SY Common Carp Brain; Cyprinid Carp Brain; Cyprinus Carpio Brain
DR CCLV; CCLV-RIE 0816
DR ECACC; 10072802
RX CelloPub=CLPUB00374;
RX PubMed=19941903;
CC Group: Fish cell line.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCC-Ca761-03
AC CVCL_L290
DR CCRID; 3111C0001CCC000165
CC Breed/subspecies: 615.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L289 ! Ca761-03
SX Female
CA Cancer cell line
//
ID CCC-ESF-1
AC CVCL_6884
DR CCRID; 3111C0001CCC000108
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID CCC-HPF-1
AC CVCL_6885
DR CCRID; 3111C0001CCC000107
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID CCC-HSF-1
AC CVCL_6886
DR CCRID; 3111C0001CCC000069
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID CCC3a subline 8C
AC CVCL_W183
SY 8C
RX PubMed=4123287;
OX NCBI_TaxID=9685; ! Felis catus
HI CVCL_2426 ! CRFK
SX Female
CA Transformed cell line
//
ID CCCL-1
AC CVCL_J320
SY C85
RX PubMed=10428757;
RX PubMed=11589301;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CCCL-10
AC CVCL_J321
DR Cosmic; 1479616
RX DOI=10.1007/BF02715859;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-11
AC CVCL_J322
SY CCCL11
DR Cosmic; 1479577
RX DOI=10.1007/BF02715859;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-12
AC CVCL_J323
DR Cosmic; 1479578
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CCCL-13
AC CVCL_J341
SY CCCL13
RX DOI=10.1007/BF02715859;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-14
AC CVCL_J324
DR Cosmic; 1479622
RX DOI=10.1007/BF02715859;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CCCL-15
AC CVCL_J342
RX DOI=10.1007/BF02715859;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CCCL-16
AC CVCL_J343
RX DOI=10.1007/BF02715859;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-18
AC CVCL_J325
SY CCCL18
DR Cosmic; 1479563
RX DOI=10.1007/BF02715859;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-19
AC CVCL_J326
SY CCCL19
DR Cosmic; 1479595
RX DOI=10.1007/BF02715859;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-2
AC CVCL_J327
SY C86
DR Cosmic; 1479576
RX DOI=10.1007/BF02715859;
RX PubMed=10428757;
RX PubMed=11589301;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-20
AC CVCL_J328
DR Cosmic; 1479623
RX DOI=10.1007/BF02715859;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-21
AC CVCL_J329
DR Cosmic; 1479624
RX DOI=10.1007/BF02715859;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CCCL-22
AC CVCL_J344
RX DOI=10.1007/BF02715859;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-23
AC CVCL_J330
SY CCCL23
DR Cosmic; 1479565
RX DOI=10.1007/BF02715859;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CCCL-26
AC CVCL_J331
DR Cosmic; 1479625
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CCCL-28
AC CVCL_J332
SY CCCL28
DR Cosmic; 1479596
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CCCL-3
AC CVCL_J333
SY CCCL3
DR Cosmic; 1479585
RX DOI=10.1007/BF02715859;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CCCL-30
AC CVCL_J334
DR Cosmic; 1479626
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CCCL-4
AC CVCL_J335
SY C18
RX DOI=10.1007/BF02715859;
RX PubMed=10428757;
RX PubMed=11589301;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-5
AC CVCL_J337
RX DOI=10.1007/BF02715859;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-6
AC CVCL_J336
SY C29
DR Cosmic; 1479617
RX DOI=10.1007/BF02715859;
RX PubMed=10428757;
RX PubMed=11589301;
RX PubMed=20570890;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-7
AC CVCL_J338
RX DOI=10.1007/BF02715859;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-8
AC CVCL_J339
RX DOI=10.1007/BF02715859;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCCL-9
AC CVCL_J340
RX DOI=10.1007/BF02715859;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CCD-1001Sk
AC CVCL_0F51
SY CCD-1001sk
DR ATCC; CRL-1987
DR BioSample; SAMN03471269
CC Discontinued: ATCC; CRL-1987; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,15
ST D13S317: 11,12
ST D16S539: 10,13
ST D5S818: 10,11
ST D7S820: 9,11
ST TH01: 8,9
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1037Sk
AC CVCL_2325
DR CLO; CLO_0002253
DR ATCC; CRL-2054
DR BioSample; SAMN03471422
DR GEO; GSM426278
RX PubMed=19727395;
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2054; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 10,13
ST TH01: 8,9.3
ST TPOX: 9,10
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1043Sk
AC CVCL_U268
SY CCD-1043SK; CCD 1043SK
DR ATCC; CRL-2056
DR BioSample; SAMN03471423
CC Discontinued: ATCC; CRL-2056; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 13
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1056Sk
AC CVCL_U270
SY CCD-1056SK; CCD1056SK
DR ATCC; CRL-2068
DR BioSample; SAMN03471430
CC Discontinued: ATCC; CRL-2068; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 10,13
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1058Sk
AC CVCL_2326
SY CCD 1058 SK
DR CLO; CLO_0002254
DR ATCC; CRL-2071
DR BioSample; SAMN03471431
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 12
ST D7S820: 7,11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1059Sk
AC CVCL_2327
SY CCD-1059 Sk; CCD-1059SK; CCD1059Sk
DR CLO; CLO_0002255
DR ATCC; CRL-2072
DR BCRJ; 0061
DR BioSample; SAMN03471432
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1064Sk
AC CVCL_2328
SY CCD-1064SK; CCD1064Sk; 1064SK
DR CLO; CLO_0002256
DR ATCC; CRL-2076
DR BioSample; SAMN03471434
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/1/cell-lines-detail-572.html
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 13
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1065Sk
AC CVCL_2329
DR CLO; CLO_0002257
DR ATCC; CRL-2077
DR BioSample; SAMN03471435
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 7,8
ST TPOX: 9,11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1066Sk
AC CVCL_0F52
DR ATCC; CRL-2080
CC Discontinued: ATCC; CRL-2080; true.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID CCD-1068Sk
AC CVCL_2330
SY CCD-1068SK; CCD1068SK
DR CLO; CLO_0002258
DR ATCC; CRL-2086
DR BioSample; SAMN03471442
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 8,9
ST TH01: 6
ST TPOX: 8,10
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1069Sk
AC CVCL_2331
SY CCD 1069SK; CCD1069Sk
DR CLO; CLO_0002259
DR ATCC; CRL-2089
DR BioSample; SAMN03471444
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 12,13
ST D5S818: 9,11
ST D7S820: 9,10
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1070Sk
AC CVCL_2332
SY CCD-1070sk; CCD-1070SK; CCD1070Sk; CCD1070SK
DR CLO; CLO_0002260
DR ATCC; CRL-2091
DR BioSample; SAMN03471446
WW http://www.atcc.org/support/faqs/2a07e/Origin%20of%20ATCC%20CRL-2091-813.aspx
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 9,14
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1072Sk
AC CVCL_2333
SY CCD-1072sk; CCD 1072SK; CCD1072SK
DR CLO; CLO_0002261
DR ATCC; CRL-2088
DR BCRJ; 0062
DR BioSample; SAMN03471443
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,14
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 6,10
ST vWA: 15,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1074Sk
AC CVCL_2334
DR CLO; CLO_0002262
DR ATCC; CRL-2090
DR BioSample; SAMN03471445
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1076Sk
AC CVCL_2335
SY CCD-1076SK; CCD 1076Sk; CCD1076SK
DR CLO; CLO_0002263
DR ATCC; CRL-2096
DR BioSample; SAMN03471447
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1077Sk
AC CVCL_2336
SY CCD-1077sk
DR CLO; CLO_0002264
DR ATCC; CRL-2094
DR BioSample; SAMN03471448
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 9,11
ST D5S818: 9,13
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 8,10
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1079Sk
AC CVCL_2337
SY CCD1079SK; CCD1079sk
DR CLO; CLO_0002265
DR ATCC; CRL-2097
DR BioSample; SAMN03471450
DR GEO; GSM909334
DR GEO; GSM909335
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6,9.3
ST TPOX: 10,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1086Sk
AC CVCL_2338
DR CLO; CLO_0002266
DR ATCC; CRL-2103
DR BioSample; SAMN03472541
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 9,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1087Sk
AC CVCL_2339
DR CLO; CLO_0002267
DR ATCC; CRL-2104
DR BioSample; SAMN03472542
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 10,13
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 7
ST TPOX: 8
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1090Sk
AC CVCL_2340
DR CLO; CLO_0002268
DR ATCC; CRL-2106
DR BioSample; SAMN03472544
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1092Sk
AC CVCL_2341
SY CCD-1092SK; CCD-1092sk
DR CLO; CLO_0002269
DR ATCC; CRL-2114
DR BioSample; SAMN03472545
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 11
ST D7S820: 8,13
ST TH01: 7
ST TPOX: 8,11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1093Sk
AC CVCL_2342
DR CLO; CLO_0002270
DR ATCC; CRL-2115
DR BioSample; SAMN03472546
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 9,13
ST D7S820: 8,11
ST TH01: 5,6
ST TPOX: 8,10
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1094Sk
AC CVCL_2343
DR CLO; CLO_0002271
DR ATCC; CRL-2120
DR BioSample; SAMN03472547
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 10,11
ST D7S820: 11
ST TH01: 7,8
ST TPOX: 8,10
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1095Sk
AC CVCL_2344
SY CCD1095Sk
DR CLO; CLO_0002272
DR ATCC; CRL-2122
DR BioSample; SAMN03472548
DR CCRID; 3131C0001000200015
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1096Sk
AC CVCL_2345
SY CCD1096sk
DR CLO; CLO_0002273
DR ATCC; CRL-2129
DR BioSample; SAMN03472553
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9,13
ST D5S818: 12
ST D7S820: 8,12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1097Sk
AC CVCL_2346
SY CCD1097SK
DR CLO; CLO_0002274
DR ATCC; CRL-2124
DR BioSample; SAMN03472550
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1098Sk
AC CVCL_2347
DR CLO; CLO_0002275
DR ATCC; CRL-2127
DR BioSample; SAMN03472552
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 9,13
ST D5S818: 9,12
ST D7S820: 9,10
ST TH01: 6,9
ST TPOX: 10,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1099Sk
AC CVCL_2348
DR CLO; CLO_0002276
DR ATCC; CRL-2201
DR BioSample; SAMN03472564
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 12,13
ST D16S539: 10,14
ST D5S818: 9,13
ST D7S820: 9,10
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1100Sk
AC CVCL_2350
DR CLO; CLO_0002277
DR ATCC; CRL-2211
DR BioSample; SAMN03472566
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 9,11
ST D5S818: 12,13
ST D7S820: 7,9
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1101Sk
AC CVCL_2351
DR CLO; CLO_0002278
DR ATCC; CRL-2281
DR BioSample; SAMN03471859
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 12,13
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1102 KERTr
AC CVCL_3297
SY CCD 1102 KERTr; CCD-1102KerTr
DR CLO; CLO_0002240
DR ATCC; CRL-2310
DR BioSample; SAMN03471867
RX CelloPub=CLPUB00347;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,13
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 7,9.3
ST TPOX: 6,8,10
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CCD-1103 KIDTr
AC CVCL_3298
SY CCD 1103 KIDTr; CCD-1103KidTr; CCD1103KIDTR
DR CLO; CLO_0002241
DR ATCC; CRL-2304
DR BioSample; SAMN03471863
DR GEO; GSM827246
RX CelloPub=CLPUB00347;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12,13
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6,7
ST TPOX: 9
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCD-1105 KIDTr
AC CVCL_3299
SY CCD 1105 KIDTr; CCD 1105 KIDTR; CCD-1105KidTr; CCD1105KIDTR
DR CLO; CLO_0002242
DR ATCC; CRL-2305
DR BioSample; SAMN03471864
DR GEO; GSM827247
RX CelloPub=CLPUB00347;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 10,11
ST D7S820: 9
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCD-1106 KERTr
AC CVCL_3300
SY CCD 1106 KERTr; CCD-1106KerTr
DR CLO; CLO_0002243
DR ATCC; CRL-2309
DR BioSample; SAMN03471866
RX CelloPub=CLPUB00347;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 8,12
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCD-1108Sk
AC CVCL_2352
SY CCD 1108Sk; CCD1108Sk; CCD1108SK
DR CLO; CLO_0002244
DR ATCC; CRL-2352
DR BioSample; SAMN03471827
DR GEO; GSM426279
RX PubMed=19727395;
CC Characteristics: Senesces at ~32 PDL.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 9,12
ST D5S818: 12,13
ST D7S820: 12
ST TH01: 6,9
ST TPOX: 8,10
ST vWA: 14,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1109Sk
AC CVCL_2353
SY CCD 1109SK
DR CLO; CLO_0002279
DR ATCC; CRL-2361
DR BioSample; SAMN03471828
CC Characteristics: Senesces at ~20 PDL.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 12
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1110Sk
AC CVCL_0E06
DR ATCC; CRL-2412
DR BioSample; SAMN03471838
CC Misspelling: 'CCD-110Sk' in BioSample SAMN03471838.
CC Discontinued: ATCC; CRL-2412; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 10,12,13
ST D16S539: 8,10,11
ST D5S818: 12,13
ST D7S820: 10,11,12
ST TH01: 7,8,9.3
ST TPOX: 8,11
ST vWA: 15,16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1112Sk
AC CVCL_2769
SY CCD 1112SK; CCD1112Sk
DR CLO; CLO_0002280
DR ATCC; CRL-2429
DR BioSample; SAMN03472834
RX PubMed=18415935;
CC Misspelling: 'CCD 112SK' in BioSample SAMN03472834.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1113Sk
AC CVCL_2354
SY CCD 1113SK
DR CLO; CLO_0002281
DR ATCC; CRL-2439
DR BioSample; SAMN03471842
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,13
ST D5S818: 12,13
ST D7S820: 11,13
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 13,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1114Sk
AC CVCL_2355
SY CCD 1114SK; CCD1114sk
DR CLO; CLO_0002282
DR ATCC; CRL-2450
DR BioSample; SAMN03471580
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 12,13
ST D7S820: 10
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1117Sk
AC CVCL_2356
SY CCD-1117SK
DR CLO; CLO_0002283
DR ATCC; CRL-2465
DR BioSample; SAMN03471583
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 10,12
ST D5S818: 10,11
ST D7S820: 12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1118Sk
AC CVCL_2357
DR CLO; CLO_0002284
DR ATCC; CRL-2466
DR BioSample; SAMN03471584
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 12,13
ST D7S820: 9,10
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1120Sk
AC CVCL_2358
DR CLO; CLO_0002286
DR ATCC; CRL-2510
DR BioSample; SAMN03471602
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 10,13
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1121Sk
AC CVCL_2359
DR CLO; CLO_0002287
DR ATCC; CRL-2511
DR BioSample; SAMN03471603
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1122Sk
AC CVCL_2360
DR CLO; CLO_0002288
DR ATCC; CRL-2513
DR BioSample; SAMN03471604
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 9,12
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 8
ST vWA: 17,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1123Sk
AC CVCL_2361
DR CLO; CLO_0002289
DR ATCC; CRL-2524
DR BioSample; SAMN03471606
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 8,9.3
ST TPOX: 9,12
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1124Sk
AC CVCL_2362
SY CCD 1124Sk
DR CLO; CLO_0002290
DR ATCC; CRL-2529
DR BioSample; SAMN03471607
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1126Sk
AC CVCL_2363
DR CLO; CLO_0002291
DR ATCC; CRL-2564
DR BioSample; SAMN03471672
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 12,13
ST D16S539: 10,11
ST D5S818: 12
ST D7S820: 8,9
ST TH01: 6,7
ST TPOX: 9
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1127Sk
AC CVCL_2364
SY CCD1127Sk
DR CLO; CLO_0002292
DR ATCC; CRL-2565
DR BioSample; SAMN03471673
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 9,9.3
ST TPOX: 8,10
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1128Sk
AC CVCL_2365
DR CLO; CLO_0002293
DR ATCC; CRL-2566
DR BioSample; SAMN03471674
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10
ST TH01: 7,8
ST TPOX: 8
ST vWA: 17,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1129Sk
AC CVCL_2366
SY CCD-1129SK
DR CLO; CLO_0002294
DR ATCC; CRL-2575
DR BioSample; SAMN03471681
DR PRIDE; PXD000691
RX PubMed=26055192;
CC Omics: Deep proteome analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-112CoN
AC CVCL_6382
SY CCD-112 CoN
DR ATCC; CRL-1541
DR BioSample; SAMN03471392
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9,13
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 12
ST D7S820: 8,9
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1131Sk
AC CVCL_2367
DR CLO; CLO_0002295
DR ATCC; CRL-2617
DR BioSample; SAMN03471677
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,13
ST D16S539: 9,10
ST D5S818: 8,12
ST D7S820: 8,13
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1132Sk
AC CVCL_2368
DR CLO; CLO_0002296
DR ATCC; CRL-2622
DR BioSample; SAMN03471676
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,14
ST D16S539: 10
ST D5S818: 8,11
ST D7S820: 10,11
ST TH01: 6,8
ST TPOX: 9
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1134Sk
AC CVCL_2369
DR CLO; CLO_0002297
DR ATCC; CRL-2673
DR BioSample; SAMN03471759
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,14
ST D16S539: 8,11
ST D5S818: 9,10
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,10
ST vWA: 14,15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-1135Sk
AC CVCL_2370
DR CLO; CLO_0002298
DR ATCC; CRL-2691
DR BioSample; SAMN03471765
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,11
ST D16S539: 9,12
ST D5S818: 12,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1136Sk
AC CVCL_2371
DR CLO; CLO_0002299
DR ATCC; CRL-2697
DR BioSample; SAMN03471767
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12,13
ST D16S539: 9,12
ST D5S818: 12,13
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8,10
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1137Sk
AC CVCL_2372
DR CLO; CLO_0002300
DR ATCC; CRL-2703
DR BioSample; SAMN03471768
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 9
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 7,9.3
ST TPOX: 6,11
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1138Sk
AC CVCL_2373
SY CCD1138sk
DR CLO; CLO_0002301
DR ATCC; CRL-2707
DR BioSample; SAMN03471770
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8,9
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1139Sk
AC CVCL_2374
SY CCD-1139SK; CCD1139Sk
DR CLO; CLO_0002302
DR ATCC; CRL-2708
DR BioSample; SAMN03471771
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,14
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1140Sk
AC CVCL_2375
SY CCD-1140sk; CCD1140Sk; CCD1140sk
DR CLO; CLO_0002303
DR ATCC; CRL-2714
DR BioSample; SAMN03471773
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 9
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1141Sk
AC CVCL_2376
DR CLO; CLO_0002304
DR ATCC; CRL-2796
DR BioSample; SAMN03471790
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 8,12
ST TH01: 6
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-1142 FeAE (E6/E7)
AC CVCL_B043
DR ATCC; CRL-2997
DR BioSample; SAMN03471704
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Discontinued: ATCC; CRL-2997; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 12,13
ST D7S820: 7,10
ST TH01: 6,8
ST TPOX: 8
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CCD-118Sk
AC CVCL_Y116
DR ATCC; CRL-1537
CC Discontinued: ATCC; CRL-1537; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-11Lu
AC CVCL_2349
SY CCD 11Lu; CCD11Lu
DR CLO; CLO_0002305
DR EFO; EFO_0005360
DR CLDB; cl668
DR ATCC; CCL-202
DR BioSample; SAMN03471467
DR ECACC; 94060302
DR GEO; GSM426284
RX PubMed=7065527;
RX PubMed=19727395;
CC Omics: Transcriptome analysis.
CC Discontinued: ECACC; 94060302; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-13Lu
AC CVCL_2377
SY CCD 13Lu; CCD-13 Lu; CCD13Lu
DR BTO; BTO:0002644
DR CLO; CLO_0002245
DR CLO; CLO_0002306
DR EFO; EFO_0005361
DR CLDB; cl654
DR ATCC; CCL-200
DR BioSample; SAMN03471464
DR ECACC; 90112704
DR GEO; GSM426285
RX PubMed=7065527;
RX PubMed=19727395;
CC Characteristics: Senesces at ~20 PDL.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10,14
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 10
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-14Br
AC CVCL_2870
SY CCD-14BR; CCD-14 Br
DR ATCC; CCL-203
DR BioSample; SAMN03471466
DR BioSample; SAMN03472363
DR GEO; GSM784279
DR JCRB; JCRB9101
RX PubMed=7065527;
WW http://www.atcc.org/support/faqs/27658/CCD14BR%20ATCC%20CCL203-1081.aspx
CC Problematic cell line: On the basis of the STR profile the cell line at ATCC (no longer available) and the one at JCRB are not the same.
CC Misspelling: 'CDD14BR' in GEO GSM784279.
CC Discontinued: ATCC; CCL-203; true.
ST Source(s): ATCC; JCRB
ST Amelogenin: X
ST CSF1PO: 11,12 (ATCC)
ST CSF1PO: 10,11 (JCRB)
ST D13S317: 8,11 (ATCC)
ST D13S317: 8,12 (JCRB)
ST D16S539: 10,12 (ATCC)
ST D16S539: 11,12 (JCRB)
ST D5S818: 11,12 (ATCC)
ST D5S818: 11,13 (JCRB)
ST D7S820: 10,12 (ATCC)
ST D7S820: 8,10 (JCRB)
ST TH01: 7,8 (ATCC)
ST TH01: 6,10 (JCRB)
ST TPOX: 8,11
ST vWA: 17 (ATCC)
ST vWA: 17,18 (JCRB)
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U329 ! CCD-14Sk
SX Female
CA Finite cell line
//
ID CCD-14Sk
AC CVCL_U329
DR ATCC; CRL-1454
CC Discontinued: ATCC; CRL-1454; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2870 ! CCD-14Br
SX Female
CA Finite cell line
//
ID CCD-15Sk
AC CVCL_Y305
DR ATCC; CRL-1457
CC Discontinued: ATCC; CRL-1457; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-16Lu
AC CVCL_2378
SY CCD 16Lu; CCD-16 Lu; CCD16Lu
DR CLO; CLO_0002246
DR CLO; CLO_0002307
DR EFO; EFO_0005362
DR CLDB; cl655
DR ATCC; CCL-204
DR BioSample; SAMN03471468
DR ECACC; 86090301
DR GEO; GSM426286
RX PubMed=7065527;
RX PubMed=19727395;
CC Characteristics: Senesces at ~11 PDL.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,12
ST D16S539: 13
ST D5S818: 11,13
ST D7S820: 7,11
ST TH01: 9
ST TPOX: 10,11
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-186Sk
AC CVCL_2381
SY CCD-186SK
DR CLO; CLO_0002308
DR ATCC; CRL-1563
DR BioSample; SAMN03471396
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 7,10
ST TH01: 7,8
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-187Sk
AC CVCL_Y117
DR ATCC; CRL-1564
CC Discontinued: ATCC; CRL-1564; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-18Co
AC CVCL_2379
SY CCD18Co
DR BTO; BTO:0004059
DR CLO; CLO_0002309
DR ATCC; CRL-1459
DR ECACC; 90070503
DR IZSLER; BS CL 204
DR KCLB; 21459
DR Lonza; 1019
CC Discontinued: ECACC; 90070503; probable.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 8
ST D13S317: 12
ST D16S539: 12,13
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 8
ST FGA: 18,24.2
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2380 ! CCD-18Lu
SX Female
CA Finite cell line
//
ID CCD-18Lu
AC CVCL_2380
SY CCD 18Lu; CCD-18 Lu
DR CLO; CLO_0002247
DR CLDB; cl656
DR ATCC; CCL-205
DR BioSample; SAMN03471469
DR ECACC; 90112706
DR KCLB; 10205
RX PubMed=7065527;
CC Discontinued: KCLB; 10205; probable.
ST Source(s): ATCC; ECACC
ST Amelogenin: X
ST CSF1PO: 8
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 8
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2379 ! CCD-18Co
SX Female
CA Finite cell line
//
ID CCD-19Lu
AC CVCL_2382
SY CCD 19Lu; CCD-19LU; CCD19Lu
DR BTO; BTO:0003862
DR CLO; CLO_0002248
DR CLO; CLO_0002310
DR EFO; EFO_0005363
DR CLDB; cl657
DR ATCC; CCL-210
DR BioSample; SAMN03471471
DR ChEMBL-Cells; CHEMBL3308347
DR ChEMBL-Targets; CHEMBL614538
DR ECACC; 90112708
DR GEO; GSM426287
DR KCLB; 10210
RX PubMed=7065527;
RX PubMed=19727395;
CC Omics: Transcriptome analysis.
CC Discontinued: ECACC; 90112708; probable.
CC Discontinued: KCLB; 10210; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U306 ! CCD-19Sk
SX Female
CA Finite cell line
//
ID CCD-19Sk
AC CVCL_U306
SY CCD-19SK
DR ATCC; CRL-1471
CC Discontinued: ATCC; CRL-1471; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2382 ! CCD-19Lu
SX Female
CA Finite cell line
//
ID CCD-1Sk
AC CVCL_Y307
DR ATCC; CRL-1445
CC Discontinued: ATCC; CRL-1445; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-21Sk
AC CVCL_Y118
DR ATCC; CRL-1467
CC Discontinued: ATCC; CRL-1467; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-25Lu
AC CVCL_2383
SY CCD 25Lu; CCD25Lu
DR BTO; BTO:0002646
DR CLO; CLO_0002249
DR CLO; CLO_0002311
DR EFO; EFO_0005364
DR CLDB; cl658
DR ATCC; CCL-215
DR BioSample; SAMN03471474
DR ECACC; 90112710
DR GEO; GSM426288
DR KCLB; 10215
RX PubMed=7065527;
RX PubMed=19727395;
CC Characteristics: Senesces at ~9 PDL.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 10215; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,14
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 6,7
ST TPOX: 11,12
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2384 ! CCD-25Sk
SX Male
CA Finite cell line
//
ID CCD-25Sk
AC CVCL_2384
SY CCD25SK; CCD25Sk
DR CLO; CLO_0002312
DR ATCC; CRL-1474
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,14
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 6,7
ST TPOX: 11,12
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2383 ! CCD-25Lu
SX Male
CA Finite cell line
//
ID CCD-27Sk
AC CVCL_2385
SY CCD-27SK; CCD27SK; CCD27Sk
DR BTO; BTO:0002647
DR CLO; CLO_0002313
DR ATCC; CRL-1475
DR BioSample; SAMN03471361
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 10,12
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 7,8
ST TPOX: 8,12
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-28Sk
AC CVCL_U307
SY CCD-28SK; CCD28Sk
DR ATCC; CRL-1477
DR BioSample; SAMN03471363
CC Discontinued: ATCC; CRL-1477; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 11
ST D5S818: 9,12
ST D7S820: 8,10
ST TH01: 7
ST TPOX: 9,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-29Lu
AC CVCL_2386
SY CCD29Lu
DR CLO; CLO_0002314
DR EFO; EFO_0005365
DR CLDB; cl661
DR ATCC; CRL-1478
DR BioSample; SAMN03471364
DR ECACC; 90110516
DR GEO; GSM426289
RX PubMed=7065527;
RX PubMed=19727395;
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12,13
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 8,9
ST TH01: 6,8
ST TPOX: 8,9
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-32Lu
AC CVCL_2387
SY CCD32Lu
DR CLO; CLO_0002315
DR CLDB; cl662
DR ATCC; CRL-1485
DR ECACC; 90110517
RX PubMed=7065527;
CC Discontinued: ATCC; CRL-1485; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2388 ! CCD-32Sk
SX Male
CA Finite cell line
//
ID CCD-32Sk
AC CVCL_2388
SY CCD-32SK; CCD-32sk; CCD32SK; CCD32Sk
DR CLO; CLO_0002316
DR ATCC; CRL-1489
DR BioSample; SAMN03471367
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 7,9.3
ST TPOX: 11,12
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2387 ! CCD-32Lu
SX Male
CA Finite cell line
//
ID CCD-33Co
AC CVCL_2389
DR CLO; CLO_0002317
DR ATCC; CRL-1539
DR IFO; IFO50483
ST Source(s): ATCC; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 11,13
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2390 ! CCD-33Lu
OI CVCL_U328 ! CCD-33Sk
SX Male
CA Finite cell line
//
ID CCD-33Lu
AC CVCL_2390
SY CCD33Lu
DR CLO; CLO_0002318
DR EFO; EFO_0005366
DR CLDB; cl664
DR ATCC; CRL-1490
DR BioSample; SAMN03471368
DR ECACC; 90110515
DR GEO; GSM426290
RX PubMed=7065527;
RX PubMed=19727395;
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 11,13
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2389 ! CCD-33Co
OI CVCL_U328 ! CCD-33Sk
SX Male
CA Finite cell line
//
ID CCD-33Sk
AC CVCL_U328
SY CCD-33SK; CCD33SK
DR ATCC; CRL-1493
CC Discontinued: ATCC; CRL-1493; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2389 ! CCD-33Co
OI CVCL_2390 ! CCD-33Lu
SX Male
CA Finite cell line
//
ID CCD-34Lu
AC CVCL_2391
DR CLO; CLO_0002319
DR CLDB; cl665
DR ATCC; CRL-1491
DR BioSample; SAMN03471369
DR ECACC; 90110514
RX PubMed=7065527;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 9,13
ST D16S539: 8,13
ST D5S818: 12
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2392 ! CCD-34Sk
SX Female
CA Finite cell line
//
ID CCD-34Sk
AC CVCL_2392
SY CCD-34SK; CCD34SK; CCD34Sk
DR CLO; CLO_0002320
DR ATCC; CRL-1497
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 9,13
ST D16S539: 8,13
ST D5S818: 12
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2391 ! CCD-34Lu
SX Female
CA Finite cell line
//
ID CCD-37Lu
AC CVCL_2393
SY CCD-37LU
DR CLO; CLO_0002321
DR CLDB; cl666
DR ATCC; CRL-1496
DR ECACC; 90110513
RX PubMed=7065527;
CC Discontinued: ATCC; CRL-1496; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-39Lu
AC CVCL_2394
DR CLO; CLO_0002322
DR CLDB; cl667
DR ATCC; CRL-1498
DR BioSample; SAMN03471370
DR ECACC; 90110512
RX PubMed=7065527;
ST Source(s): ATCC; ECACC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 9,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2395 ! CCD-39Sk
SX Female
CA Finite cell line
//
ID CCD-39Sk
AC CVCL_2395
SY CCD-39SK; CCD 39SK; CCD39SK
DR CLO; CLO_0002323
DR ATCC; CRL-1501
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 9,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2394 ! CCD-39Lu
SX Female
CA Finite cell line
//
ID CCD-41Sk
AC CVCL_U330
SY CCD-41SK
DR ATCC; CRL-1505
CC Discontinued: ATCC; CRL-1505; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-42Sk
AC CVCL_2396
SY CCD-42SK; CCD42SK
DR CLO; CLO_0002324
DR ATCC; CRL-1513
DR BioSample; SAMN03471373
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,13
ST D16S539: 9,11
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-43Sk
AC CVCL_2397
SY CCD-43SK
DR BTO; BTO:0003442
DR CLO; CLO_0002325
DR ATCC; CRL-1509
DR BioSample; SAMN03471372
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12,14
ST D13S317: 11,13
ST D16S539: 9,15
ST D5S818: 12,13
ST D7S820: 12,13
ST TH01: 7
ST TPOX: 8,11
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-45Sk
AC CVCL_U296
SY CCD-45SK; CCD45SK
DR ATCC; CRL-1506
CC Discontinued: ATCC; CRL-1506; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-48Sk
AC CVCL_U297
SY CCD48Sk
DR ATCC; CRL-1507
CC Discontinued: ATCC; CRL-1507; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-50Sk
AC CVCL_U298
SY CCD-50SK
DR ATCC; CRL-1508
CC Discontinued: ATCC; CRL-1508; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-55Sk
AC CVCL_U331
SY CCD55SK
DR ATCC; CRL-1510
CC Discontinued: ATCC; CRL-1510; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-57Sk
AC CVCL_Y119
DR ATCC; CRL-1517
CC Discontinued: ATCC; CRL-1517; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-76Sk
AC CVCL_Y120
DR ATCC; CRL-1521
CC Discontinued: ATCC; CRL-1521; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-82Sk
AC CVCL_Y121
DR ATCC; CRL-1527
CC Discontinued: ATCC; CRL-1527; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-841CoN
AC CVCL_2871
SY CCD 841 CoN; CCD841CoN; CCD-841-CoN
DR BTO; BTO:0003171
DR CLO; CLO_0002250
DR ATCC; CRL-1790
DR BioSample; SAMN01821544
DR BioSample; SAMN01821726
DR BioSample; SAMN03471420
DR Cosmic; 1609509
DR IFO; IFO50482
WW http://www.atcc.org/support/faqs/e5a33/Lifetime%20of%20ATCC%20CRL-1790-463.aspx
CC Discontinued: IFO; IFO50482; true.
ST Source(s): ATCC; JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 7,8
ST TPOX: 9,10
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2872 ! CCD-841CoTr
SX Female
CA Finite cell line
//
ID CCD-841CoTr
AC CVCL_2872
SY CCD 841 CoTr; CCD841CoTr; CCD-841-CoTr
DR CLO; CLO_0002251
DR ATCC; CRL-1807
CC Characteristics: Pentaploid cell line; the karyology is very different from that of the parental cell line.
CC Characteristics: Exhibits the transformed phenotype at the permissive temperature (33 Celsius).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [ts].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 7,8
ST TPOX: 9,10
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2871 ! CCD-841CoN
SX Female
CA Transformed cell line
//
ID CCD-860Sk
AC CVCL_0E39
DR ATCC; CRL-1782
CC Discontinued: ATCC; CRL-1782; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-862Sk
AC CVCL_0E40
SY CCD-862SK
DR ATCC; CRL-1784
CC Discontinued: ATCC; CRL-1784; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-864Sk
AC CVCL_0E41
DR ATCC; CRL-1791
CC Discontinued: ATCC; CRL-1791; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-866Sk
AC CVCL_0E42
SY CCD-866SK
DR ATCC; CRL-1792
CC Discontinued: ATCC; CRL-1792; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-8Lu
AC CVCL_2398
SY CCD 8Lu; CCD8Lu
DR BTO; BTO:0002645
DR CLO; CLO_0002252
DR CLO; CLO_0002326
DR EFO; EFO_0005367
DR CLDB; cl659
DR ATCC; CCL-201
DR BioSample; SAMN03471465
DR ECACC; 90112705
DR GEO; GSM426283
RX PubMed=7065527;
RX PubMed=19727395;
CC Omics: Transcriptome analysis.
CC Discontinued: ECACC; 90112705; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 10,11
ST D5S818: 13
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 8,9
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-919Sk
AC CVCL_U266
SY CCD-919SK; CCD-919 Sk
DR ATCC; CRL-1826
DR BioSample; SAMN03471251
CC Discontinued: ATCC; CRL-1826; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12,14
ST D16S539: 12
ST D5S818: 10,11
ST D7S820: 7,11
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-922Sk
AC CVCL_0E43
SY CCD-922SK; CCD 922SK; CCD922SK
DR ATCC; CRL-1828
CC Discontinued: ATCC; CRL-1828; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-944Sk
AC CVCL_2399
SY CCD-944SK; CCD 944SK
DR CLO; CLO_0002327
DR ATCC; CRL-1836
DR BioSample; SAMN03471254
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 12
ST D5S818: 10,11
ST D7S820: 7,10
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-965Sk
AC CVCL_0F53
SY CCD-965SK; CCD 965 SK; CCD965Sk
DR ATCC; CRL-1876
CC Discontinued: ATCC; CRL-1876; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-966Sk
AC CVCL_U267
SY CCD-966SK; CCD 966SK; CCD 966 SK; CCD966SK
DR ATCC; CRL-1881
DR BCRC; 60153
DR BioSample; SAMN03471257
CC Discontinued: ATCC; CRL-1881; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 12,13
ST D7S820: 10
ST TH01: 7,8
ST TPOX: 9,11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-967Sk
AC CVCL_0F54
DR ATCC; CRL-1884
DR BioSample; SAMN03471258
CC Discontinued: ATCC; CRL-1884; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 7,8
ST D13S317: 11,12
ST D16S539: 10,13
ST D5S818: 9,12
ST D7S820: 10,13
ST TH01: 9,9.3
ST TPOX: 11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-969Sk
AC CVCL_0F55
SY CCD-969sk; CCD969SK
DR ATCC; CRL-1885
DR BioSample; SAMN03471259
CC Discontinued: ATCC; CRL-1885; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 9,11
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 6,9.3
ST TPOX: 6,8
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-973Sk
AC CVCL_0F60
DR ATCC; CRL-1892
DR BioSample; SAMN03471260
CC Discontinued: ATCC; CRL-1892; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 8,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-974Sk
AC CVCL_U295
SY CCD-974SK; CCD 974 SK
DR ATCC; CRL-1906
CC Discontinued: ATCC; CRL-1906; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-976Sk
AC CVCL_0F61
SY CCD-976SK; CCD 976Sk
DR ATCC; CRL-1904
CC Discontinued: ATCC; CRL-1904; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-977Sk
AC CVCL_0E73
DR ATCC; CRL-1900
DR BioSample; SAMN03471262
CC Discontinued: ATCC; CRL-1900; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 11
ST D7S820: 7,11
ST TH01: 7
ST TPOX: 8
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-978Sk
AC CVCL_0E74
DR ATCC; CRL-1905
DR BioSample; SAMN03471263
CC Discontinued: ATCC; CRL-1905; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 9,12
ST D16S539: 8,11
ST D5S818: 10,12
ST D7S820: 9,11
ST TH01: 8,9
ST TPOX: 11,12
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CCD-986Sk
AC CVCL_2400
SY CCD-986SK; CCD 986 SK; CCD986SK
DR BTO; BTO:0005133
DR CLO; CLO_0002328
DR ATCC; CRL-1947
DR BioSample; SAMN03472815
DR KCLB; 21947
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 9,12
ST D16S539: 8
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 10,11
ST FGA: 21,26
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CCD-IC
AC CVCL_4676
SY Cortical Collecting Ducts-Immortalized Cells
DR CLO; CLO_0050252
DR RCB; RCB1911
RX PubMed=7966244;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Male
CA Transformed cell line
//
ID CCE
AC CVCL_C313
SY EK; EK.CCE
DR BTO; BTO:0003560
RX PubMed=7242681;
CC Breed/subspecies: 129S/SvEv-Gpi1
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID CCE1
AC CVCL_Z191
DR TCB; 3151
RX PubMed=17662657;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
CC Group: Tick cell line.
OX NCBI_TaxID=176285; ! Carios capensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCE1.1
AC CVCL_HL96
SY ConCordant Epilepsy 1.1
DR GEO; GSM181381
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCE1.2 (CVCL_HL97).
DI NCIt; C128189; Childhood absence epilepsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CCE1.2
AC CVCL_HL97
SY ConCordant Epilepsy 1.2
DR GEO; GSM181382
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCE1.1 (CVCL_HL96).
DI NCIt; C128189; Childhood absence epilepsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CCE2
AC CVCL_Z192
RX PubMed=17662657;
RX PubMed=18047211;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
CC Group: Tick cell line.
OX NCBI_TaxID=176285; ! Carios capensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCE2.1
AC CVCL_HL98
SY ConCordant Epilepsy 2.1
DR GEO; GSM181384
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCE2.2 (CVCL_HL99).
DI NCIt; C128189; Childhood absence epilepsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CCE2.2
AC CVCL_HL99
SY ConCordant Epilepsy 2.2
DR GEO; GSM181385
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCE2.1 (CVCL_HL98).
DI NCIt; C128189; Childhood absence epilepsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CCE3
AC CVCL_Z193
RX PubMed=17662657;
RX PubMed=18047211;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
CC Group: Tick cell line.
OX NCBI_TaxID=176285; ! Carios capensis
SX Female
CA Spontaneously immortalized cell line
//
ID CCE3.1
AC CVCL_HM00
SY ConCordant Epilepsy 3.1
DR GEO; GSM181389
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCE3.2 (CVCL_HM01).
DI NCIt; C128189; Childhood absence epilepsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCE3.2
AC CVCL_HM01
SY ConCordant Epilepsy 3.2
DR GEO; GSM181390
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCE3.1 (CVCL_HM00).
DI NCIt; C128189; Childhood absence epilepsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCE4.1
AC CVCL_HM02
SY ConCordant Epilepsy 4.1
DR GEO; GSM181391
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCE4.2 (CVCL_HM03).
DI NCIt; C128189; Childhood absence epilepsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCE4.2
AC CVCL_HM03
SY ConCordant Epilepsy 4.2
DR GEO; GSM181392
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCE4.1 (CVCL_HM02).
DI NCIt; C128189; Childhood absence epilepsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCE5
AC CVCL_Z194
RX PubMed=17662657;
CC Group: Tick cell line.
OX NCBI_TaxID=176285; ! Carios capensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCES
AC CVCL_Z509
RX PubMed=21039493;
CC Group: Fish cell line.
OX NCBI_TaxID=72446; ! Gibelion catla
SX Sex undetermined
CA Embryonic stem cell
//
ID CCf
AC CVCL_T716
SY Channel Catfish Fin
RX PubMed=22358545;
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCF [Carp fin China]
AC CVCL_R837
SY Cyprinus Carpio Fin
RX DOI=10.1007/BF01404746;
CC Group: Fish cell line.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCF [Carp fin India]
AC CVCL_1H03
SY Cyprinus Carpio Fin
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=4
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC004.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCF-K104
AC CVCL_X184
RX PubMed=24820532;
CC Group: Fish cell line.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCF-RC1
AC CVCL_9703
RX PubMed=2582448;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9704 ! CCF-RC2
SX Male
CA Cancer cell line
//
ID CCF-RC2
AC CVCL_9704
RX PubMed=2582448;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9703 ! CCF-RC1
SX Male
CA Cancer cell line
//
ID CCF-STTG1
AC CVCL_1118
SY CCFSTTG1
DR BTO; BTO:0003863
DR CLO; CLO_0002329
DR EFO; EFO_0002127
DR CLDB; cl669
DR CLDB; cl5177
DR ATCC; CRL-1718
DR BioSample; SAMN01821545
DR BioSample; SAMN03470976
DR CCLE; CCFSTTG1_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3308795
DR ChEMBL-Targets; CHEMBL1075419
DR CLS; 300388/p721_CCF-STTG1
DR Cosmic; 687565
DR Cosmic; 849857
DR Cosmic; 897441
DR Cosmic; 906823
DR Cosmic; 920820
DR Cosmic; 1175808
DR Cosmic; 1610750
DR Cosmic; 1746959
DR Cosmic; 2302324
DR Cosmic; 2367511
DR Cosmic-CLP; 906823
DR ECACC; 90021502
DR GDSC; 906823
DR GEO; GSM326233
DR GEO; GSM886923
DR GEO; GSM887989
DR GEO; GSM1374443
DR GEO; GSM1669668
DR IGRhCellID; CCFSTTG1
DR IZSLER; BS TCL 125
DR PRIDE; PXD003914
DR RCB; RCB1977
RX PubMed=19435942;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC Characteristics: Has no IDH1 mutation.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; RCB1977; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 11,12
ST D18S51: 15
ST D19S433: 15.2,16
ST D21S11: 28,29
ST D2S1338: 20,26
ST D3S1358: 16,17
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 20,22
ST Penta D: 11,13
ST Penta E: 10
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCG
AC CVCL_R838
SY Cyprinus Carpio Gill
RX DOI=10.1007/BF01404746;
CC Group: Fish cell line.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCK-81
AC CVCL_2873
SY CCK81
DR BioSample; SAMN03471656
DR CCLE; CCK81_LARGE_INTESTINE
DR Cosmic; 1187301
DR Cosmic; 2301965
DR Cosmic-CLP; 1240123
DR GDSC; 1240123
DR GEO; GSM827260
DR GEO; GSM886924
DR GEO; GSM887990
DR GEO; GSM1346831
DR GEO; GSM1374444
DR GEO; GSM1448097
DR GEO; GSM1669669
DR JCRB; JCRB0208
RX PubMed=7418977;
RX PubMed=9290701;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25926053;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Instable (MSI-high) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 9,12,13
ST D16S539: 9,10
ST D5S818: 11,12,13
ST D7S820: 8,8.1,10.3
ST TH01: 6,8
ST TPOX: 9,11
ST vWA: 14,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCK061
AC CVCL_J949
DR CLO; CLO_0002330
DR ATCC; HB-8786
RX Patent=EP0200464B1;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CCKF
AC CVCL_1G73
SY Cyprinus Carpio Koi Fin; KCF
RX PubMed=25990269;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=7
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC007.
CC Breed/subspecies: Koi.
OX NCBI_TaxID=1045269; ! Cyprinus carpio haematopterus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCL16-B1
AC CVCL_U437
SY B1
RX PubMed=9298714;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_3472 ! Don
SX Male
CA Spontaneously immortalized cell line
//
ID CCL16-B10
AC CVCL_U438
RX PubMed=1027147;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_3472 ! Don
SX Male
CA Spontaneously immortalized cell line
//
ID CCL16-B11
AC CVCL_U439
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_U438 ! CCL16-B10
SX Male
CA Spontaneously immortalized cell line
//
ID CCL16-B2
AC CVCL_U440
SY B2
RX PubMed=483122;
RX PubMed=947896;
RX PubMed=1027147;
RX PubMed=9298714;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_U437 ! CCL16-B1
SX Male
CA Spontaneously immortalized cell line
//
ID CCL16-B9
AC CVCL_U441
SY CCL-16-B9; B9
RX PubMed=483122;
RX PubMed=558831;
RX PubMed=1027147;
RX PubMed=7592812;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-181.html
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_U440 ! CCL16-B2
SX Male
CA Spontaneously immortalized cell line
//
ID CCL3
AC CVCL_M023
DR BioSample; SAMN03152003
RX PubMed=19050584;
RX PubMed=21253487;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be a chordoma cell line of human origin but found to be from mouse (PubMed=21253487).
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Undefined cell line type
//
ID CCL4
AC CVCL_M024
RX PubMed=18091487;
RX PubMed=21253487;
CC Problematic cell line: Misidentified. Originally thought to be a chordoma cell line but is either contaminated or established from nonchordoma cells (PubMed=21253487).
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CCM
AC CVCL_R825
SY Catla Catla Macrophage
RX PubMed=22678754;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=34
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC034.
OX NCBI_TaxID=72446; ! Gibelion catla
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CCN1.1
AC CVCL_HM14
DR GEO; GSM181395
DR GEO; GSM181399
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCN1.2 (CVCL_HM15).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCN1.2
AC CVCL_HM15
DR GEO; GSM181396
DR GEO; GSM181400
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCN1.1 (CVCL_HM14).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCN2.1
AC CVCL_HM16
DR GEO; GSM181405
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCN2.2 (CVCL_HM17).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCN2.2
AC CVCL_HM17
DR GEO; GSM181406
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCN2.1 (CVCL_HM16).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCN3.1
AC CVCL_HM18
DR GEO; GSM181409
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCN3.2 (CVCL_HM19).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCN3.2
AC CVCL_HM19
DR GEO; GSM181410
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCN3.1 (CVCL_HM18).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCN4.1
AC CVCL_HM20
DR GEO; GSM181412
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCN4.2 (CVCL_HM21).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CCN4.2
AC CVCL_HM21
DR GEO; GSM181413
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCN4.1 (CVCL_HM20).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CCN5.1
AC CVCL_HM22
DR GEO; GSM181416
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCN5.2 (CVCL_HM23).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CCN5.2
AC CVCL_HM23
DR GEO; GSM181417
RX PubMed=18435749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Established from monozygotic twin of CCN5.1 (CVCL_HM22).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CCO
AC CVCL_4142
SY Channel Catfish Ovary
DR CLO; CLO_0002332
DR CLDB; cl671
DR ATCC; CRL-2748
DR ATCC; CRL-2772
DR ECACC; 95060212
RX DOI=10.3147/jsfp.28.27;
RX PubMed=7390534;
RX PubMed=24993608;
CC Group: Fish cell line.
CC Doubling time: 12 hours (ECACC).
CC Discontinued: ATCC; CRL-2748; true.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
SX Female
CA Spontaneously immortalized cell line
//
ID CCO7
AC CVCL_D879
SY CC07; Cco-7
DR Cosmic; 1312297
CC From: Bodmer W.F.; International Cancer Research Fund; London; UK.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CCP-2
AC CVCL_4566
DR BTO; BTO:0002000
DR CLO; CLO_0050274
DR RCB; RCB1528
RX PubMed=11456411;
RX PubMed=12172786;
CC Transformant: Coculture with X-ray irradiated hamster chondrocytes.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_4567 ! CCP-7
OI CVCL_4568 ! CCP-8
CA Transformed cell line
//
ID CCP-7
AC CVCL_4567
DR BTO; BTO:0002002
DR CLO; CLO_0050273
DR RCB; RCB1530
RX PubMed=11456411;
RX PubMed=12172786;
CC Transformant: Coculture with X-ray irradiated hamster chondrocytes.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_4566 ! CCP-2
OI CVCL_4568 ! CCP-8
CA Transformed cell line
//
ID CCP-8
AC CVCL_4568
DR BTO; BTO:0002001
DR CLO; CLO_0050275
DR RCB; RCB1531
RX PubMed=11456411;
RX PubMed=12172786;
CC Transformant: Coculture with X-ray irradiated hamster chondrocytes.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_4566 ! CCP-2
OI CVCL_4567 ! CCP-7
CA Transformed cell line
//
ID CCR5
AC CVCL_V322
RX PubMed=2073461;
CC Selected for resistance to: ChEBI; CHEBI:48775; Cadmium(2+).
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_9126 ! DM87
SX Male
CA Spontaneously immortalized cell line
//
ID CCRF S-180 II
AC CVCL_2874
SY CCRF S 180 II; S-180 II; CCRF S-180; S-180; S180; Sarcoma-180; Sarcoma 180; CCRF-180II
DR BTO; BTO:0001197
DR CLO; CLO_0002333
DR CLDB; cl672
DR CLDB; cl673
DR ATCC; CCL-8
DR BCRC; 60337
DR BCRJ; 0314
DR BCRJ; 0320
DR CCRID; 3111C0001CCC000319
DR CCRID; 3131C0001000800015
DR CCRID; 3142C0001000000055
DR ChEMBL-Cells; CHEMBL3307278
DR ChEMBL-Targets; CHEMBL612567
DR ChEMBL-Targets; CHEMBL614027
DR ECACC; 90011901
DR IZSLER; BS TCL 13
DR JCRB; JCRB9089
DR KCLB; 10008
DR TKG; TKG 0173
DR Wikidata; Q7388195
RX PubMed=1546443;
RX PubMed=13823721;
RX PubMed=14221803;
WW https://en.wikipedia.org/wiki/S180
CC Breed/subspecies: Swiss Webster (CFW).
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID CCRF-6
AC CVCL_6G39
RX PubMed=6244232;
RX PubMed=13823721;
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CCRF-CEM
AC CVCL_0207
SY CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671
DR BTO; BTO:0000225
DR BTO; BTO:0000736
DR CLO; CLO_0002334
DR CLO; CLO_0015478
DR CLO; CLO_0050143
DR EFO; EFO_0002128
DR MCCL; MCC:0000096
DR MCCL; MCC:0000097
DR CLDB; cl675
DR CLDB; cl676
DR CLDB; cl677
DR ATCC; CCL-119
DR ATCC; CRM-CCL-119
DR ATCC; CRL-7916
DR ATCC; CRL-8436
DR BCRC; 60137
DR BCRJ; 0063
DR BioSample; SAMN01821675
DR BioSample; SAMN03471121
DR BioSample; SAMN03471203
DR BioSample; SAMN03472050
DR BioSample; SAMN03472700
DR BioSample; SAMN03472808
DR BioSample; SAMN03473385
DR CCRID; 3131C0001000700129
DR CCRID; 3131C0001000700147
DR ChEMBL-Cells; CHEMBL3307641
DR ChEMBL-Cells; CHEMBL3307510
DR ChEMBL-Targets; CHEMBL382
DR ChEMBL-Targets; CHEMBL393
DR ChEMBL-Targets; CHEMBL614028
DR CLS; 300147/p752_CCRF-CEM
DR Coriell; GM03671
DR Cosmic; 683716
DR Cosmic; 721708
DR Cosmic; 801728
DR Cosmic; 846384
DR Cosmic; 850198
DR Cosmic; 875863
DR Cosmic; 897449
DR Cosmic; 905952
DR Cosmic; 913411
DR Cosmic; 919157
DR Cosmic; 922674
DR Cosmic; 932765
DR Cosmic; 933544
DR Cosmic; 974251
DR Cosmic; 1012060
DR Cosmic; 1037690
DR Cosmic; 1044252
DR Cosmic; 1070703
DR Cosmic; 1071876
DR Cosmic; 1092595
DR Cosmic; 1115588
DR Cosmic; 1118462
DR Cosmic; 1127261
DR Cosmic; 1151774
DR Cosmic; 1175854
DR Cosmic; 1176599
DR Cosmic; 1191691
DR Cosmic; 1224367
DR Cosmic; 1226857
DR Cosmic; 1247870
DR Cosmic; 1281365
DR Cosmic; 1305336
DR Cosmic; 1330503
DR Cosmic; 1375587
DR Cosmic; 1483363
DR Cosmic; 1509201
DR Cosmic; 1523831
DR Cosmic; 1524793
DR Cosmic; 1639635
DR Cosmic; 1664520
DR Cosmic; 1760519
DR Cosmic; 1998437
DR Cosmic; 2165706
DR Cosmic; 2301560
DR Cosmic; 2361364
DR Cosmic; 2433754
DR Cosmic; 2458763
DR Cosmic; 2462863
DR Cosmic-CLP; 905952
DR DSMZ; ACC-240
DR ECACC; 85112105
DR GDSC; 905952
DR GEO; GSM50193
DR GEO; GSM50257
DR GEO; GSM236780
DR GEO; GSM236816
DR GEO; GSM750806
DR GEO; GSM799345
DR GEO; GSM799408
DR GEO; GSM1153416
DR GEO; GSM1181330
DR GEO; GSM1181347
DR GEO; GSM1374445
DR GEO; GSM1669670
DR IFO; IFO50412
DR IGRhCellID; CCRFCEM
DR IMGT/HLA; 10403
DR IZSLER; BS TCL 11
DR JCRB; JCRB0033
DR JCRB; JCRB9023
DR KCLB; 10119
DR Lonza; 647
DR NCBI_Iran; C105
DR RCB; RCB1980
DR SKY/M-FISH/CGH; 2784
DR TKG; TKG 0563
RX CelloPub=CLPUB00158;
RX PubMed=2041050;
RX PubMed=3495441;
RX PubMed=6582512;
RX PubMed=6600440;
RX PubMed=8547074;
RX PubMed=9290701;
RX PubMed=9557624;
RX PubMed=9685479;
RX PubMed=9738977;
RX PubMed=9933131;
RX PubMed=10071127;
RX PubMed=16408098;
RX PubMed=17088437;
RX PubMed=17117183;
RX PubMed=19372543;
RX PubMed=22675565;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=29
WW http://www.addexbio.com/productdetail?pid=32
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-12.html
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0005&theme=default
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 26.7 hours (DTP); ~24-30 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7916; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; PubMed=19372543; RCB
ST Amelogenin: X
ST CSF1PO: 10,11 (ATCC_CCL-119; Cosmic-CLP; JCRB_IFO50412_JCRB9023; KCLB)
ST CSF1PO: 10,13 (ATCC_CRL-8436; CLS; DSMZ)
ST CSF1PO: 11 (ECACC; JCRB_JCRB0033; PubMed=19372543)
ST CSF1PO: 9,10,11 (RCB)
ST D13S317: 11,12 (ATCC_CCL-119; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=19372543)
ST D13S317: 11 (ATCC_CRL-8436; CLS; DSMZ)
ST D13S317: 10,11,12 (RCB)
ST D16S539: 10,13 (ATCC_CCL-119; ATCC_CRL-8436; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=19372543)
ST D16S539: 10,13,14 (RCB)
ST D18S51: 13,18
ST D19S433: 14,15
ST D21S11: 30,33.2,34.2 (CLS)
ST D21S11: 30,33.2 (PubMed=19372543)
ST D2S1338: 24
ST D3S1358: 14,15,16 (CLS)
ST D3S1358: 14,15 (KCLB)
ST D3S1358: 15 (PubMed=19372543)
ST D5S818: 12,13 (ATCC_CCL-119; ATCC_CRL-8436; CLS; DSMZ; ECACC; KCLB; PubMed=19372543; RCB)
ST D5S818: 12,13,14 (Cosmic-CLP)
ST D7S820: 9,13 (ATCC_CCL-119; ATCC_CRL-8436; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB_IFO50412_JCRB9023; KCLB; PubMed=19372543; RCB)
ST D7S820: 9,12 (JCRB_JCRB0033)
ST D8S1179: 12,13 (CLS)
ST D8S1179: 13 (PubMed=19372543)
ST FGA: 23,24,25 (CLS)
ST FGA: 23,24 (PubMed=19372543)
ST Penta D: 10,11
ST Penta E: 5,14
ST TH01: 6,7
ST TPOX: 8 (ATCC_CCL-119; ATCC_CRL-8436; Cosmic-CLP; ECACC; JCRB; KCLB; RCB; PubMed=19372543)
ST TPOX: 7,8 (CLS; DSMZ)
ST vWA: 17,19 (ATCC_CCL-119; ATCC_CRL-8436; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; PubMed=19372543)
ST vWA: 17,18,19,20 (CLS)
ST vWA: 18,19 (RCB)
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CCRF-CEM C7
AC CVCL_6825
SY CCRF/CEM-C7; CEM-C7; CEM C7; CEMC7; CEM clone 7
DR Lonza; 240
RX PubMed=269011;
RX PubMed=3871171;
RX PubMed=6965106;
RX PubMed=7812967;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM C7A
AC CVCL_6826
SY CEM-C7A; CEMC7A
DR Lonza; 1047
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6825 ! CCRF-CEM C7
SX Female
CA Cancer cell line
//
ID CCRF-CEM C7H2
AC CVCL_EP75
SY CCRF-CEM-C7H2; CEM-C7H2; CEM-C7.H2; CEM-C7-H2; CEMC7H2; C7H2
DR GEO; GSM286229
DR GEO; GSM286230
DR GEO; GSM286231
DR GEO; GSM286232
DR GEO; GSM286233
DR GEO; GSM286234
DR GEO; GSM286235
DR GEO; GSM286236
DR GEO; GSM286237
DR GEO; GSM286238
DR GEO; GSM286239
DR GEO; GSM286240
RX PubMed=7812967;
RX PubMed=8895760;
RX PubMed=10467407;
RX PubMed=15637111;
ST Source(s): PubMed=15637111
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 10,13
ST D18S51: 13,17
ST D21S11: 30,33.2
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 9,12
ST D8S1179: 13
ST FGA: 23
ST Penta D: 11
ST Penta E: 5,14
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6825 ! CCRF-CEM C7
SX Female
CA Cancer cell line
//
ID CCRF-CEM C7H2-2C8
AC CVCL_EP76
SY CCRF-CEM-C7H2-2C8; CEM-C7H2-2C8; C7H2-2C8; CEMC7H2pEFrtTA-2C8
RX PubMed=10467407;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EP75 ! CCRF-CEM C7H2
SX Female
CA Cancer cell line
//
ID CCRF-CEM R3/7
AC CVCL_V324
RX PubMed=2450647;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM R30/6
AC CVCL_V323
RX PubMed=2450647;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM R30dm
AC CVCL_V325
SY R30dm-CCRF-CEM; R30dm
DR ChEMBL-Cells; CHEMBL3307546
DR ChEMBL-Targets; CHEMBL614143
RX PubMed=2007575;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V323 ! CCRF-CEM R30/6
SX Female
CA Cancer cell line
//
ID CCRF-CEM/HU-R
AC CVCL_5H79
SY CEM/HUR90; HU-R
RX PubMed=10037195;
RX PubMed=12482398;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM/MTX R1
AC CVCL_5H80
SY CEM/MTX R1; CEM/MTXR1
RX PubMed=2754745;
RX PubMed=12482398;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM/MTX R2
AC CVCL_5H81
SY CEM/MTX R2; CEM/MTXR2
RX PubMed=2754745;
RX PubMed=12482398;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM/MTX R3
AC CVCL_5H82
SY CEM/MTX R3; CEM/MTXR3
RX PubMed=2754745;
RX PubMed=12482398;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM/MTX140-LV
AC CVCL_5H83
SY CEM/MTX140LV
RX PubMed=9369939;
RX PubMed=12482398;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM/MTX1500-LV
AC CVCL_5H84
SY CEM/MTX1500LV
RX PubMed=9369939;
RX PubMed=12482398;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM/MTX5000-PGA
AC CVCL_5H85
SY CEM/MTX5000PGA
RX PubMed=9369939;
RX PubMed=12482398;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM/MTX60-PGA
AC CVCL_5H86
SY CEM/MTX60PGA
RX PubMed=9369939;
RX PubMed=12482398;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM/R1
AC CVCL_S649
SY R1-CCRF-CEM
DR ChEMBL-Cells; CHEMBL3307611
DR ChEMBL-Targets; CHEMBL614384
RX CelloPub=CLPUB00028;
RX PubMed=3855284;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-CEM/R2
AC CVCL_S650
SY R2-CCRF-CEM
DR ChEMBL-Cells; CHEMBL3307764
DR ChEMBL-Targets; CHEMBL613523
RX PubMed=3855284;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S649 ! CCRF-CEM/R1
SX Female
CA Cancer cell line
//
ID CCRF-CEM/R3
AC CVCL_S651
SY CEM/MTX
RX PubMed=3855284;
RX PubMed=6929188;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF-HSB-2
AC CVCL_1859
AS CVCL_5938
SY CCRF HSB-2; CCRF-HSB2; HSB-2; HSB2; H-SB2; HSB; GM04155
DR BTO; BTO:0005370
DR CLO; CLO_0002335
DR CLO; CLO_0004258
DR CLO; CLO_0016177
DR CLO; CLO_0050971
DR CLDB; cl678
DR ATCC; CCL-120.1
DR BioSample; SAMN03472334
DR BioSample; SAMN03472701
DR BioSample; SAMN03473542
DR ChEMBL-Cells; CHEMBL3307642
DR ChEMBL-Targets; CHEMBL614541
DR CLS; 300214/p639_HSB
DR Coriell; GM04155
DR Cosmic; 683532
DR Cosmic; 801729
DR Cosmic; 850195
DR Cosmic; 913416
DR Cosmic; 922679
DR Cosmic; 932768
DR Cosmic; 996307
DR Cosmic; 998723
DR Cosmic; 1037688
DR Cosmic; 1115591
DR Cosmic; 1175128
DR Cosmic; 1226856
DR Cosmic; 1281369
DR Cosmic; 1330497
DR Cosmic; 1524797
DR Cosmic; 1641390
DR Cosmic; 1760523
DR Cosmic; 2165712
DR Cosmic; 2361365
DR Cosmic; 2458762
DR Cosmic; 2462861
DR DSMZ; ACC-435
DR ECACC; 85112801
DR IZSLER; BS TCL 185
DR JCRB; JCRB0031
DR KCLB; 10120.1
DR NCBI_Iran; C530
DR NIH-ARP; 497-277
DR RCB; RCB0016
RX PubMed=3495441;
RX PubMed=4523807;
RX PubMed=6582512;
RX PubMed=6600440;
RX PubMed=8316623;
RX PubMed=8547074;
RX PubMed=9933131;
RX PubMed=17117183;
RX PubMed=22675565;
CC Doubling time: ~25 hours (DSMZ).
CC Misspelling: 'CCRF-HBS-2' in NCBI_Iran C530.
ST Source(s): ATCC; CLS; DSMZ; ECACC; JCRB; KCLB; RCB
ST Amelogenin: X,Y (ATCC; DSMZ; ECACC; JCRB; KCLB; RCB)
ST Amelogenin: X (CLS)
ST CSF1PO: 10,12 (ATCC; ECACC; JCRB; KCLB; RCB)
ST CSF1PO: 8,12 (CLS)
ST CSF1PO: 10,11 (DSMZ)
ST D13S317: 10,12
ST D16S539: 9,13 (ATCC; ECACC; JCRB; RCB)
ST D16S539: 9,13,14 (CLS)
ST D16S539: 9,12 (DSMZ)
ST D18S51: 9,13,14
ST D21S11: 28,29
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 11,12 (ATCC; DSMZ; ECACC; JCRB; KCLB; RCB)
ST D7S820: 10,14 (CLS)
ST D8S1179: 9,15
ST FGA: 22,23,24 (CLS)
ST FGA: 24,25 (KCLB)
ST Penta D: 9
ST Penta E: 6,13
ST TH01: 9,10 (ATCC; DSMZ; ECACC; JCRB; RCB)
ST TH01: 8,10 (CLS)
ST TH01: 9,9.3 (KCLB)
ST TPOX: 8
ST vWA: 18,19 (ATCC; DSMZ; ECACC; JCRB; KCLB)
ST vWA: 18,19,20 (CLS; RCB)
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1860 ! CCRF-SB
SX Male
CA Cancer cell line
//
ID CCRF-RKB
AC CVCL_IQ35
RX PubMed=4927348;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34726; Infectious mononucleosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CCRF-SB
AC CVCL_1860
SY CCRF SB; SB; GM04154
DR CLO; CLO_0002336
DR CLO; CLO_0016198
DR EFO; EFO_0006550
DR CLDB; cl679
DR CLDB; cl680
DR CLDB; cl681
DR BioSample; SAMN03471043
DR BioSample; SAMN03472769
DR ChEMBL-Cells; CHEMBL3307643
DR ChEMBL-Targets; CHEMBL614542
DR Coriell; GM04154
DR Cosmic; 683533
DR Cosmic; 2301562
DR ATCC; CCL-120
DR ECACC; 89090405
DR IFO; IFO50026
DR IGRhCellID; CCRFSB
DR IZSLER; BS TCL 12
DR JCRB; JCRB0032
RX PubMed=4523807;
RX PubMed=8316623;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): ATCC; JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,12
ST D16S539: 13 (JCRB)
ST D16S539: 9,13 (ATCC; PubMed=25877200)
ST D18S51: 9,14
ST D21S11: 27,28
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 9,15
ST FGA: 25
ST Penta D: 9,12
ST Penta E: 6,13
ST TH01: 9,10
ST TPOX: 8
ST vWA: 18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1859 ! CCRF-HSB-2
SX Male
CA Cancer cell line
//
ID CCRF/ACTD400
AC CVCL_D545
SY CCRF ACTD400; CCRF-ACTD400; ACTD400
RX PubMed=1698543;
CC Selected for resistance to: ChEBI; CHEBI:27666; Actinomycin D (ActD).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF/ADR5000
AC CVCL_D544
SY CCRF ADR5000; CCRF-ADR5000; CEM/ADR5000; CEM/ADR 5000; CEM-ADR5000; CEM ADR5000; ADR5000
DR BTO; BTO:0005199
DR ChEMBL-Cells; CHEMBL3307900
DR ChEMBL-Targets; CHEMBL614266
RX PubMed=1698543;
RX PubMed=12482398;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF/CEM/ara-C/3A
AC CVCL_4V17
RX PubMed=7805176;
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF/CEM/ara-C/7A
AC CVCL_4V18
SY CEM/ara-C/7A
RX PubMed=7805176;
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRF/VCR1000
AC CVCL_D546
SY CCRF VCR1000; CCRF-VCR 1000; CCRF VCR 1000; CCRF-CEM/VCR-1000; CEM-VCR 1000; CEM/VCR1000; VCR1000
DR ChEMBL-Cells; CHEMBL3307393
DR ChEMBL-Targets; CHEMBL614540
RX PubMed=1698543;
RX PubMed=12482398;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CCRM-hESC-22
AC CVCL_9T84
RX PubMed=23564289;
CC From: Center of Clinical Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University; Nanjing; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CCRM-hESC-23
AC CVCL_9T85
RX PubMed=23564289;
CC From: Center of Clinical Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University; Nanjing; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CCRM8
AC CVCL_9T86
SY Center of Clinical Reproductive Medicine 8
RX PubMed=26522100;
CC From: Center of Clinical Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University; Nanjing; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CCS292
AC CVCL_0J30
RX PubMed=16766266;
DI NCIt; C3745; Clear cell sarcoma of soft tissue
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CCT [Carp]
AC CVCL_R839
SY Cyprinus Carpio Testis
RX DOI=10.1007/BF01404746;
CC Group: Fish cell line.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Male
CA Spontaneously immortalized cell line
//
ID CCT [Dog]
AC CVCL_L312
RX PubMed=12867736;
CC Breed/subspecies: Borzoi.
DI NCIt; C128125; Canine histiocytic sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CCTL 10
AC CVCL_C857
SY CCTL-10; CCTL10; Center for Cell Therapy Line 10; MUNIe004-A
DR hPSCreg; MUNIe004-A
DR IGRhCellID; CCTL-10%20p33
DR ISCR; 506
RX PubMed=15955829;
CC From: Masaryk University; Brno; Czech Republic.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CCTL 12
AC CVCL_C858
SY CCTL-12; CCTL12; CCTL-12 p143; Center for Cell Therapy Line 12; MUNIe005-A
DR hPSCreg; MUNIe005-A
DR IGRhCellID; CCTL-12%20p143
DR ISCR; 507
RX PubMed=15955829;
RX PubMed=17572666;
CC From: Masaryk University; Brno; Czech Republic.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CCTL 13
AC CVCL_C859
SY CCTL-13; CCTL13; Center for Cell Therapy Line 13; MUNIe006-A
DR hPSCreg; MUNIe006-A
DR ISCR; 508
CC From: Masaryk University; Brno; Czech Republic.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CCTL 14
AC CVCL_C860
SY CCTL-14; CCTL14; Center for Cell Therapy Line 14; MUNIe007-A
DR hPSCreg; MUNIe007-A
DR IGRhCellID; CCTL-14%20p38
DR IGRhCellID; CCTL-14%20p49
DR ISCR; 509
RX PubMed=15955829;
RX PubMed=17572666;
CC From: Masaryk University; Brno; Czech Republic.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CCTL 6
AC CVCL_C861
SY CCTL-6; CCTL6; Center for Cell Therapy Line 6; MUNIe001-A
DR hPSCreg; MUNIe001-A
DR ISCR; 503
CC From: Masaryk University; Brno; Czech Republic.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CCTL 8
AC CVCL_C862
SY CCTL-8; CCTL8; Center for Cell Therapy Line 8; MUNIe002-A
DR hPSCreg; MUNIe002-A
DR ISCR; 504
CC From: Masaryk University; Brno; Czech Republic.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CCTL 9
AC CVCL_C863
SY CCTL-9; CCTL9; Center for Cell Therapy Line 9; MUNIe003-A
DR hPSCreg; MUNIe003-A
DR ISCR; 505
RX PubMed=15955829;
RX PubMed=17572666;
CC From: Masaryk University; Brno; Czech Republic.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CD
AC CVCL_W955
SY Cancer research institute Developed
RX DOI=10.1155/2014/286013;
CC Doubling time: 31 +- 1 hours (DOI=10.1155/2014/286013).
ST Source(s): DOI=10.1155/2014/286013
ST Amelogenin: X,Y
ST CSF1PO: 9.3,12
ST D13S317: 8,13
ST D16S539: 10,12
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 7
ST TPOX: 9,11
ST vWA: 14,19.2
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CD-rA7
AC CVCL_6E53
RX PubMed=10530804;
CC Knockout cell: Method=KO mouse; MGI; MGI:97171; Mt1.
CC Knockout cell: Method=KO mouse; MGI; MGI:97172; Mt2.
CC Selected for resistance to: ChEBI; CHEBI:48775; Cadmium(2+).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6E52 ! Mt1/Mt2 DKO SV40
CA Transformed cell line
//
ID CD-rB5
AC CVCL_6E54
RX PubMed=10530804;
RX PubMed=10688626;
CC Knockout cell: Method=KO mouse; MGI; MGI:97171; Mt1.
CC Knockout cell: Method=KO mouse; MGI; MGI:97172; Mt2.
CC Selected for resistance to: ChEBI; CHEBI:48775; Cadmium(2+).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6E52 ! Mt1/Mt2 DKO SV40
CA Transformed cell line
//
ID CD114
AC CVCL_DR66
DR PRIDE; PXD001205
RX PubMed=25502872;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: HLA class II peptidome analysis by proteomics.
DI NCIt; C26714; Celiac disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CD34 iPS1
AC CVCL_C946
DR ISCR; 1321
RX PubMed=19299331;
CC From: Children's Hospital Boston; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C947 ! CD34 iPS2
SX Male
CA Induced pluripotent stem cell
//
ID CD34 iPS2
AC CVCL_C947
DR ISCR; 1322
RX PubMed=19299331;
CC From: Children's Hospital Boston; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C946 ! CD34 iPS1
SX Male
CA Induced pluripotent stem cell
//
ID CD4+ N#2 500
AC CVCL_2G94
DR NIH-ARP; 12533-409
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CDC 1C42H11
AC CVCL_K221
DR CLO; CLO_0002342
DR ATCC; HB-216
CC Monoclonal antibody target: Canine distemper virus.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Cdelta2+
AC CVCL_CW65
RX PubMed=23610747;
CC Characteristics: Bactericidal against Gram- (E.coli) and Gram+ (S.aureus) organisms.
CC Breed/subspecies: USMARC mixed breed.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Spontaneously immortalized cell line
//
ID Cdelta2-
AC CVCL_CW66
RX PubMed=23610747;
CC Characteristics: Bactericidal against Gram- (E.coli) and Gram+ (S.aureus) organisms.
CC Breed/subspecies: USMARC mixed breed.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_CW65 ! Cdelta2+
SX Female
CA Spontaneously immortalized cell line
//
ID CDIi001-A
AC CVCL_IT57
SY 01279
DR BioSamples; SAMEA104012950
DR hPSCreg; CDIi001-A
CC From: Cellular Dynamics International, Inc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID cdLEC
AC CVCL_F701
RX PubMed=22293671;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Wire Fox Terrier.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Transformed cell line
//
ID CDNR1
AC CVCL_5717
RX PubMed=2544547;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5731 ! COMMA-D
SX Female
CA Spontaneously immortalized cell line
//
ID CDNR2
AC CVCL_5718
RX PubMed=2544547;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5731 ! COMMA-D
SX Female
CA Spontaneously immortalized cell line
//
ID CDNR4
AC CVCL_5719
DR CLS; 400391/p877_CDNR4
RX PubMed=2544547;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5731 ! COMMA-D
SX Female
CA Spontaneously immortalized cell line
//
ID Cd R200
AC CVCL_Z899
SY CdR200
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=3919723;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z897 ! 1182-6
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CDR1
AC CVCL_9168
DR CLO; CLO_0002344
DR ATCC; HB-213
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID CDR2
AC CVCL_H172
DR CLO; CLO_0002345
DR ATCC; HB-214
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID CE
AC CVCL_6D96
SY CE-1; Celebensis Embryo
RX PubMed=7881826;
RX PubMed=16341864;
CC Group: Fish cell line.
OX NCBI_TaxID=126373; ! Oryzias celebensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Ce Ar
AC CVCL_3660
DR CLO; CLO_0002347
DR ATCC; CRL-1165
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Ce Geg
AC CVCL_3661
SY Culture 345
DR CLO; CLO_0002348
DR ATCC; CRL-1173
RX PubMed=4582519;
CC Discontinued: ATCC; CRL-1173; true.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Ce Rel
AC CVCL_U772
DR ATCC; CRL-1196
CC Discontinued: ATCC; CRL-1196; true.
DI NCIt; C62505; Fanconi anemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Ce Wal
AC CVCL_3662
DR CLO; CLO_0002349
DR ATCC; CRL-1351
DR BioSample; SAMN03471355
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 10,11
ST D16S539: 10,14
ST D5S818: 11
ST D7S820: 11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C53975; Poikiloderma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Ce Wo
AC CVCL_U773
DR ATCC; CRL-1340
CC Discontinued: ATCC; CRL-1340; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CE-1
AC CVCL_8949
SY CE1; Cassette Exchange-1
DR CLO; CLO_0002350
DR ATCC; SCRC-1038
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Embryonic stem cell
//
ID CE-25
AC CVCL_Y989
SY CE 25; CE25
RX Patent=US5047507;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-719.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CE-3
AC CVCL_8950
SY CE3; Cassette Exchange-3
DR CLO; CLO_0002351
DR ATCC; SCRC-1039
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Embryonic stem cell
//
ID CE0001
AC CVCL_8U00
DR ECACC; 92121301
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID cE1
AC CVCL_S005
SY ADI-Ca cE1
RX PubMed=20631921;
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S006 ! cE2
SX Male
CA Cancer cell line
//
ID CE146T/VGH
AC CVCL_Y008
SY CE 146T/VGH; CE 146T; CE146T; 146T
DR BCRC; 60167
RX PubMed=20392990;
ST Source(s): BCRC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 9,12
ST D5S818: 10,12
ST D7S820: 8,11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID cE2
AC CVCL_S006
SY ADI-Ca cE2
RX PubMed=20631921;
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S005 ! cE1
SX Male
CA Cancer cell line
//
ID CE48T/VGH
AC CVCL_Y009
SY CE-48T/VGH; CE 48T/VGH; CE48T; 48T
DR BCRC; 60165
RX PubMed=3943066;
RX PubMed=6583441;
RX PubMed=12432233;
RX PubMed=20392990;
CC Discontinued: BCRC; 60165; probable.
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CE69T/VGH
AC CVCL_Y010
SY CE-69T/VGH
RX PubMed=2827967;
RX PubMed=6583441;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CE81T/VGH
AC CVCL_Y011
SY CE-81T/VGH; CE 81T/VGH; CE 81T; CE81T; 81-T; 81T
DR BCRC; 60166
RX PubMed=6583441;
RX PubMed=12432233;
RX PubMed=15885884;
RX PubMed=20392990;
ST Source(s): BCRC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 10,12
ST D5S818: 10,11
ST D7S820: 9,10
ST TH01: 9
ST TPOX: 8
ST vWA: 17
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CE81T1
AC CVCL_Y184
RX PubMed=20392990;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y011 ! CE81T/VGH
SX Male
CA Cancer cell line
//
ID CE81T1-0
AC CVCL_Y186
RX PubMed=20392990;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y184 ! CE81T1
SX Male
CA Cancer cell line
//
ID CE81T1-1
AC CVCL_Y187
RX PubMed=20392990;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y184 ! CE81T1
SX Male
CA Cancer cell line
//
ID CE81T1-2
AC CVCL_Y188
RX PubMed=20392990;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y184 ! CE81T1
SX Male
CA Cancer cell line
//
ID CE81T1-3
AC CVCL_Y189
RX PubMed=20392990;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y184 ! CE81T1
SX Male
CA Cancer cell line
//
ID CE81T1-4
AC CVCL_Y190
RX PubMed=20392990;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y184 ! CE81T1
SX Male
CA Cancer cell line
//
ID CE81T2
AC CVCL_Y185
RX PubMed=20392990;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y011 ! CE81T/VGH
SX Male
CA Cancer cell line
//
ID CE81T2-1
AC CVCL_Y191
RX PubMed=20392990;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y185 ! CE81T2
SX Male
CA Cancer cell line
//
ID CE81T2-4
AC CVCL_Y192
RX PubMed=20392990;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y185 ! CE81T2
SX Male
CA Cancer cell line
//
ID CE9H9
AC CVCL_G644
DR CLO; CLO_0002352
DR ATCC; HB-127
RX PubMed=6193965;
CC Monoclonal antibody target: UniProtKB; P01308; Human INS (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID CEC CC 128
AC CVCL_Z883
SY CEC-CC-128; CCE/CC128
RX PubMed=7280302;
RX PubMed=19003376;
CC Group: Insect cell line.
OX NCBI_TaxID=7213; ! Ceratitis capitata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CEC CC 130
AC CVCL_Z884
SY CEC-CC-130
RX PubMed=7280302;
CC Group: Insect cell line.
OX NCBI_TaxID=7213; ! Ceratitis capitata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CEC-32
AC CVCL_D160
SY SPCC-CEC32
DR BCRJ; 0064
RX PubMed=6293961;
RX PubMed=10954914;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Problematic cell line: Misidentified. Originally thought to be of chicken origin but found to be from quail (PubMed=10954914).
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Spontaneously immortalized cell line
//
ID CEINGE clone 3
AC CVCL_3362
SY CEINGE CLONE 3; Ceinge clone 3; CEINGE CL3
DR CLO; CLO_0002354
DR CLDB; cl690
DR CLDB; cl4979
DR ICLC; ATL99012
RX PubMed=8264960;
CC Transformant: Polyoma middle T antigen (PyMLV).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID CEL-im
AC CVCL_T063
RX PubMed=23687157;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Spontaneously immortalized cell line
//
ID CEM 2cl
AC CVCL_Y484
RX PubMed=12747969;
RX PubMed=14720195;
DI NCIt; C35701; Salivary gland epithelial myoepithelial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CEM cl13
AC CVCL_V186
SY CEM-CL13; CEM clone 13; CEM-C113; CEM-c113; CEM c113
DR ChEMBL-Cells; CHEMBL3307394
DR ChEMBL-Targets; CHEMBL614545
RX PubMed=2464361;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-AGR
AC CVCL_J396
SY CEM-AGR.RTM
DR ATCC; CRL-8081
RX Patent=US4544632;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Discontinued: ATCC; CRL-8081; true.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-CL10
AC CVCL_X635
SY CEM-CL 10; CEM-A
DR NIH-ARP; 588-173
RX PubMed=2570823;
CC Doubling time: 18-24 hours (NIH-ARP).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-CM3
AC CVCL_3930
SY CCRF-CEM C3; CEM-C3; CEM/C3; CEMC3
DR CLO; CLO_0002357
DR CLDB; cl692
DR ATCC; TIB-195
DR BioSample; SAMN03471943
DR Cosmic; 683536
DR KCLB; 40195
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 10,12
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 10,13
ST FGA: 23,24
ST TH01: 6,7
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-GFP
AC CVCL_1G53
DR NIH-ARP; 3655-128
RX PubMed=9114046;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-LAV-2
AC CVCL_3931
SY CEM/LAV-2
DR CLO; CLO_0002358
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-ON
AC CVCL_J395
SY AGR-ON
DR ATCC; CRL-8199
DR BioSample; SAMN03471198
RX PubMed=3259875;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 10,13
ST D5S818: 12
ST D7S820: 10,13
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_J396 ! CEM-AGR
SX Female
CA Cancer cell line
//
ID CEM-R6
AC CVCL_HF38
RX PubMed=7812967;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-SS
AC CVCL_J318
SY CEM SS; CEM_SS
DR ChEMBL-Cells; CHEMBL3307644
DR ChEMBL-Targets; CHEMBL614548
DR Cosmic; 1247869
DR NIH-ARP; 776-174
DR TOKU-E; 4084
RX PubMed=3481271;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0048&theme=default
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-T4
AC CVCL_8178
SY CEM T4; CemT4; CEMT4
DR NIH-ARP; 117-336
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-TART
AC CVCL_X697
SY CEM/TART; CEMTART
DR NIH-ARP; 1944-86
RX PubMed=1502183;
CC Doubling time: ~48 hours (NIH-ARP).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-TART clone 1A2
AC CVCL_0R18
SY Clone 1A2
DR NIH-ARP; 2884-80
RX PubMed=1502183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X697 ! CEM-TART
SX Female
CA Cancer cell line
//
ID CEM-VBL16
AC CVCL_D598
DR BTO; BTO:0005154
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-VCR R
AC CVCL_3933
SY CEM/VCR R
DR BTO; BTO:0002143
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM-VLB
AC CVCL_4V08
DR ChEMBL-Cells; CHEMBL3307645
DR ChEMBL-Targets; CHEMBL614554
RX PubMed=11801309;
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM.NKR
AC CVCL_X622
SY CEM.NKr; CEM-NKR
DR NIH-ARP; 458-366
RX PubMed=3871222;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM.NKR-CCR5
AC CVCL_X623
DR NIH-ARP; 4376-29
RX PubMed=10516002;
CC Transfected with: HGNC; 1606; CCR5.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X622 ! CEM.NKR
SX Female
CA Cancer cell line
//
ID CEM.NKR-CCR5-Luc
AC CVCL_X624
SY CEM-NKR-CCR5-Luc
DR NIH-ARP; 5198-379
RX PubMed=11162843;
CC Transfected with: HGNC; 1606; CCR5.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X623 ! CEM.NKR-CCR5
SX Female
CA Cancer cell line
//
ID CEM/A5
AC CVCL_U260
RX PubMed=7514153;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/A7
AC CVCL_U261
SY CEM-A7
RX PubMed=7514153;
RX PubMed=7903222;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/ara-C
AC CVCL_4V21
RX PubMed=21290089;
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/C1
AC CVCL_3496
SY CCRF-CEM C1; CEM-C1; CEM.C1; CEMC1
DR CLO; CLO_0002355
DR EFO; EFO_0001667
DR ATCC; CRL-2265
DR BioSample; SAMN03471854
DR CCRID; 3131C0001001200011
DR Cosmic; 724837
DR IGRhCellID; CEMC1
DR IZSLER; BS TCL 160
DR Lonza; 241
RX PubMed=7579731;
RX PubMed=8895760;
CC Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,10,12
ST D16S539: 10,13
ST D5S818: 12,13
ST D7S820: 9,12
ST TH01: 6,7
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/C2
AC CVCL_3497
SY CCRF-CEM C2; CEM-C2; CEMC2
DR BTO; BTO:0005931
DR CLO; CLO_0002356
DR CLDB; cl5178
DR ATCC; CRL-2264
DR BioSample; SAMN03471853
DR ChEMBL-Cells; CHEMBL3307952
DR ChEMBL-Targets; CHEMBL612406
DR Cosmic; 683535
DR IZSLER; BS TCL 153
RX PubMed=7579731;
CC Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 10,13
ST D5S818: 13
ST D7S820: 8.3,9
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/DNR
AC CVCL_S256
SY CEM-DNR
DR ChEMBL-Cells; CHEMBL3307396
DR ChEMBL-Targets; CHEMBL614547
CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/MX1
AC CVCL_0U11
DR ATCC; CRL-2259
DR BioSample; SAMN03471852
CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.
CC Discontinued: ATCC; CRL-2259; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11,13,14
ST D13S317: 8,11,12
ST D16S539: 10,11,13
ST D5S818: 11,12
ST D7S820: 9,11,12,13
ST TH01: 6,7,8
ST TPOX: 8,11
ST vWA: 16,18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/VLB10
AC CVCL_D597
SY CEM-VBL10
DR BTO; BTO:0005153
RX PubMed=571759;
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/VLB10-2
AC CVCL_4V10
SY CEM/VLB(10-2)
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D597 ! CEM/VLB10
SX Female
CA Cancer cell line
//
ID CEM/VLB100
AC CVCL_3932
SY CEM-VLB100; CEM/VLB 100; CEM/VBL 100; CEM-VBL100
DR BTO; BTO:0005155
DR Cosmic; 922676
RX PubMed=571759;
RX PubMed=2888532;
RX PubMed=3469013;
RX PubMed=9557624;
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
CC Caution: Seems to be interchangeably called VLB100 or VBL100.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/VLB500
AC CVCL_4V12
SY CEM/VBL500
RX PubMed=571759;
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
CC Caution: Seems to be interchangeably called VLB500 or VBL500.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/VLB55
AC CVCL_4V09
RX PubMed=571759;
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEM/VLB55-8
AC CVCL_4V11
SY CEM/VLB55 8; CEM/VLB(55-8)
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4V09 ! CEM/VLB55
SX Female
CA Cancer cell line
//
ID CEM/VM-1
AC CVCL_1B35
SY CEM/VM1; CEM-VM1
DR ChEMBL-Cells; CHEMBL3307511
DR ChEMBL-Targets; CHEMBL614030
RX PubMed=2888532;
RX PubMed=3469013;
CC Selected for resistance to: ChEBI; CHEBI:75988; Teniposide (VM-26).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEMO-1
AC CVCL_9489
DR Cosmic; 1130243
RX PubMed=8642878;
RX PubMed=9490669;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CEMR.3
AC CVCL_7905
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID CEMx174/HIV-2ST
AC CVCL_X615
DR NIH-ARP; 234-220
CC Doubling time: ~18 hours (NIH-ARP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7904 ! T1
CA Hybrid cell line
//
ID cen2tel
AC CVCL_S895
RX PubMed=12927806;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID cen3tel
AC CVCL_S896
SY Cen3tel
RX PubMed=12927806;
RX PubMed=16357149;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID CEPH-1332-NA00000
AC CVCL_G393
SY 1332-8251
DR dbMHC; 48552
DR IHW; IHW1020
DR IMGT/HLA; 25821
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CEPH-1344-NA00000
AC CVCL_G436
SY 1344-8323
DR dbMHC; 48595
DR IHW; IHW1066
DR IMGT/HLA; 25864
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CERV-186
AC CVCL_5720
SY Cerv-186; MRI-H-186; MRI-H186
DR CLS; 300290/p773_CERV-186
RX PubMed=15531914;
RX PubMed=21439369;
CC Characteristics: Contains around 26 copies of the HPV16 genome; some complete and others truncated.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 12
ST D16S539: 13
ST D18S51: 16
ST D21S11: 29,30
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 14
ST FGA: 19,20
ST Penta D: 10,12
ST Penta E: 5,7
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CERV-196
AC CVCL_5721
SY Cerv-196; MRI-H-196; MRI-H196
DR CLS; 300291/p787_CERV-196
RX PubMed=15531914;
RX PubMed=21439369;
CC Characteristics: Contains 4 to 6 copies of the HPV16 genome.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 12
ST D18S51: 14
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 11,12
ST D8S1179: 13
ST FGA: 20
ST Penta D: 12
ST Penta E: 12,16
ST TH01: 6
ST TPOX: 8
ST vWA: 14
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CERV-215
AC CVCL_5722
SY Cerv-215; MRI-H-215; MRI-H215
DR CLS; 300292/p776_CERV-215
RX PubMed=15531914;
CC Characteristics: Contains a HPV45 genome.
CC Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,12
ST D16S539: 9,12
ST D18S51: 12
ST D21S11: 33.2
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 19,21
ST Penta D: 10
ST Penta E: 12,13
ST TH01: 9
ST TPOX: 8
ST vWA: 16
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CESS
AC CVCL_0209
SY Cess
DR BTO; BTO:0004327
DR CLO; CLO_0002360
DR EFO; EFO_0002130
DR MCCL; MCC:0000098
DR CLDB; cl695
DR ATCC; TIB-190
DR BioSample; SAMN03471942
DR ChEMBL-Cells; CHEMBL3308863
DR ChEMBL-Targets; CHEMBL2366361
DR Cosmic; 683658
DR Cosmic; 910688
DR Cosmic; 2131534
DR Cosmic; 2306201
DR Cosmic-CLP; 910688
DR ECACC; 92110206
DR GDSC; 910688
DR GEO; GSM1669671
DR IGRhCellID; CESS
RX PubMed=3106068;
RX PubMed=27397505;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=CESS
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,11 (ATCC; ECACC)
ST CSF1PO: 10,11,12 (Cosmic-CLP)
ST D13S317: 12
ST D16S539: 12
ST D5S818: 11,12 (ATCC; ECACC)
ST D5S818: 10,11,12,13 (Cosmic-CLP)
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 16,17 (ATCC; ECACC)
ST vWA: 15,16,17,18 (Cosmic-CLP)
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CET.IPS ALZ-500
AC CVCL_5I57
WW http://www.celleng-tech.com/#!ips-cell-lines/c1nga
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID CET.IPS FFAD-500
AC CVCL_5I58
WW http://www.celleng-tech.com/#!ips-cell-lines/c1nga
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID CET.IPS FFHFF-500
AC CVCL_5I59
WW http://www.celleng-tech.com/#!ips-cell-lines/c1nga
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID CET.IPS FFMP-500
AC CVCL_5I60
WW http://www.celleng-tech.com/#!ips-cell-lines/c1nga
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID CET.IPS HFF-500
AC CVCL_5I61
WW http://www.celleng-tech.com/#!ips-cell-lines/c1nga
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID CET.IPS MULT-500
AC CVCL_5I62
WW http://www.celleng-tech.com/#!ips-cell-lines/c1nga
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID CF [Chitala]
AC CVCL_9T87
SY Chitala Fin
RX PubMed=23877365;
CC Group: Fish cell line.
OX NCBI_TaxID=112163; ! Chitala chitala
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CF [Cobia]
AC CVCL_6F70
SY Cobia Fin
RX PubMed=19925591;
CC Group: Fish cell line.
OX NCBI_TaxID=141264; ! Rachycentron canadum
OI CVCL_6F69 ! CB [Cobia]
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CF [Human myeloma]
AC CVCL_Y433
RX PubMed=17760811;
CC Doubling time: ~4-6 days (PubMed=17760811).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CF [Rat heart fibroblast]
AC CVCL_HA34
DR BCRJ; 0065
CC Discontinued: BCRJ; 0065; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID CF-1 MEF
AC CVCL_5251
SY MEF (CF-1)
DR CLO; CLO_0002361
DR CLO; CLO_0007666
DR ATCC; SCRC-1040
CC Breed/subspecies: CF-1.
OX NCBI_TaxID=10090; ! Mus musculus
SX Mixed sex
CA Finite cell line
//
ID CF-1 MEF IRR
AC CVCL_K232
SY MEF (CF-1) IRR
DR ATCC; SCRC-1040.1
CC Breed/subspecies: CF-1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5251 ! CF-1 MEF
SX Mixed sex
CA Finite cell line
//
ID CF-1 MEF MITC
AC CVCL_K233
SY MEF (CF-1) MITC
DR ATCC; SCRC-1040.2a
CC Breed/subspecies: CF-1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5251 ! CF-1 MEF
SX Mixed sex
CA Finite cell line
//
ID CF-10H5
AC CVCL_1975
DR CLO; CLO_0002362
DR DSMZ; ACC-477
CC Doubling time: ~30-45 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CF-1D12
AC CVCL_1976
DR CLO; CLO_0002365
DR DSMZ; ACC-476
CC Doubling time: ~30-35 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P31358; Human CD52.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CF-KM4
AC CVCL_IN80
RX PubMed=10101000;
RX PubMed=15463957;
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CF-RiPS-1.2
AC CVCL_C194
SY CF_RiPS_1.2
DR GEO; GSM579910
DR ISCR; 1724
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C195 ! CF-RiPS-1.3
OI CVCL_C196 ! CF-RiPS-1.4
CA Induced pluripotent stem cell
//
ID CF-RiPS-1.3
AC CVCL_C195
SY CF_RiPS_1.3
DR GEO; GSM579911
DR ISCR; 1725
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C194 ! CF-RiPS-1.2
OI CVCL_C196 ! CF-RiPS-1.4
CA Induced pluripotent stem cell
//
ID CF-RiPS-1.4
AC CVCL_C196
SY CF_RiPS_1.4
DR GEO; GSM579912
DR ISCR; 1726
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C194 ! CF-RiPS-1.2
OI CVCL_C195 ! CF-RiPS-1.3
CA Induced pluripotent stem cell
//
ID CF/T43
AC CVCL_HA79
SY CF-T43; CFT43
RX PubMed=2472008;
RX PubMed=8755664;
RX PubMed=9277448;
RX PubMed=15463957;
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pZIPneoSV(X)1/SV40T].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CF10.Br
AC CVCL_S245
DR ATCC; CRL-6212
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6212; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S244 ! CF10.Ht
OI CVCL_S243 ! CF10.Int
OI CVCL_S369 ! CF10.Li
OI CVCL_S242 ! CF10.Res
OI CVCL_S241 ! CF10.Sm
OI CVCL_S370 ! CF10.Sp
SX Sex undetermined
CA Finite cell line
//
ID CF10.Ht
AC CVCL_S244
DR ATCC; CRL-6213
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6213; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S245 ! CF10.Br
OI CVCL_S243 ! CF10.Int
OI CVCL_S369 ! CF10.Li
OI CVCL_S242 ! CF10.Res
OI CVCL_S241 ! CF10.Sm
OI CVCL_S370 ! CF10.Sp
SX Sex undetermined
CA Finite cell line
//
ID CF10.Int
AC CVCL_S243
DR ATCC; CRL-6214
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6214; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S245 ! CF10.Br
OI CVCL_S244 ! CF10.Ht
OI CVCL_S369 ! CF10.Li
OI CVCL_S242 ! CF10.Res
OI CVCL_S241 ! CF10.Sm
OI CVCL_S370 ! CF10.Sp
SX Sex undetermined
CA Finite cell line
//
ID CF10.Li
AC CVCL_S369
DR ATCC; CRL-6578
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6578; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S245 ! CF10.Br
OI CVCL_S244 ! CF10.Ht
OI CVCL_S243 ! CF10.Int
OI CVCL_S242 ! CF10.Res
OI CVCL_S241 ! CF10.Sm
OI CVCL_S370 ! CF10.Sp
SX Sex undetermined
CA Finite cell line
//
ID CF10.Res
AC CVCL_S242
DR ATCC; CRL-6215
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6215; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S245 ! CF10.Br
OI CVCL_S244 ! CF10.Ht
OI CVCL_S243 ! CF10.Int
OI CVCL_S369 ! CF10.Li
OI CVCL_S241 ! CF10.Sm
OI CVCL_S370 ! CF10.Sp
SX Sex undetermined
CA Finite cell line
//
ID CF10.Sm
AC CVCL_S241
DR ATCC; CRL-6216
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6216; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S245 ! CF10.Br
OI CVCL_S244 ! CF10.Ht
OI CVCL_S243 ! CF10.Int
OI CVCL_S369 ! CF10.Li
OI CVCL_S242 ! CF10.Res
OI CVCL_S370 ! CF10.Sp
SX Sex undetermined
CA Finite cell line
//
ID CF10.Sp
AC CVCL_S370
DR ATCC; CRL-6579
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6579; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S245 ! CF10.Br
OI CVCL_S244 ! CF10.Ht
OI CVCL_S243 ! CF10.Int
OI CVCL_S369 ! CF10.Li
OI CVCL_S242 ! CF10.Res
OI CVCL_S241 ! CF10.Sm
SX Sex undetermined
CA Finite cell line
//
ID CF11.T
AC CVCL_5252
DR CLO; CLO_0002363
DR ATCC; CRL-6217
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6217; probable.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CF15.T
AC CVCL_S240
DR ATCC; CRL-6218
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6218; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CF17.T
AC CVCL_5253
DR CLO; CLO_0002364
DR ATCC; CRL-6219
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6219; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CF1TKB
AC CVCL_J695
DR CLO; CLO_0050703
DR BioSample; SAMN03472132
DR RCB; RCB1382
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 9,10
ST D16S539: 9,13
ST D5S818: 9,10
ST D7S820: 11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CF2.Ln
AC CVCL_S237
DR ATCC; CRL-6199
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6199; true.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S234 ! CF2.Sk
OI CVCL_S238 ! CF2.Sp
OI CVCL_3363 ! CF2.Th
SX Female
CA Finite cell line
//
ID CF2.Sk
AC CVCL_S234
DR ATCC; CRL-6198
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6198; true.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S237 ! CF2.Ln
OI CVCL_S238 ! CF2.Sp
OI CVCL_3363 ! CF2.Th
SX Female
CA Finite cell line
//
ID CF2.Sp
AC CVCL_S238
DR ATCC; CRL-6200
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6200; true.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S234 ! CF2.Sk
OI CVCL_S237 ! CF2.Ln
OI CVCL_3363 ! CF2.Th
SX Female
CA Finite cell line
//
ID CF2.Th
AC CVCL_3363
SY Cf2Th; CF2Th; CF2TH; Cf2TH; FCf2Th
DR CLO; CLO_0002369
DR CLO; CLO_0002370
DR CLDB; cl696
DR CLDB; cl697
DR CLDB; cl698
DR CLDB; cl699
DR ATCC; CRL-1430
DR ATCC; CRL-6574
DR ECACC; 90110521
DR ICLC; AL97003
DR IZSLER; BS CL 13
RX PubMed=190163;
RX PubMed=6500159;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-439.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6574; true.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S234 ! CF2.Sk
OI CVCL_S237 ! CF2.Ln
OI CVCL_S238 ! CF2.Sp
SX Female
CA Spontaneously immortalized cell line
//
ID CF21.T
AC CVCL_5254
DR CLO; CLO_0002366
DR ATCC; CRL-6220
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CF24.T
AC CVCL_5255
DR CLO; CLO_0002367
DR ATCC; CRL-6221
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6221; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Sex undetermined
CA Cancer cell line
//
ID CF27
AC CVCL_S235
DR ATCC; CRL-6222
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6222; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Sex undetermined
CA Finite cell line
//
ID CF28
AC CVCL_5256
DR CLO; CLO_0002368
DR ATCC; CRL-6223
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6223; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID CF29.Mg
AC CVCL_S236
DR ATCC; CRL-6224
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6224; true.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_N776 ! CF51.Mg/L1
OI CVCL_N777 ! CF51.Mg/L3
SX Female
CA Cancer cell line
//
ID CF2A.Thy
AC CVCL_Y442
DR ATCC; CRL-6197
CC Discontinued: ATCC; CRL-6197; probable.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Sex undetermined
CA Finite cell line
//
ID Cf2Th-CCR5
AC CVCL_1G50
SY Cf2Th/syn CCR5; Cf2Th/PACH/synCCR5
DR NIH-ARP; 4662-298
RX PubMed=11489906;
CC Transfected with: HGNC; 1606; CCR5.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_3363 ! CF2.Th
SX Female
CA Spontaneously immortalized cell line
//
ID Cf2Th-CXCR4
AC CVCL_1G51
DR NIH-ARP; 9398-225
RX PubMed=11489906;
CC Transfected with: HGNC; 2561; CXCR4.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_3363 ! CF2.Th
SX Female
CA Spontaneously immortalized cell line
//
ID CF3.Ln
AC CVCL_S263
DR ATCC; CRL-6202
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6202; true.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S239 ! CF3.Sk
OI CVCL_S264 ! CF3.Sp
OI CVCL_5257 ! CF3.Th
SX Male
CA Finite cell line
//
ID CF3.Sk
AC CVCL_S239
DR ATCC; CRL-6201
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6201; true.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S263 ! CF3.Ln
OI CVCL_S264 ! CF3.Sp
OI CVCL_5257 ! CF3.Th
SX Male
CA Finite cell line
//
ID CF3.Sp
AC CVCL_S264
DR ATCC; CRL-6203
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6203; true.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S263 ! CF3.Ln
OI CVCL_S239 ! CF3.Sk
OI CVCL_5257 ! CF3.Th
SX Male
CA Finite cell line
//
ID CF3.Th
AC CVCL_5257
DR CLO; CLO_0002371
DR ATCC; CRL-6575
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6575; true.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S263 ! CF3.Ln
OI CVCL_S264 ! CF3.Sp
OI CVCL_S239 ! CF3.Sk
SX Male
CA Finite cell line
//
ID CF30.Mg
AC CVCL_5258
DR CLO; CLO_0002372
DR ATCC; CRL-6225
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6225; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID CF31A
AC CVCL_N773
DR ATCC; CRL-6226
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6226; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Sex undetermined
CA Finite cell line
//
ID CF33.MT
AC CVCL_5259
SY CF33; CF33.Mg
DR CLO; CLO_0002373
DR ATCC; CRL-6227
DR IZSLER; BS TCL 225
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6227; true.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CF34.Mg
AC CVCL_5260
DR CLO; CLO_0002374
DR ATCC; CRL-6228
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: Beagle.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CF35.Mg
AC CVCL_5261
SY CF35
DR CLO; CLO_0002375
DR ATCC; CRL-6229
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6229; true.
CC Breed/subspecies: Beagle.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CF37.Mg
AC CVCL_5262
DR CLO; CLO_0002376
DR ATCC; CRL-6230
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID CF38.Mg
AC CVCL_5263
DR CLO; CLO_0002377
DR ATCC; CRL-6231
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID CF4
AC CVCL_R840
SY CF-4
RX DOI=10.1016/j.cbpa.2007.01.072;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CF4-C4
AC CVCL_5272
DR CLO; CLO_0002386
DR ATCC; CRL-1716
RX PubMed=6833281;
CC Monoclonal antibody target: ChEBI; CHEBI:61793; Sialyl Lewis A.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CF41.Mg
AC CVCL_5264
SY CF41
DR CLO; CLO_0002378
DR ATCC; CRL-6232
DR NCBI_Iran; C627
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: Beagle.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CF42.Mg
AC CVCL_N774
DR ATCC; CRL-6233
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6233; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Undefined cell line type
//
ID CF43.Mg
AC CVCL_5265
DR CLO; CLO_0002379
DR ATCC; CRL-6234
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6234; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID CF44.Mg
AC CVCL_5266
DR CLO; CLO_0002380
DR ATCC; CRL-6235
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6235; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID CF45A.Mg
AC CVCL_N775
DR ATCC; CRL-6236
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6236; true.
CC Breed/subspecies: Beagle.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_5267 ! CF45B.Mg
SX Female
CA Cancer cell line
//
ID CF45B.Mg
AC CVCL_5267
DR CLO; CLO_0002381
DR ATCC; CRL-6237
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6237; true.
CC Breed/subspecies: Beagle.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_N775 ! CF45A.Mg
SX Female
CA Cancer cell line
//
ID CF46.Tr
AC CVCL_5268
DR CLO; CLO_0002382
DR ATCC; CRL-6238
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6238; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Sex undetermined
CA Finite cell line
//
ID CF47.Mg
AC CVCL_5269
DR CLO; CLO_0002383
DR ATCC; CRL-6239
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6239; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID CF48.Mg
AC CVCL_5270
DR CLO; CLO_0002384
DR ATCC; CRL-6240
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6240; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID CF49.Mg
AC CVCL_5271
DR CLO; CLO_0002385
DR ATCC; CRL-6241
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6241; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID CF5.Thy
AC CVCL_S265
DR ATCC; CRL-6204
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6204; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Mixed sex
CA Finite cell line
//
ID CF51.Mg/L1
AC CVCL_N776
SY CF51L1.Mg
DR ATCC; CRL-6242
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6242; true.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S236 ! CF29.Mg
OI CVCL_N777 ! CF51.Mg/L3
SX Female
CA Cancer cell line
//
ID CF51.Mg/L3
AC CVCL_N777
SY CF51L3.Mg
DR ATCC; CRL-6243
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6243; true.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S236 ! CF29.Mg
OI CVCL_N776 ! CF51.Mg/L1
SX Female
CA Cancer cell line
//
ID CF52.Tr
AC CVCL_5273
DR CLO; CLO_0002387
DR ATCC; CRL-6244
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID CF7.Bm
AC CVCL_S266
DR ATCC; CRL-6205
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6205; true.
CC Breed/subspecies: Boxer.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S267 ! CF7.Ln
OI CVCL_0F43 ! CF7.Lu
OI CVCL_S229 ! CF7.Thy
OI CVCL_S368 ! CF7.Sp
SX Female
CA Finite cell line
//
ID CF7.Ln
AC CVCL_S267
DR ATCC; CRL-6206
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6206; true.
CC Breed/subspecies: Boxer.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S266 ! CF7.Bm
OI CVCL_0F43 ! CF7.Lu
OI CVCL_S368 ! CF7.Sp
OI CVCL_S229 ! CF7.Thy
SX Female
CA Finite cell line
//
ID CF7.Lu
AC CVCL_0F43
DR ATCC; CRL-6209
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6209; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S266 ! CF7.Bm
OI CVCL_S267 ! CF7.Ln
OI CVCL_S368 ! CF7.Sp
OI CVCL_S229 ! CF7.Thy
SX Female
CA Finite cell line
//
ID CF7.Sp
AC CVCL_S368
DR ATCC; CRL-6576
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6576; true.
CC Breed/subspecies: Boxer.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S266 ! CF7.Bm
OI CVCL_S267 ! CF7.Ln
OI CVCL_0F43 ! CF7.Lu
OI CVCL_S229 ! CF7.Thy
SX Female
CA Finite cell line
//
ID CF7.Thy
AC CVCL_S229
SY CF7.Th
DR ATCC; CRL-6207
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6207; true.
CC Breed/subspecies: Boxer.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S266 ! CF7.Bm
OI CVCL_S267 ! CF7.Ln
OI CVCL_0F43 ! CF7.Lu
OI CVCL_S368 ! CF7.Sp
SX Female
CA Finite cell line
//
ID CF8.Ln
AC CVCL_S268
DR ATCC; CRL-6208
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6208; true.
CC Breed/subspecies: Boxer.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S270 ! CF8.Lu
OI CVCL_S269 ! CF8.Sp
OI CVCL_5274 ! CF8.Thy
SX Female
CA Finite cell line
//
ID CF8.Lu
AC CVCL_S270
DR ATCC; CRL-6577
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6577; true.
CC Breed/subspecies: Boxer.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S268 ! CF8.Ln
OI CVCL_S269 ! CF8.Sp
OI CVCL_5274 ! CF8.Thy
SX Female
CA Finite cell line
//
ID CF8.Sp
AC CVCL_S269
DR ATCC; CRL-6210
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6210; true.
CC Breed/subspecies: Boxer.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S268 ! CF8.Ln
OI CVCL_S270 ! CF8.Lu
OI CVCL_5274 ! CF8.Thy
SX Female
CA Finite cell line
//
ID CF8.Thy
AC CVCL_5274
DR CLO; CLO_0002388
DR ATCC; CRL-6211
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6211; true.
CC Breed/subspecies: Boxer.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S268 ! CF8.Ln
OI CVCL_S270 ! CF8.Lu
OI CVCL_S269 ! CF8.Sp
SX Female
CA Finite cell line
//
ID CF996
AC CVCL_E521
DR dbMHC; 48719
DR ECACC; 88052094
DR IHW; IHW9094
DR IMGT/HLA; 11626
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl94.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID cFA404-KiPS4F-1
AC CVCL_C192
SY cFA404-KiPS4F1; ESi005-A
DR BioSamples; SAMEA3303130
DR hPSCreg; ESi005-A
DR ISCR; 2267
RX PubMed=19483674;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Linea_cFA404-KiPS4F-1_DEF.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C193 ! cFA404-KiPS4F-3
SX Male
CA Induced pluripotent stem cell
//
ID cFA404-KiPS4F-3
AC CVCL_C193
SY cFA404-KiPS4F3; ESi029-A
DR hPSCreg; ESi029-A
DR ISCR; 2268
RX PubMed=19483674;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Linea_cFA404-KiPS4F-3_DEF.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C192 ! cFA404-KiPS4F-1
SX Male
CA Induced pluripotent stem cell
//
ID cFA90-44-01
AC CVCL_W356
SY cFA90-44-1
RX PubMed=19483674;
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W357 ! cFA90-44-11
OI CVCL_W358 ! cFA90-44-14
OI CVCL_W359 ! cFA90-44-20
OI CVCL_W360 ! cFA90-44-21
SX Female
CA Induced pluripotent stem cell
//
ID cFA90-44-11
AC CVCL_W357
RX PubMed=19483674;
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W356 ! cFA90-44-01
OI CVCL_W358 ! cFA90-44-14
OI CVCL_W359 ! cFA90-44-20
OI CVCL_W360 ! cFA90-44-21
SX Female
CA Induced pluripotent stem cell
//
ID cFA90-44-14
AC CVCL_W358
RX PubMed=19483674;
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W356 ! cFA90-44-01
OI CVCL_W357 ! cFA90-44-11
OI CVCL_W359 ! cFA90-44-20
OI CVCL_W360 ! cFA90-44-21
SX Female
CA Induced pluripotent stem cell
//
ID cFA90-44-20
AC CVCL_W359
RX PubMed=19483674;
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W356 ! cFA90-44-01
OI CVCL_W357 ! cFA90-44-11
OI CVCL_W358 ! cFA90-44-14
OI CVCL_W360 ! cFA90-44-21
SX Female
CA Induced pluripotent stem cell
//
ID cFA90-44-21
AC CVCL_W360
RX PubMed=19483674;
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W356 ! cFA90-44-01
OI CVCL_W357 ! cFA90-44-11
OI CVCL_W358 ! cFA90-44-14
OI CVCL_W359 ! cFA90-44-20
SX Female
CA Induced pluripotent stem cell
//
ID CFBE41o-
AC CVCL_HL93
SY CFBE41o(-); CF41o; CFBE
DR GEO; GSM2126999
DR GEO; GSM2127001
DR GEO; GSM2127003
RX PubMed=9614386;
RX PubMed=12032687;
RX PubMed=15463957;
RX PubMed=16249874;
WW http://www.dartmouth.edu/~cysfib/cell-lines.html
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CFBE45o-
AC CVCL_IN63
SY CF45o-
RX PubMed=15463957;
CC Characteristics: Heterozygous for the CFTR p.Phe508del and p.Arg117His mutations.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CFBE46o-
AC CVCL_IN64
RX PubMed=15463957;
CC Characteristics: Has a CFTR p.Arg117His mutation.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CFBR
AC CVCL_1G74
SY ClownFish BRain
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=11
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC011.
OX NCBI_TaxID=229075; ! Amphiprion sebae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFC004
AC CVCL_9U86
RX PubMed=8639765;
RX PubMed=9108096;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CFC008
AC CVCL_9U87
RX PubMed=8639765;
RX PubMed=9108096;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CFC032
AC CVCL_9U88
RX PubMed=8639765;
RX PubMed=9108096;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CFC034
AC CVCL_9U89
RX PubMed=8639765;
RX PubMed=9108096;
RX PubMed=9192756;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CFCP1
AC CVCL_1G75
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=13
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC013.
OX NCBI_TaxID=229075; ! Amphiprion sebae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFF
AC CVCL_R805
SY Catopra Fasciata Fin
RX PubMed=23933168;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=39
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC039.
OX NCBI_TaxID=302777; ! Pristolepis fasciata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFFN2
AC CVCL_1G76
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=10
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC010.
OX NCBI_TaxID=229075; ! Amphiprion sebae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFG
AC CVCL_6F71
SY CatFish Gonad
RX CelloPub=CLPUB00305;
CC Group: Fish cell line.
OX NCBI_TaxID=59899; ! Clarias batrachus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFH
AC CVCL_6F72
SY CatFish Heart
RX CelloPub=CLPUB00305;
CC Group: Fish cell line.
OX NCBI_TaxID=59899; ! Clarias batrachus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFI-3
AC CVCL_IN79
RX PubMed=1718974;
RX PubMed=15463957;
CC Characteristics: Heterozygous for the CFTR p.Ser549Asn and p.Asn1303Lys mutations.
CC Doubling time: 24 hours (PubMed=1718974).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9640 ! CFT-1
CA Transformed cell line
//
ID CFK
AC CVCL_6F73
SY CatFish Kidney
RX CelloPub=CLPUB00305;
CC Group: Fish cell line.
OX NCBI_TaxID=59899; ! Clarias batrachus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFK1
AC CVCL_U887
RX PubMed=2246327;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_U886 ! OBCK6
CA Spontaneously immortalized cell line
//
ID CFK2
AC CVCL_U888
RX PubMed=2246327;
RX PubMed=8475797;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-185.html
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_U886 ! OBCK6
CA Spontaneously immortalized cell line
//
ID CFNPE14o-
AC CVCL_IN66
RX PubMed=1375758;
RX PubMed=15463957;
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CFNPE9o-
AC CVCL_IN65
SY CFNPE9o(-); CFNPE9o; 2CFNPE9o-
RX PubMed=1375758;
WW http://www.dartmouth.edu/~cysfib/cell-lines.html
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CFPAC-1
AC CVCL_1119
SY CFPac-1; CF PAC-1; CF-PAC1; CF-Pac1; CF Pac1; CFPAC1; CFPac1; CFPAC
DR BTO; BTO:0004738
DR CLO; CLO_0002395
DR EFO; EFO_0006551
DR CLDB; cl705
DR CLDB; cl7121
DR ATCC; CRL-1918
DR BioSample; SAMN03471976
DR CCLE; CFPAC1_PANCREAS
DR CCRID; 3111C0001CCC000245
DR CCRID; 3131C0001000700112
DR CGH-DB; 164-1
DR CGH-DB; 9273-4
DR ChEMBL-Cells; CHEMBL3308032
DR ChEMBL-Targets; CHEMBL613506
DR Cosmic; 710854
DR Cosmic; 868245
DR Cosmic; 872998
DR Cosmic; 906821
DR Cosmic; 913305
DR Cosmic; 922259
DR Cosmic; 923168
DR Cosmic; 932518
DR Cosmic; 948375
DR Cosmic; 948741
DR Cosmic; 949322
DR Cosmic; 1006363
DR Cosmic; 1122343
DR Cosmic; 1198207
DR Cosmic; 1299298
DR Cosmic; 1358477
DR Cosmic; 1518233
DR Cosmic; 1571776
DR Cosmic; 2434110
DR Cosmic-CLP; 906821
DR ECACC; 91112501
DR GDSC; 906821
DR GEO; GSM206454
DR GEO; GSM244428
DR GEO; GSM621903
DR GEO; GSM784694
DR GEO; GSM886925
DR GEO; GSM887991
DR GEO; GSM1024400
DR GEO; GSM1374446
DR GEO; GSM1374447
DR GEO; GSM1374448
DR GEO; GSM1669672
DR ICLC; HTL01019
DR IZSLER; BS TCL 166
DR KCB; KCB 200730YJ
DR PRIDE; PXD003198
DR SKY/M-FISH/CGH; 1998
DR Wikidata; Q28199352
RX DOI=10.4172/jpb.1000057;
RX PubMed=1692630;
RX PubMed=10027410;
RX PubMed=11169959;
RX PubMed=11787853;
RX PubMed=12800145;
RX PubMed=14695172;
RX PubMed=15126341;
RX PubMed=15463957;
RX PubMed=15688027;
RX PubMed=18380791;
RX PubMed=20418756;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27259358;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/CF%20PAC-1.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=CFPAC-1
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
CC Doubling time: 45 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'CFPANC1' in CGH-DB 164-1.
CC Derived from metastatic site: Liver.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 9,11
ST D18S51: 12
ST D21S11: 30,31.2
ST D3S1358: 16
ST D5S818: 10,11
ST D7S820: 8,10
ST D8S1179: 11,15
ST FGA: 21,22
ST Penta D: 11,13
ST Penta E: 10,12
ST TH01: 8
ST TPOX: 8
ST vWA: 17
DI NCIt; C2975; Cystic fibrosis
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CFS [Carassius]
AC CVCL_6F75
SY Carassius Fin from lake Suwa
RX PubMed=9156334;
CC Group: Fish cell line.
OX NCBI_TaxID=138676; ! Carassius auratus langsdorfii
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFS [Catfish]
AC CVCL_6F74
SY CatFish Spleen
RX CelloPub=CLPUB00305;
CC Group: Fish cell line.
OX NCBI_TaxID=59899; ! Clarias batrachus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFSa1
AC CVCL_6F76
SY Caudal fin Sparus aurata 1
RX PubMed=15820747;
CC Group: Fish cell line.
OX NCBI_TaxID=8175; ! Sparus aurata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFSC
AC CVCL_M104
SY CCl4-treated Fat Storing Cells
DR BTO; BTO:0003522
RX PubMed=1753710;
RX PubMed=8394478;
RX PubMed=17760834;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID CFSC-2G
AC CVCL_4U34
RX PubMed=7635427;
RX PubMed=8394478;
RX PubMed=20594261;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M104 ! CFSC
SX Male
CA Spontaneously immortalized cell line
//
ID CFSC-3H
AC CVCL_4U35
RX PubMed=8394478;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M104 ! CFSC
SX Male
CA Spontaneously immortalized cell line
//
ID CFSC-5H
AC CVCL_4U36
RX PubMed=7635427;
RX PubMed=8394478;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M104 ! CFSC
SX Male
CA Spontaneously immortalized cell line
//
ID CFSC-8B
AC CVCL_4U37
RX PubMed=8394478;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M104 ! CFSC
SX Male
CA Spontaneously immortalized cell line
//
ID CFSP
AC CVCL_1G77
SY ClownFish SPleen
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=12
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC012.
OX NCBI_TaxID=229075; ! Amphiprion sebae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CFT-1
AC CVCL_9640
RX PubMed=7682954;
RX PubMed=15463957;
CC Characteristics: Heterozygous for the CFTR p.Ser549Asn and p.Asn1303Lys mutations.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IN79 ! CFI-3
CA Transformed cell line
//
ID CFT-2
AC CVCL_9641
DR EFO; EFO_0001102
RX PubMed=7682954;
RX PubMed=15463957;
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
CC Misspelling: 'CFT-3' in PubMed=15463957.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CFT012
AC CVCL_9U90
RX PubMed=8639765;
RX PubMed=9108096;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CFT1
AC CVCL_G214
RX Patent=US5576206;
RX DOI=10.1007/978-1-4612-0411-4_17;
RX PubMed=7684560;
RX PubMed=15463957;
WW https://www.kerafast.com/product/2838/cystic-fibrosis-human-bronchial-epithelial-cell-line-cft1
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CFTE29o-
AC CVCL_IN57
SY CFTE29o(-); CFTE-29o-
RX PubMed=15463957;
WW http://www.dartmouth.edu/~cysfib/cell-lines.html
CC Characteristics: Homozygous for the CFTR p.Phe508del mutation.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CFZT(A)
AC CVCL_3498
DR CLO; CLO_0002396
DR ATCC; CRL-6338
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6338; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID CFZT(B)
AC CVCL_3499
DR CLO; CLO_0002397
DR ATCC; CRL-6339
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6339; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID CG-1
AC CVCL_4J65
RX PubMed=8358942;
DI NCIt; C4304; Malignant giant cell tumor of bone
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CG-4
AC CVCL_0210
SY CG4
DR BTO; BTO:0005724
DR MCCL; MCC:0000099
RX PubMed=1613821;
RX PubMed=7751054;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-187.html
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID CG-91
AC CVCL_M729
RX Patent=RU2061753;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/acg-91.htm
OX NCBI_TaxID=9925; ! Capra hircus
SX Female
CA Spontaneously immortalized cell line
//
ID CG-SH
AC CVCL_1K03
DR Cosmic; 1246920
RX PubMed=19414191;
RX PubMed=25934047;
CC Characteristics: Has a normal karyotype.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced.
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CG1 [Human nasopharyngeal carcinoma]
AC CVCL_J445
RX PubMed=2479472;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CG1 [Mouse mammary carcinoma]
AC CVCL_0A62
RX PubMed=6087454;
RX PubMed=6415065;
CC Transfected with: UniProtKB; P03522; VSV G protein.
CC Breed/subspecies: RIII.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6550 ! C127
SX Female
CA Cancer cell line
//
ID CG1476
AC CVCL_GT20
DR BCRC; 08C0057
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GT21 ! CG1485
SX Female
CA Finite cell line
//
ID CG1485
AC CVCL_GT21
DR BCRC; 08C0044
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): BCRC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 7,8
ST TPOX: 8,9
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GT20 ! CG1476
SX Female
CA Transformed cell line
//
ID CG5/Dx
AC CVCL_4D05
RX PubMed=8712686;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4D04 ! MCF-7/CG-5
CA Cancer cell line
//
ID CG7C7
AC CVCL_G645
DR CLO; CLO_0002399
DR ATCC; HB-126
RX PubMed=6193965;
CC Monoclonal antibody target: UniProtKB; P01308; Human INS (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID CGBQ
AC CVCL_6383
SY CG-BQ; SPGC-CCL169
DR CLO; CLO_0002404
DR ATCC; CCL-169
RX CelloPub=CLPUB00029;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=8844; ! Anser anser anser
CA Spontaneously immortalized cell line
//
ID CGCCA
AC CVCL_5U54
SY Chang Gung CCA
RX PubMed=21734803;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60372; Rat cholangiocarcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID CGLK-1
AC CVCL_HF49
RX PubMed=23460275;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CGLK-2
AC CVCL_HF50
RX PubMed=23460275;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CGM1
AC CVCL_7251
DR CLO; CLO_0050078
DR BioSample; SAMN03472291
DR CCRID; 3131C0001000200002
DR dbMHC; 48720
DR ECACC; 94050319
DR IHW; IHW9207
DR IMGT/HLA; 10407
DR RCB; RCB0566
WW http://bioinformatics.hsanmartino.it/ecbr/cl207.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 8,13
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6
ST TPOX: 9,10
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CGP04
AC CVCL_E522
DR dbMHC; 48721
DR IHW; IHW9425
DR IMGT/HLA; 26028
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CGR8
AC CVCL_3987
SY CGR-8
DR BTO; BTO:0004308
DR CLO; CLO_0002405
DR EFO; EFO_0006273
DR CLDB; cl713
DR ECACC; 07032901
DR ECACC; 95011018
DR TOKU-E; 4123
RX PubMed=8183905;
CC Discontinued: ECACC; 95011018; probable.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID CGFR-BO-1
AC CVCL_1E25
RX PubMed=15529005;
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
CA Spontaneously immortalized cell line
//
ID CGFR-BO-2
AC CVCL_1E26
RX PubMed=15529005;
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
CA Spontaneously immortalized cell line
//
ID CGT-6
AC CVCL_6566
SY AtT-20ins (CGT-6); CGT6
DR CLO; CLO_0001768
DR ATCC; CRL-11285
RX Patent=US5427940;
RX PubMed=1309953;
RX PubMed=8325893;
RX PubMed=8433987;
CC Transfected with: HGNC; 6081; INS.
CC Transfected with: RGD; 3705; Slc2a2.
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1G40 ! AtT-20ins
CA Cancer cell line
//
ID CGTH-W-1
AC CVCL_1120
SY CGTH-W1; CGTH W-1; CGTHW1
DR BTO; BTO:0004740
DR CLO; CLO_0002406
DR EFO; EFO_0002131
DR BioSample; SAMN03470999
DR BioSample; SAMN03473318
DR CCLE; CGTHW1_THYROID
DR ChEMBL-Cells; CHEMBL3308849
DR ChEMBL-Targets; CHEMBL2366300
DR Cosmic; 910568
DR Cosmic; 1995365
DR Cosmic; 2054098
DR Cosmic-CLP; 910568
DR DSMZ; ACC-360
DR GDSC; 910568
DR GEO; GSM886926
DR GEO; GSM887992
DR GEO; GSM1669673
DR IGRhCellID; CGTHW1
RX PubMed=8888804;
RX PubMed=22460905;
RX PubMed=23833040;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~20-25 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 13
ST D16S539: 11
ST D18S51: 15,17
ST D19S433: 13,14
ST D21S11: 29,31
ST D2S1338: 17,18
ST D3S1358: 15,18
ST D5S818: 9,11 (DSMZ)
ST D5S818: 11 (Cosmic-CLP; PubMed=25877200)
ST D7S820: 8,9
ST D8S1179: 11,13
ST FGA: 21,24
ST Penta D: 9
ST Penta E: 11
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 14,18
DI NCIt; C8054; Thyroid gland follicular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CGTH-W-2
AC CVCL_3897
SY CGTH-W2; CGTH W-2
DR BTO; BTO:0004741
RX PubMed=8888804;
DI NCIt; C8054; Thyroid gland follicular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CGTH-W-3
AC CVCL_3898
SY CGTH-W3; CGTH W-3
DR BTO; BTO:0004739
RX PubMed=8888804;
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ch 1 Es
AC CVCL_2401
SY Ch1.Es; Ch1Es; Ch 1 Es (NBL-8); NBL-8
DR CLO; CLO_0002407
DR CLO; CLO_0002409
DR ATCC; CCL-73
DR ATCC; CRL-6581
DR BCRJ; 0066
DR JCRB; JCRB9037
DR KCLB; 10073
RX PubMed=5587551;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6581; true.
CC Discontinued: KCLB; 10073; probable.
OX NCBI_TaxID=9925; ! Capra hircus
SX Male
CA Spontaneously immortalized cell line
//
ID CH 8
AC CVCL_M020
SY CH8
RX PubMed=20461036;
DI NCIt; C5156; Spinal chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ch-1
AC CVCL_M602
RX PubMed=9820274;
CC Doubling time: 2 days (PubMed=9820274).
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CH-157MN
AC CVCL_5723
SY CH157-MN; CH-157-MN; CH-157 MN; CH157MN
DR CCLE; CH157MN_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 2516046
RX PubMed=7714613;
RX PubMed=10083766;
RX PubMed=18261772;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 22 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CH-157MN-LucNeo
AC CVCL_HA68
SY CH-157-MN-LucNeo
RX PubMed=18240927;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5723 ! CH-157MN
SX Female
CA Cancer cell line
//
ID CH-235MG
AC CVCL_5724
RX PubMed=1639861;
RX PubMed=1732280;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ch-2879
AC CVCL_9921
SY CH-2879; CH2879
DR Cosmic; 1602477
DR Cosmic; 1992324
RX PubMed=12808123;
RX PubMed=19787792;
RX PubMed=22057234;
CC Characteristics: Has no IDH1 or IDH2 mutation.
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CH-3573
AC CVCL_A013
RX PubMed=22350793;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Ch-8-OA
AC CVCL_F763
RX PubMed=11562770;
CC Transformant: Ad-SV40.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CH-EB6
AC CVCL_K203
DR CLO; CLO_0002416
DR ATCC; HB-200
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Ch-Huang-1
AC CVCL_B392
RX PubMed=22613331;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CH-N-1
AC CVCL_W520
RX PubMed=2486614;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CH03
AC CVCL_V562
SY BCSCH03
DR Cosmic; 2076359
RX PubMed=23958880;
ST Source(s): PubMed=23958880
ST Amelogenin: X
ST D16S539: 9,12
ST D18S51: 14
ST D19S433: 13,14
ST D21S11: 29,30
ST D2S1338: 24
ST D3S1358: 15,17
ST D8S1179: 11,14
ST FGA: 23
ST TH01: 8,9
ST vWA: 17
DI NCIt; C6476; Dedifferentiated chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CH1 [Human ESC]
AC CVCL_D177
DR ISCR; 1727
RX PubMed=21542965;
CC From: Peking University; Beijing; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CH1 [Human ovarian carcinoma]
AC CVCL_4992
DR BioSample; SAMN03151886
DR ChEMBL-Cells; CHEMBL3307620
DR ChEMBL-Targets; CHEMBL614455
DR GEO; GSM459735
DR GEO; GSM851914
DR IGRhCellID; CH1
RX PubMed=1423261;
RX PubMed=1617660;
RX PubMed=1892748;
RX PubMed=2653399;
RX PubMed=15677628;
RX PubMed=22710073;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PA-1 derivative (PubMed=22710073).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D21S11: 29,31.2
ST D8S1179: 14,15
ST FGA: 24
ST TH01: 7,9
ST vWA: 15,17
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0479 ! PA-1
SX Female
CA Cancer cell line
//
ID CH1 [Mouse lymphoma]
AC CVCL_5424
DR CLO; CLO_0002408
DR ATCC; TIB-221
DR Lonza; 374
RX PubMed=6983495;
RX PubMed=2582425;
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID CH1-cisR
AC CVCL_X012
SY CH1/cisR; CH1cisR; CH1Cis
DR GEO; GSM851915
RX PubMed=1617660;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (CH1) has been shown to be a DOV13 derivative.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 15,18
ST D21S11: 29,31.2
ST D8S1179: 14,15
ST FGA: 24
ST TH01: 7,9
ST vWA: 15,17
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4992 ! CH1 [Human ovarian carcinoma]
SX Female
CA Cancer cell line
//
ID CH1:RD1694
AC CVCL_Y426
RX PubMed=7537518;
CC Problematic cell line: Contaminated. Parent cell line (CH1) has been shown to be a DOV13 derivative.
CC Selected for resistance to: ChEBI; CHEBI:5847; ICI D1694 (Tomudex; ZD1694).
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4992 ! CH1 [Human ovarian carcinoma]
SX Female
CA Cancer cell line
//
ID CH12
AC CVCL_6818
DR Lonza; 243
RX PubMed=2582425;
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID CH12.LX
AC CVCL_0211
SY CH12-LX; CH12LX
DR BTO; BTO:0002493
DR EFO; EFO_0005233
DR MCCL; MCC:0000100
DR ENCODE; ENCBS042ZWV
DR ENCODE; ENCBS044ENC
DR ENCODE; ENCBS045ENC
DR ENCODE; ENCBS076QIH
DR ENCODE; ENCBS091RNA
DR ENCODE; ENCBS092RNA
DR ENCODE; ENCBS443MXB
DR ENCODE; ENCBS777FXN
DR ENCODE; ENCBS782ENP
DR ENCODE; ENCBS789HDO
DR ENCODE; ENCBS824VDB
DR ENCODE; ENCBS912CAS
DR ENCODE; ENCBS940UDN
DR ENCODE; ENCBS948OTG
DR GEO; GSM1000091
DR GEO; GSM1000114
DR GEO; GSM1000115
DR GEO; GSM1000116
DR GEO; GSM1000117
DR GEO; GSM1000118
DR GEO; GSM1000119
DR GEO; GSM1000122
DR GEO; GSM1014153
RX PubMed=2945204;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/CH12_Weissman_protocol.pdf
CC Part of: ENCODE project mouse cell lines.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6818 ! CH12
CA Cancer cell line
//
ID CH12F3
AC CVCL_E067
RX PubMed=8671604;
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0211 ! CH12.LX
CA Cancer cell line
//
ID CH12F3 (AID+/-)
AC CVCL_GZ20
WW https://www.kerafast.com/product/2785/ch12f3-aid-cell-line
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); MGI:1342279; Aicda.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (AID-/-)
AC CVCL_GZ21
WW https://www.kerafast.com/product/2786/ch12f3-aid-cell-line
CC Knockout cell: Method=Homologous recombination; MGI:1342279; Aicda.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (APE1-/-/-APE2-)
AC CVCL_GZ22
RX PubMed=23382073;
WW https://www.kerafast.com/product/2783/ch12f3-ape1-ape2-cell-line
CC Knockout cell: Method=Homologous recombination; MGI:88042; Apex1.
CC Knockout cell: Method=Homologous recombination; MGI:1924872; Apex2.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (APE2-)
AC CVCL_GZ23
RX PubMed=23382073;
WW https://www.kerafast.com/product/2783/ch12f3-ape1-ape2-cell-line
CC Knockout cell: Method=Homologous recombination; MGI:1924872; Apex2.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (CTNNBL1+/-)
AC CVCL_GZ24
RX PubMed=20585033;
WW https://www.kerafast.com/product/2793/ch12f3-ctnnbl1-cell-line
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); MGI:1913892; Ctnnbl1.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (CTNNBL1-/-)
AC CVCL_GZ25
RX PubMed=20585033;
WW https://www.kerafast.com/product/2794/ch12f3-ctnnbl1-cell-line
CC Knockout cell: Method=Homologous recombination; MGI:1913892; Ctnnbl1.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (Lig1+/-)
AC CVCL_GZ26
RX PubMed=24726358;
WW https://www.kerafast.com/product/2789/ch12f3-lig1-cell-line
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); MGI; MGI:101789; Lig1.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (Lig1+/-Lig4-/-)
AC CVCL_GZ27
RX PubMed=26787901;
WW https://www.kerafast.com/product/2791/ch12f3-lig1-lig4-cell-line
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); MGI; MGI:101789; Lig1.
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1335098; Lig4.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (Lig1-/-)
AC CVCL_GZ28
RX PubMed=24726358;
RX PubMed=26787901;
WW https://www.kerafast.com/product/2790/ch12f3-lig1-cell-line
CC Knockout cell: Method=Homologous recombination; MGI; MGI:101789; Lig1.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (Lig1-/-Lig4-/-)
AC CVCL_GZ29
RX PubMed=26787901;
WW https://www.kerafast.com/product/2792/ch12f3-lig1-lig4-cell-line
CC Knockout cell: Method=Homologous recombination; MGI; MGI:101789; Lig1.
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1335098; Lig4.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (Lig4+/-)
AC CVCL_GZ30
RX PubMed=19001141;
WW https://www.kerafast.com/product/2787/ch12f3-lig4-cell-line
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); MGI; MGI:1335098; Lig4.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3 (Lig4-/-)
AC CVCL_GZ31
SY Lig4-null CH12F3
RX PubMed=19001141;
RX PubMed=26787901;
WW https://www.kerafast.com/product/2788/ch12f3-lig4-cell-line
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1335098; Lig4.
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID CH12F3-2A
AC CVCL_E068
DR BTO; BTO:0003990
DR CLO; CLO_0051570
DR RCB; RCB2809
RX PubMed=11606740;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-460.html
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E067 ! CH12F3
CA Cancer cell line
//
ID Ch13
AC CVCL_8951
SY Ch-13
DR CLO; CLO_0002410
DR ATCC; HB-8573
RX Patent=US4695538;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Ch2.D
AC CVCL_5275
SY Ch2D
DR CLO; CLO_0002411
DR ATCC; CRL-6270
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6270; true.
OX NCBI_TaxID=9925; ! Capra hircus
SX Sex undetermined
CA Finite cell line
//
ID CH22
AC CVCL_C159
RX PubMed=22504929;
WW https://www.chordomafoundation.org/reagents-data/cell-line-repository/ch22/
CC Doubling time: 33 hours (PubMed=22504929).
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CH26-1352
AC CVCL_K222
DR CLO; CLO_0002412
DR ATCC; HB-8329
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID CH27 [Human lung carcinoma]
AC CVCL_7177
SY CH-27
DR BTO; BTO:0004891
RX PubMed=11730720;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CH27 [Mouse lymphoma]
AC CVCL_7178
DR Lonza; 251
RX PubMed=3491037;
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID CH31
AC CVCL_S465
RX PubMed=2582425;
CC Breed/subspecies: B10.H-2aH-4bp/Wts.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID CH34
AC CVCL_W889
SY BCSCH34
DR Cosmic; 2076360
RX PubMed=23958880;
CC Caution: Cell line not maintained.
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CH3A4A7
AC CVCL_IQ36
RX Patent=US20080038272;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2667.
CC Monoclonal antibody target: UniProtKB; Q9ULV1; Human FZD4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Ch5
AC CVCL_DD89
SY CH5; Ch-5
DR ATCC; HB-8572
RX Patent=US4695538;
CC Discontinued: ATCC; HB-8572; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CH56
AC CVCL_V563
SY BCSCH56
DR Cosmic; 2076361
RX PubMed=23958880;
ST Source(s): PubMed=23958880
ST Amelogenin: X
ST D16S539: 12
ST D18S51: 15,26
ST D19S433: 12,13
ST D21S11: 29,30
ST D2S1338: 20,23
ST D3S1358: 16
ST D8S1179: 11,14
ST FGA: 24
ST TH01: 6,9
ST vWA: 14,18
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CH7C17
AC CVCL_GX97
SY CH7-C17
DR TOKU-E; 4175
RX PubMed=1588277;
RX PubMed=7614994;
CC Transfected with: HGNC; 12155; TRB (from HA1.7).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1316 ! J.RT3-T3.5
SX Male
CA Cancer cell line
//
ID CHA-hES1
AC CVCL_IU46
SY CHA hES-1; CHA-hES-1; CH01
RX PubMed=17356540;
CC From: CHA University; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CHA-hES10
AC CVCL_9736
SY CHA-hES 10; Kor-hES13
DR ISCR; 1728
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010022.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES11
AC CVCL_9737
SY CHA-hES 11; Kor-hES14
DR ISCR; 1729
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010023.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES12
AC CVCL_9738
SY CHA-hES 12; Kor-hES15
DR ISCR; 1730
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010024.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES13
AC CVCL_9739
SY CHA-hES 13; Kor-hES28
DR ISCR; 1731
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010026.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES14
AC CVCL_9740
SY CHA-hES 14; Kor-hES29
DR ISCR; 1732
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010027.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES15
AC CVCL_9741
SY CHA-hES 15; Kor-hES30
DR ISCR; 1733
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010028.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES16
AC CVCL_9742
SY CHA-hES 16; Kor-hES47
DR ISCR; 1734
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010029.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Embryonic stem cell
//
ID CHA-hES17
AC CVCL_9743
SY CHA-hES 17; Kor-hES31
DR ISCR; 1735
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010030.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES18
AC CVCL_9744
SY CHA-hES 18; Kor-hES32
DR ISCR; 1736
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010038.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES19
AC CVCL_9745
SY CHA-hES 19; Kor-hES48
DR ISCR; 1737
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010031.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES2
AC CVCL_IU47
SY CHA hES-2; CHA-hES-2; CH02
RX PubMed=17356540;
CC From: CHA University; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CHA-hES20
AC CVCL_9746
SY CHA-hES 20; Kor-hES33
DR ISCR; 1738
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010032.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES21
AC CVCL_9747
SY CHA-hES 21; Kor-hES34
DR ISCR; 1739
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010033.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES22
AC CVCL_9748
SY CHA-hES 22; Kor-hES35
DR ISCR; 1740
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010039.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES23
AC CVCL_9749
SY CHA-hES 23; Kor-hES36
DR ISCR; 1741
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010034.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES24
AC CVCL_9750
SY CHA-hES 24; Kor-hES37
DR ISCR; 1742
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010035.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES25
AC CVCL_9751
SY CHA-hES 25; Kor-hES38
DR ISCR; 1743
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010040.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES26
AC CVCL_9752
SY CHA-hES 26; Kor-hES49
DR ISCR; 1744
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010036.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES27
AC CVCL_Y993
SY CHA-hES 27
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011006.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CHA-hES28
AC CVCL_Y994
SY CHA-hES 28
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011007.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES29
AC CVCL_Y995
SY CHA-hES 29
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011008.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES3
AC CVCL_9753
SY CHA-HES3; CHA-hES 3; Kor-hES5; CHAe001-A
DR hPSCreg; CHAe001-A
DR ISCR; 1745
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010001.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES3-eGFP
AC CVCL_X167
CC From: CHA University; South Korea.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9753 ! CHA-hES3
SX Male
CA Embryonic stem cell
//
ID CHA-hES3-RFP
AC CVCL_X168
CC From: CHA University; South Korea.
CC Transfected with: UniProtKB; Q9U6Y8; RFP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9753 ! CHA-hES3
SX Male
CA Embryonic stem cell
//
ID CHA-hES30
AC CVCL_Y996
SY CHA-hES 30
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012001.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES31
AC CVCL_Y997
SY CHA-hES 31
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012002.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES32
AC CVCL_Y998
SY CHA-hES 32
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012003.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES33
AC CVCL_Y999
SY CHA-hES 33
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012004.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES34
AC CVCL_Z000
SY CHA-hES 34
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012005.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CHA-hES35
AC CVCL_Z001
SY CHA-hES 35
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012006.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES36
AC CVCL_Z002
SY CHA-hES 36
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012007.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES37
AC CVCL_Z003
SY CHA-hES 37
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012008.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES38
AC CVCL_Z004
SY CHA-hES 38
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012010.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES39
AC CVCL_Z005
SY CHA-hES 39
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012011.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES4
AC CVCL_9754
SY CHA-HES4; CHA-hES 4; Kor-hES6; CHAe002-A
DR hPSCreg; CHAe002-A
DR ISCR; 1746
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010002.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES4-eGFP
AC CVCL_X169
CC From: CHA University; South Korea.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9754 ! CHA-hES4
SX Male
CA Embryonic stem cell
//
ID CHA-hES4-RFP
AC CVCL_X170
CC From: CHA University; South Korea.
CC Transfected with: UniProtKB; Q9U6Y8; RFP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9754 ! CHA-hES4
SX Male
CA Embryonic stem cell
//
ID CHA-hES40
AC CVCL_Z006
SY CHA-hES 40
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012012.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES41
AC CVCL_Z007
SY CHA-hES 41
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012013.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES42
AC CVCL_Z008
SY CHA-hES 42
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012014.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES43
AC CVCL_Z009
SY CHA-hES 43
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013001.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES44
AC CVCL_Z010
SY CHA-hES 44
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013002.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES45
AC CVCL_Z011
SY CHA-hES 45
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013003.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES46
AC CVCL_Z012
SY CHA-hES 46
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013004.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES47
AC CVCL_Z013
SY CHA-hES 47
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013005.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES48
AC CVCL_Z014
SY CHA-hES 48
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013006.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES49
AC CVCL_IS19
SY CHA-hES 49
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014004.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES5
AC CVCL_9755
SY CHA-hES 5; Kor-hES7
DR ISCR; 1747
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010017.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES50
AC CVCL_IS17
SY CHA-hES 50
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014005.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES51
AC CVCL_IS18
SY CHA-hES 51
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014006.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES52
AC CVCL_IS13
SY CHA-hES 52
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016001.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES53
AC CVCL_IS14
SY CHA-hES 53
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016002.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES54
AC CVCL_IS15
SY CHA-hES 54
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016003.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hES55
AC CVCL_IS16
SY CHA-hES 55
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016004.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES6
AC CVCL_9756
SY CHA-hES 6; Kor-hES8
DR ISCR; 1748
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010018.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES7
AC CVCL_9757
SY CHA-hES 7; Kor-hES9
DR ISCR; 1749
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010019.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES8
AC CVCL_9758
SY CHA-hES 8; Kor-hES10
DR ISCR; 1750
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010020.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hES9
AC CVCL_9759
SY CHA-hES 9; Kor-hES11
DR ISCR; 1751
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010021.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hESB1
AC CVCL_L124
SY CHA-hES B1; Kor-hES44
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010046.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hESB2
AC CVCL_L125
SY CHA-hES B2; Kor-hES45
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010047.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hESB3
AC CVCL_L126
SY CHA-hES B3; Kor-hES46
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010048.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hESM1
AC CVCL_9760
SY CHA-hES M1; Kor-hES39
DR ISCR; 1752
RX PubMed=24159464;
WW http://www.chaivf.co.kr/publication/list_content_subA.asp?no_index=294&page=2
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010041.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hESR1
AC CVCL_9761
SY CHA-hES R1; Kor-hES40
DR ISCR; 1753
RX PubMed=24159464;
WW http://www.chaivf.co.kr/publication/list_content_subA.asp?no_index=294&page=2
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010042.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA-hESR2
AC CVCL_9762
SY CHA-hES R2; Kor-hES41
DR ISCR; 1754
RX PubMed=24159464;
WW http://www.chaivf.co.kr/publication/list_content_subA.asp?no_index=294&page=2
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010043.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hESR3
AC CVCL_9763
SY CHA-hES R3; Kor-hES42
DR ISCR; 1755
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010044.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHA-hESR4
AC CVCL_9764
SY CHA-hES R4; Kor-hES43
DR ISCR; 1756
RX PubMed=24159464;
CC From: CHA University; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010045.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHA,AJ
AC CVCL_E523
SY CHA, AJ
DR dbMHC; 48722
DR ECACC; 94082211
DR IHW; IHW9112
DR IMGT/HLA; 11657
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl112.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CHA08-023
AC CVCL_9T34
DR IMGT/HLA; 25439
RX PubMed=22077627;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CHA59
AC CVCL_GZ61
SY CHA-59
DR GEO; GSM1676352
DR GEO; GSM1701682
RX PubMed=22870217;
RX PubMed=26351324;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Chab1KMM
AC CVCL_K104
DR CLO; CLO_0050702
DR BioSample; SAMN03472187
DR RCB; RCB0875
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 11
ST vWA: 19,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CHAD-B7
AC CVCL_0C88
SY CHAD-B7.4
RX PubMed=15064773;
RX PubMed=16797414;
CC Breed/subspecies: Border Collie.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CHAD-G4
AC CVCL_0C89
SY CHAD-G4.1; CHAD G4
RX PubMed=15064773;
RX PubMed=16797414;
RX PubMed=19461996;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CHAD-G6
AC CVCL_0C90
SY CHAD-G6.4; CHAD G6
RX PubMed=15064773;
RX PubMed=19461996;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CHAD-G8
AC CVCL_0C91
SY CHAD-G8.2; CHAD G8
RX PubMed=15064773;
RX PubMed=19461996;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CHAD-P9
AC CVCL_0C92
SY CHAD-P9.5; CHAD P9
RX PubMed=15064773;
RX PubMed=19461996;
CC Breed/subspecies: Portuguese water dog.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID ChaGo
AC CVCL_DG43
RX PubMed=4708151;
RX PubMed=4834404;
DI NCIt; C35875; Bronchogenic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ChaGo-C-5
AC CVCL_DG44
SY ChaGo-C5
RX PubMed=62839;
RX PubMed=4514312;
DI NCIt; C35875; Bronchogenic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DG43 ! ChaGo
SX Male
CA Cancer cell line
//
ID ChaGo-K-1
AC CVCL_1121
SY CHAGO-K-1; ChaGo K-1; ChaGo-K1; ChaGoK1
DR BTO; BTO:0003108
DR CLO; CLO_0002413
DR EFO; EFO_0002155
DR ATCC; HTB-168
DR BioSample; SAMN03473197
DR CCLE; CHAGOK1_LUNG
DR ChEMBL-Cells; CHEMBL3308489
DR ChEMBL-Targets; CHEMBL1075421
DR Cosmic; 687596
DR Cosmic; 1995366
DR Cosmic-CLP; 687596
DR ECACC; 96020948
DR GDSC; 687596
DR GEO; GSM784215
DR GEO; GSM827465
DR GEO; GSM886927
DR GEO; GSM887993
DR GEO; GSM1669674
DR IZSLER; BS TCL 186
RX PubMed=62839;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11
ST D18S51: 13,20
ST D21S11: 31.2,32
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8,12
ST D8S1179: 11,12
ST FGA: 23
ST Penta D: 9,13
ST Penta E: 11,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C35875; Bronchogenic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DG43 ! ChaGo
SX Male
CA Cancer cell line
//
ID Chang Liver
AC CVCL_0238
SY Chang liver; Chang Cells
DR BTO; BTO:0002049
DR CLO; CLO_0002414
DR CLO; CLO_0002415
DR MCCL; MCC:0000128
DR CLDB; cl715
DR CLDB; cl716
DR CLDB; cl717
DR CLDB; cl718
DR ATCC; CCL-13
DR BioSample; SAMN03151672
DR BioSample; SAMN03472417
DR BioSample; SAMN03472705
DR CCRID; 3131C0001000200009
DR CLS; 300139/p774_Chang-Liver_(HeLa)
DR ECACC; 88021102
DR IFO; IFO50016
DR IZSLER; BS CL 14
DR JCRB; JCRB9066
DR RCB; RCB0491
DR TOKU-E; 937
RX CelloPub=CLPUB00262;
RX DOI=10.1007/978-1-4757-1647-4_13;
RX PubMed=1246601;
RX PubMed=13472685;
RX PubMed=20143388;
RX PubMed=23925245;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: Genome sequenced (low read coverage).
CC Discontinued: RCB; RCB0491; true.
ST Source(s): ATCC; CLS; ECACC; JCRB; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 10 (ATCC; CLS; ECACC)
ST CSF1PO: 9,10 (JCRB)
ST D13S317: 12,13.3 (ATCC; CLS; JCRB)
ST D13S317: 12,14 (ECACC)
ST D16S539: 9,10
ST D18S51: 16
ST D21S11: 27,28
ST D3S1358: 15,18
ST D5S818: 12 (ATCC; CLS; ECACC)
ST D5S818: 11,12 (JCRB)
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 21
ST Penta D: 8,15
ST Penta E: 7,17
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18 (ATCC; CLS; ECACC; PubMed=11416159)
ST vWA: 16,17,18 (JCRB)
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID CHARGE1-13
AC CVCL_Y954
DR RCB; HPS0093
DI NCIt; C75100; CHARGE syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y955 ! CHARGE1-20
OI CVCL_Y956 ! CHARGE1-25
SX Male
CA Induced pluripotent stem cell
//
ID CHARGE1-20
AC CVCL_Y955
DR RCB; HPS0094
DI NCIt; C75100; CHARGE syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y954 ! CHARGE1-13
OI CVCL_Y956 ! CHARGE1-25
SX Male
CA Induced pluripotent stem cell
//
ID CHARGE1-25
AC CVCL_Y956
DR RCB; HPS0095
DI NCIt; C75100; CHARGE syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y954 ! CHARGE1-13
OI CVCL_Y955 ! CHARGE1-20
SX Male
CA Induced pluripotent stem cell
//
ID CHAUT-C
AC CVCL_F588
RX PubMed=7850752;
OX NCBI_TaxID=10029; ! Cricetulus griseus
OI CVCL_5958 ! CHAUT-G
SX Female
CA Cancer cell line
//
ID CHAUT-G
AC CVCL_5958
DR CLO; CLO_0051583
DR RCB; RCB0715
RX PubMed=7850752;
OX NCBI_TaxID=10029; ! Cricetulus griseus
OI CVCL_F588 ! CHAUT-C
SX Female
CA Cancer cell line
//
ID CHB
AC CVCL_1R45
DR BioSample; SAMN03151996
RX PubMed=5535723;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be of human origin (astrocytoma) but found to be from rat (PubMed=6451928, PubMed=20143388).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Undefined cell line type
//
ID CHB-1
AC CVCL_A812
DR ISCR; 66
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=3
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0001.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHB-10
AC CVCL_A821
SY BCHe004-A
DR hPSCreg; BCHe004-A
DR ISCR; 75
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=12
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0009.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHB-11
AC CVCL_A822
SY BCHe005-A
DR hPSCreg; BCHe005-A
DR ISCR; 76
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=13
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0010.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHB-12
AC CVCL_A823
SY BCHe006-A
DR hPSCreg; BCHe006-A
DR ISCR; 77
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=14
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0011.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHB-13
AC CVCL_A824
DR ISCR; 1841
RX PubMed=22284529;
WW http://grants.nih.gov/stem_cells/registry/draft_intent.htm
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; draft request for approval.
DI NCIt; C118844; Hypohidrotic ectodermal dysplasia with immune deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHB-14
AC CVCL_A825
DR ISCR; 1842
RX PubMed=22284529;
WW http://grants.nih.gov/stem_cells/registry/draft_intent.htm
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; draft request for approval.
DI NCIt; C118844; Hypohidrotic ectodermal dysplasia with immune deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHB-15
AC CVCL_A826
WW http://grants.nih.gov/stem_cells/registry/draft_intent.htm
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; draft request for approval.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CHB-2
AC CVCL_A813
DR ISCR; 67
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=5
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0002.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHB-3
AC CVCL_A814
DR ISCR; 68
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=6
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0003.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHB-4
AC CVCL_A815
DR ISCR; 69
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=7
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0004.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHB-5
AC CVCL_A816
DR ISCR; 70
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=8
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0005.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHB-6
AC CVCL_A817
DR ISCR; 71
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=9
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0006.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHB-7
AC CVCL_A818
SY BCHe001-A
DR hPSCreg; BCHe001-A
WW http://grants.nih.gov/stem_cells/registry/draft_intent.htm
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; draft request for approval.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CHB-8
AC CVCL_A819
SY CHB8; BCHe002-A
DR hPSCreg; BCHe002-A
DR ISCR; 73
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=10
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0007.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHB-9
AC CVCL_A820
SY BCHe003-A
DR hPSCreg; BCHe003-A
DR ISCR; 74
RX PubMed=18223642;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=11
CC From: Children's Hospital Boston; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0008.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID cHCC
AC CVCL_L313
RX PubMed=15566568;
CC Breed/subspecies: Cairn Terrier.
DI NCIt; C129298; Canine hepatocellular carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CHCC-NYU1
AC CVCL_9Y74
SY CHCC-NYU5
RX PubMed=6186403;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID CHCC-OU1
AC CVCL_T599
RX PubMed=6204901;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=9031; ! Gallus gallus
CA Transformed cell line
//
ID CHCC-OU2
AC CVCL_Y589
SY CHCC-OU-2
DR ATCC; CRL-12302
RX Patent=US5866117;
RX PubMed=3115063;
CC Group: Bird cell line.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Discontinued: ATCC; CRL-12302; probable.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Transformed cell line
//
ID CHCY-1
AC CVCL_3899
SY CHCY 1; CHCY1
DR BTO; BTO:0004890
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHD-1
AC CVCL_EP71
SY CHD1
DR Cosmic; 1849336
RX PubMed=8168998;
RX PubMed=22808230;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHDC
AC CVCL_IU83
SY Duck 3
RX PubMed=563848;
RX PubMed=18770475;
CC Group: Bird cell line.
CC Doubling time: ~19 hours (PubMed=563848).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=8839; ! Anas platyrhynchos
CA Cancer cell line
//
ID CHE-1
AC CVCL_C111
SY CHE1; SYSUe004-A
DR hPSCreg; SYSUe004-A
RX PubMed=12509934;
RX PubMed=17341453;
CC From: Sun Yat-sen University Second Affiliated Hospital; Guangzhou; China.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CHE-2
AC CVCL_C112
SY CHE2; SYSUe005-A
DR hPSCreg; SYSUe005-A
RX PubMed=12509934;
RX PubMed=17341453;
CC From: Sun Yat-sen University Second Affiliated Hospital; Guangzhou; China.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CHE-3
AC CVCL_C113
SY CHE3; SYSUe006-A
DR hPSCreg; SYSUe006-A
RX PubMed=12509934;
RX PubMed=17341453;
CC From: Sun Yat-sen University Second Affiliated Hospital; Guangzhou; China.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CHEF/16
AC CVCL_J501
SY CHEF16; CHEF 16; CHEF 16-2; Chinese Hamster Embryo Fibroblast 16
RX PubMed=694725;
OX NCBI_TaxID=10029; ! Cricetulus griseus
OI CVCL_J502 ! CHEF/18
SX Male
CA Spontaneously immortalized cell line
//
ID CHEF/18
AC CVCL_J502
SY CHEF18; CHEF 18; CHEF 18-1; Chinese Hamster Embryo Fibroblast 18
RX PubMed=694725;
OX NCBI_TaxID=10029; ! Cricetulus griseus
OI CVCL_J501 ! CHEF/16
SX Male
CA Spontaneously immortalized cell line
//
ID Chem 7
AC CVCL_8179
SY Chem-7
RX PubMed=230517;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C80307; Waldenstrom macroglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Chem-1
AC CVCL_L474
SY ChemiSCREEN Chem-1; Wild-type control Chem-1 cell line; ChemiSCREEN Chem-1 parental cell line
DR Millipore; HTSCHEM-1RTA
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Undefined cell line type
//
ID Chem-10
AC CVCL_GS46
SY ChemiSCREEN Chem-10; Wild-type control Chem-10 cell line; ChemiSCREEN Chem-10 parental cell line
DR Millipore; HTSCHEM-10
CC Discontinued: Millipore; HTSCHEM-10; true.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Undefined cell line type
//
ID Chem-2
AC CVCL_L475
SY ChemiSCREEN Chem-2; Wild-type control Chem-2 cell line; ChemiSCREEN Chem-2 parental cell line
DR Millipore; HTSCHEM-2
CC Discontinued: Millipore; HTSCHEM-2; true.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Undefined cell line type
//
ID Chem-3
AC CVCL_L476
SY ChemiSCREEN Chem-3; Wild-type control Chem-3 cell line; ChemiSCREEN Chem-3 parental cell line
DR Millipore; HTSCHEM-3RTA
OX NCBI_TaxID=10090; ! Mus musculus
CA Undefined cell line type
//
ID Chem-4
AC CVCL_GS44
SY ChemiSCREEN Chem-4; Wild-type control Chem-4 cell line; ChemiSCREEN Chem-4 parental cell line
DR Millipore; HTSCHEM-4
CC Discontinued: Millipore; HTSCHEM-4; true.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Undefined cell line type
//
ID Chem-5
AC CVCL_GS45
SY ChemiSCREEN Chem-5; Wild-type control Chem-5 cell line; ChemiSCREEN Chem-5 parental cell line
DR Millipore; HTSCHEM-5
CC Discontinued: Millipore; HTSCHEM-5; true.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Undefined cell line type
//
ID Cheptage
AC CVCL_M652
SY Chep-BL; CHEP-BL; CHEP BL; Chep BL; CHEP; Chep
RX PubMed=2824665;
RX PubMed=2898508;
RX PubMed=2943927;
RX PubMed=2985508;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CHES-1
AC CVCL_C808
SY SYSUe003-A
DR hPSCreg; SYSUe003-A
CC From: Sun Yat-sen University; Guangzhou; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHES1
AC CVCL_9732
SY CH-ES1; UNIGEe001-A
DR hPSCreg; UNIGEe001-A
DR ISCR; 302
RX PubMed=18803035;
RX PubMed=20428235;
WW http://www.bag.admin.ch/themen/medizin/03301/03305/index.html?webgrab_path=aHR0cDovL3d3dy5hZG1pbi5iYWdoZXMucm9vdC5hZG1pbi5jaC9leHBvcnQvY2VsbEluY2x1ZGUucGhwP2xhbmd1YWdlPWVuJmxhbmc9ZW4maW5jPWNlbGx8Mzl8ZGU%3D&lang=en
CC From: Geneva University; Geneva; Switzerland.
CC Registration: Swiss research registry; BAG-hES-GEW-0001.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHES2
AC CVCL_9733
SY CH-ES2; UNIBASe001-A; UBASe001-A
DR hPSCreg; UBASe001-A
RX PubMed=19950064;
WW http://www.bag.admin.ch/themen/medizin/03301/03305/index.html?webgrab_path=aHR0cDovL3d3dy5hZG1pbi5iYWdoZXMucm9vdC5hZG1pbi5jaC9leHBvcnQvY2VsbEluY2x1ZGUucGhwP2xhbmd1YWdlPWVuJmxhbmc9ZW4maW5jPWNlbGx8NTJ8ZGU%3D&lang=en
CC From: University Hospital of Basel; Basel; Switzerland.
CC Registration: Swiss research registry; BAG-hES-GEW-0002.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHES3
AC CVCL_9734
SY CH-ES3; UNIBASe002-A; UBASe002-A
DR hPSCreg; UBASe002-A
WW http://www.bag.admin.ch/themen/medizin/03301/03305/index.html?webgrab_path=aHR0cDovL3d3dy5hZG1pbi5iYWdoZXMucm9vdC5hZG1pbi5jaC9leHBvcnQvY2VsbEluY2x1ZGUucGhwP2xhbmd1YWdlPWVuJmxhbmc9ZW4maW5jPWNlbGx8Njd8ZGU%3D&lang=en
CC From: University Hospital of Basel; Basel; Switzerland.
CC Registration: Swiss research registry; BAG-hES-GEW-0003.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHES5
AC CVCL_9735
SY CH-ES5; UNIBASe003-A; UBASe003-A
DR hPSCreg; UBASe003-A
WW http://www.bag.admin.ch/themen/medizin/03301/03305/index.html?webgrab_path=aHR0cDovL3d3dy5hZG1pbi5iYWdoZXMucm9vdC5hZG1pbi5jaC9leHBvcnQvY2VsbEluY2x1ZGUucGhwP2xhbmd1YWdlPWVuJmxhbmc9ZW4maW5jPWNlbGx8Njh8ZGU%3D&lang=en
CC From: University Hospital of Basel; Basel; Switzerland.
CC Registration: Swiss research registry; BAG-hES-GEW-0004.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHES6
AC CVCL_W089
SY CH-ES6; CHES-6
WW http://www.bag.admin.ch/themen/medizin/03301/03305/index.html?webgrab_path=aHR0cDovL3d3dy5hZG1pbi5iYWdoZXMucm9vdC5hZG1pbi5jaC9leHBvcnQvY2VsbEluY2x1ZGUucGhwP2xhbmd1YWdlPWVuJmxhbmc9ZW4maW5jPWNlbGx8Nzl8ZGU%3D&lang=en
CC From: University Hospital of Basel; Basel; Switzerland.
CC Registration: Swiss research registry; BAG-hES-GEW-0005.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CHES7
AC CVCL_W090
SY CH-ES7; CHES-7
CC From: University Hospital of Basel; Basel; Switzerland.
CC Registration: Swiss research registry; BAG-hES-GEW-0006.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID chESC-3
AC CVCL_C063
SY ChESC-3; chESC3; H3; CSUe001-A
DR hPSCreg; CSUe001-A
RX PubMed=19403374;
CC From: Central South University; China.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CHEULL1F
AC CVCL_Y271
DR CGH-DB; 9194-4
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHG-5
AC CVCL_B267
SY CHG5
RX DOI=10.3321/j.issn:1000-5404.1999.12.004;
RX DOI=10.3321/j.issn:1000-5404.2001.03.006;
RX PubMed=19781350;
CC Omics: Proteome analysis by 2D-DE.
DI NCIt; C3288; Oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHGS
AC CVCL_M272
RX CelloPub=CLPUB00275;
RX PubMed=2856440;
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHH-1
AC CVCL_4143
SY CHum salmon Heart-1
DR CLO; CLO_0002417
DR CLDB; cl719
DR ATCC; CRL-1680
DR ECACC; 92110412
RX DOI=10.3147/jsfp.28.27;
RX PubMed=6542066;
CC Group: Fish cell line.
OX NCBI_TaxID=8018; ! Oncorhynchus keta
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID chHES-10
AC CVCL_A827
SY chHES10
DR ISCR; 876
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=41
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-100
AC CVCL_A828
SY chHES100
DR ISCR; 901
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=135
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-101
AC CVCL_A829
SY chHES101
DR ISCR; 902
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=136
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-102
AC CVCL_A830
SY chHES102
DR ISCR; 903
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=137
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-103
AC CVCL_A831
SY chHES103
DR ISCR; 904
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=138
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-104
AC CVCL_A832
SY chHES104
DR ISCR; 905
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=139
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-105
AC CVCL_A833
SY chHES105
DR ISCR; 906
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=140
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-106
AC CVCL_A834
SY chHES106
DR ISCR; 907
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=141
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-107
AC CVCL_A835
SY chHES107
DR ISCR; 908
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=142
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-108
AC CVCL_A836
SY chHES108
DR ISCR; 909
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=143
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-109
AC CVCL_A837
SY chHES109
DR ISCR; 910
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=144
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Embryonic stem cell
//
ID chHES-11
AC CVCL_A838
SY chHES11
DR ISCR; 877
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=42
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-110
AC CVCL_A839
SY chHES110
DR ISCR; 911
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=145
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-111
AC CVCL_A840
SY chHES111
DR ISCR; 912
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=146
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-112
AC CVCL_A841
SY chHES112
DR ISCR; 913
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=147
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-113
AC CVCL_A842
SY chHES113
DR ISCR; 914
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=148
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-114
AC CVCL_A843
SY chHES114
DR ISCR; 915
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=149
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-115
AC CVCL_A844
SY chHES115
DR ISCR; 916
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=150
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-116
AC CVCL_A845
SY chHES116
DR ISCR; 917
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=151
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-117
AC CVCL_A846
SY chHES117
DR ISCR; 918
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=152
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-118
AC CVCL_A847
SY chHES118
DR ISCR; 919
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=153
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-119
AC CVCL_A848
SY chHES119
DR ISCR; 920
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=154
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-12
AC CVCL_A849
SY chHES12
DR ISCR; 878
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=43
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-120
AC CVCL_A850
SY chHES120
DR ISCR; 921
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=155
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-121
AC CVCL_A851
SY chHES121
DR ISCR; 922
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=156
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-122
AC CVCL_A852
SY chHES122
DR ISCR; 923
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=157
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-123
AC CVCL_A853
SY chHES123
DR ISCR; 924
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=158
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Embryonic stem cell
//
ID chHES-124
AC CVCL_A854
SY chHES124
DR ISCR; 925
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=159
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-125
AC CVCL_A855
SY chHES125
DR ISCR; 926
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=160
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-126
AC CVCL_A856
SY chHES126
DR ISCR; 927
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=161
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-127
AC CVCL_A857
SY chHES127
DR ISCR; 928
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=162
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-128
AC CVCL_A858
SY chHES128
DR ISCR; 929
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=163
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-129
AC CVCL_A859
SY chHES129
DR ISCR; 930
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=164
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-13
AC CVCL_A860
SY chHES13
DR ISCR; 879
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=44
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-130
AC CVCL_A861
SY chHES130
DR ISCR; 931
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=165
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-131
AC CVCL_A862
SY chHES131
DR ISCR; 932
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=166
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-132
AC CVCL_A863
SY chHES132
DR ISCR; 933
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=167
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-133
AC CVCL_A864
SY chHES133
DR ISCR; 934
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=168
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-134
AC CVCL_A865
SY chHES134
DR ISCR; 935
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=169
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-135
AC CVCL_A866
SY chHES135
DR ISCR; 936
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=170
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-136
AC CVCL_A867
SY chHES136
DR ISCR; 937
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=171
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-137
AC CVCL_A868
SY chHES137
DR ISCR; 938
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=172
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-138
AC CVCL_A869
SY chHES138
DR ISCR; 939
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=173
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-139
AC CVCL_A870
SY chHES139
DR ISCR; 940
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=174
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-14
AC CVCL_A871
SY chHES14
DR ISCR; 941
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=45
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-140
AC CVCL_A872
SY chHES140
DR ISCR; 942
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=175
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-141
AC CVCL_A873
SY chHES141
DR ISCR; 943
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=176
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-142
AC CVCL_A874
SY chHES142
DR ISCR; 944
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=177
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-143
AC CVCL_A875
SY chHES143
DR ISCR; 945
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=178
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-144
AC CVCL_A876
SY chHES144
DR ISCR; 946
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=179
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Embryonic stem cell
//
ID chHES-145
AC CVCL_A877
SY chHES145
DR ISCR; 947
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=180
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Embryonic stem cell
//
ID chHES-146
AC CVCL_A878
SY chHES146
DR ISCR; 948
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=181
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-147
AC CVCL_A879
SY chHES147
DR ISCR; 949
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=182
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-148
AC CVCL_A880
SY chHES148
DR ISCR; 950
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=183
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-149
AC CVCL_A881
SY chHES149
DR ISCR; 951
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=184
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-15
AC CVCL_A882
SY chHES15
DR ISCR; 952
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=46
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-150
AC CVCL_A883
SY chHES150
DR ISCR; 953
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=185
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-151
AC CVCL_A884
SY chHES151
DR ISCR; 954
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=186
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-152
AC CVCL_A885
SY chHES152
DR ISCR; 955
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=187
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-153
AC CVCL_A886
SY chHES153
DR ISCR; 956
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=188
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-154
AC CVCL_A887
SY chHES154
DR ISCR; 957
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=189
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID chHES-155
AC CVCL_A888
SY chHES155
DR ISCR; 958
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=190
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID chHES-156
AC CVCL_A889
SY chHES156
DR ISCR; 959
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=191
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-157
AC CVCL_A890
SY chHES157
DR ISCR; 960
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=192
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-158
AC CVCL_A891
SY chHES158
DR ISCR; 961
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=193
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Embryonic stem cell
//
ID chHES-159
AC CVCL_A892
SY chHES159
DR ISCR; 962
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=194
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-16
AC CVCL_A893
SY chHES16
DR ISCR; 963
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=48
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-160
AC CVCL_A894
SY chHES160
DR ISCR; 964
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=195
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-161
AC CVCL_A895
SY chHES161
DR ISCR; 965
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=196
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-162
AC CVCL_A896
SY chHES162
DR ISCR; 966
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=197
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-163
AC CVCL_A897
SY chHES163
DR ISCR; 967
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=198
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-164
AC CVCL_A898
SY chHES164
DR ISCR; 968
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=199
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-165
AC CVCL_A899
SY chHES165
DR ISCR; 969
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=200
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-166
AC CVCL_A900
SY chHES166
DR ISCR; 970
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=201
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-167
AC CVCL_A901
SY chHES167
DR ISCR; 971
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=202
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-168
AC CVCL_A902
SY chHES168
DR ISCR; 972
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=203
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-169
AC CVCL_A903
SY chHES169
DR ISCR; 973
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=204
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-17
AC CVCL_A904
SY chHES17
DR ISCR; 974
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=49
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-170
AC CVCL_A905
SY chHES170
DR ISCR; 975
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=205
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-171
AC CVCL_A906
SY chHES171
DR ISCR; 976
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=206
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-172
AC CVCL_A907
SY chHES172
DR ISCR; 977
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=207
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-173
AC CVCL_A908
SY chHES173
DR ISCR; 978
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=208
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-174
AC CVCL_A909
SY chHES174
DR ISCR; 979
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=209
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-175
AC CVCL_A910
SY chHES175
DR ISCR; 980
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=210
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-176
AC CVCL_A911
SY chHES176
DR ISCR; 981
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=211
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-177
AC CVCL_A912
SY chHES177
DR ISCR; 982
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=212
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-178
AC CVCL_A913
SY chHES178
DR ISCR; 983
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=213
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-179
AC CVCL_A914
SY chHES179
DR ISCR; 984
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=214
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-18
AC CVCL_A915
SY chHES18
DR ISCR; 985
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=50
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-180
AC CVCL_A916
SY chHES180
DR ISCR; 986
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=215
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-181
AC CVCL_A917
SY chHES181
DR ISCR; 987
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=216
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-182
AC CVCL_A918
SY chHES182
DR ISCR; 988
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=217
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-183
AC CVCL_A919
SY chHES183
DR ISCR; 989
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=218
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-184
AC CVCL_A920
SY chHES184
DR ISCR; 990
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=219
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-185
AC CVCL_A921
SY chHES185
DR ISCR; 991
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=220
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-186
AC CVCL_A922
SY chHES186
DR ISCR; 992
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=221
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-187
AC CVCL_A923
SY chHES187
DR ISCR; 993
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=222
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-188
AC CVCL_A924
SY chHES188
DR ISCR; 994
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=223
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-189
AC CVCL_A925
SY chHES189
DR ISCR; 995
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=224
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-19
AC CVCL_A926
SY chHES19
DR ISCR; 996
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=51
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-190
AC CVCL_A927
SY chHES190
DR ISCR; 997
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=225
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-191
AC CVCL_A928
SY chHES191
DR ISCR; 998
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=226
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Embryonic stem cell
//
ID chHES-192
AC CVCL_A929
SY chHES192
DR ISCR; 999
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=227
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-193
AC CVCL_A930
SY chHES193
DR ISCR; 1000
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=228
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-194
AC CVCL_A931
SY chHES194
DR ISCR; 1001
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=229
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-195
AC CVCL_A932
SY chHES195
DR ISCR; 1002
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=230
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-20
AC CVCL_A933
SY ChHES-20; chHES20; CSUe004-A
DR hPSCreg; CSUe004-A
DR ISCR; 226
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=52
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-21
AC CVCL_A934
SY chHES21
DR ISCR; 1003
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=53
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-22
AC CVCL_A935
SY ChHES-22; chHES22; CSUe005-A
DR hPSCreg; CSUe005-A
DR ISCR; 227
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=57
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-23
AC CVCL_A936
SY chHES23
DR ISCR; 1004
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=58
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-24
AC CVCL_A937
SY chHES24
DR ISCR; 1005
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=59
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-25
AC CVCL_A938
SY chHES25
DR ISCR; 1006
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=60
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-26
AC CVCL_A939
SY chHES26
DR ISCR; 1007
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=61
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-27
AC CVCL_A940
SY chHES27
DR ISCR; 1008
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=62
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-28
AC CVCL_A941
SY chHES28
DR ISCR; 1009
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=63
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-29
AC CVCL_A942
SY chHES29
DR ISCR; 1010
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=64
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-3
AC CVCL_A943
SY chHES3
DR ISCR; 1430
RX PubMed=20224969;
WW http://www.hescbank.cn/ew/show.asp?id=33
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-30
AC CVCL_A944
SY chHES30
DR ISCR; 1011
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=65
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-31
AC CVCL_A945
SY chHES31
DR ISCR; 1012
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=66
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-32
AC CVCL_A946
SY chHES32
DR ISCR; 1013
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=67
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-33
AC CVCL_A947
SY chHES33
DR ISCR; 1014
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=68
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-34
AC CVCL_A948
SY chHES34
DR ISCR; 1015
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=69
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-35
AC CVCL_A949
SY chHES35
DR ISCR; 1016
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=70
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-36
AC CVCL_A950
SY chHES36
DR ISCR; 1017
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=71
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-37
AC CVCL_A951
SY chHES37
DR ISCR; 1018
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=72
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-38
AC CVCL_A952
SY chHES38
DR ISCR; 1019
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=73
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-39
AC CVCL_A953
SY chHES39
DR ISCR; 1020
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=74
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-4
AC CVCL_A954
SY chHES4
DR ISCR; 1431
RX PubMed=20224969;
WW http://www.hescbank.cn/ew/show.asp?id=37
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-415
AC CVCL_AB80
RX PubMed=27345785;
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
DI NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-419
AC CVCL_9T88
RX PubMed=26987927;
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-40
AC CVCL_A955
SY chHES40
DR ISCR; 1021
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=75
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-41
AC CVCL_A956
SY chHES41
DR ISCR; 1022
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=76
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-42
AC CVCL_A957
SY chHES42
DR ISCR; 1023
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=77
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-427
AC CVCL_AD57
RX PubMed=27345972;
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
DI NCIt; C85075; Spinal muscular atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-43
AC CVCL_A958
SY chHES43
DR ISCR; 1024
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=78
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-44
AC CVCL_A959
SY chHES44
DR ISCR; 1025
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=79
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-45
AC CVCL_A960
SY chHES45
DR ISCR; 1026
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=80
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-46
AC CVCL_A961
SY chHES46
DR ISCR; 1027
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=81
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Embryonic stem cell
//
ID chHES-47
AC CVCL_A962
SY chHES47
DR ISCR; 1028
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=82
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-48
AC CVCL_A963
SY chHES48
DR ISCR; 1029
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=83
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-49
AC CVCL_A964
SY chHES49
DR ISCR; 1030
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=84
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
CC Caution: PubMed=19896436 indicates that this cell line is of female origin which is contradictory with the karyotype in ISCR and the Chinese ESC bank web site.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-50
AC CVCL_A965
SY chHES50
DR ISCR; 1031
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=85
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-51
AC CVCL_A966
SY chHES51
DR ISCR; 1032
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=86
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-52
AC CVCL_A967
SY chHES52
DR ISCR; 1033
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=87
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-53
AC CVCL_A968
SY chHES53
DR ISCR; 1034
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=88
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-54
AC CVCL_A969
SY chHES54
DR ISCR; 1035
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=89
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-55
AC CVCL_A970
SY chHES55
DR ISCR; 1036
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=90
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-56
AC CVCL_A971
SY chHES56
DR ISCR; 1037
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=91
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-57
AC CVCL_A972
SY chHES57
DR ISCR; 1038
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=92
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-58
AC CVCL_A973
SY chHES58
DR ISCR; 1039
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=93
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-59
AC CVCL_A974
SY chHES59
DR ISCR; 1040
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=94
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-60
AC CVCL_A975
SY chHES60
DR ISCR; 1041
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=95
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-61
AC CVCL_A976
SY chHES61
DR ISCR; 1042
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=96
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-62
AC CVCL_A977
SY chHES62
DR ISCR; 1043
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=97
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-63
AC CVCL_A978
SY chHES63
DR ISCR; 1044
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=98
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-64
AC CVCL_A979
SY chHES64
DR ISCR; 1045
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=99
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-65
AC CVCL_A980
SY chHES65
DR ISCR; 1046
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=100
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-66
AC CVCL_A981
SY chHES66
DR ISCR; 1047
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=101
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-67
AC CVCL_A982
SY chHES67
DR ISCR; 1048
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=102
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-68
AC CVCL_A983
SY chHES68
DR ISCR; 1049
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=103
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-69
AC CVCL_A984
SY chHES69
DR ISCR; 1050
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=104
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-7
AC CVCL_A985
SY chHES7
DR ISCR; 1432
RX PubMed=20224969;
WW http://www.hescbank.cn/ew/show.asp?id=38
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-70
AC CVCL_A986
SY chHES70
DR ISCR; 1051
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=105
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-71
AC CVCL_A987
SY chHES71
DR ISCR; 1052
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=106
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-72
AC CVCL_A988
SY chHES72
DR ISCR; 1053
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=107
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-73
AC CVCL_A989
SY chHES73
DR ISCR; 1054
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=108
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-74
AC CVCL_A990
SY chHES74
DR ISCR; 1055
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=109
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-75
AC CVCL_A991
SY chHES75
DR ISCR; 1056
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=110
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-76
AC CVCL_A992
SY chHES76
DR ISCR; 1057
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=111
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-77
AC CVCL_A993
SY chHES77
DR ISCR; 1058
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=112
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-78
AC CVCL_A994
SY chHES78
DR ISCR; 1059
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=113
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-79
AC CVCL_A995
SY chHES79
DR ISCR; 1060
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=114
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-8
AC CVCL_A996
SY ChHES-8; chHES8; CSUe003-A
DR hPSCreg; CSUe003-A
DR ISCR; 228
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=39
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-80
AC CVCL_A997
SY chHES80
DR ISCR; 1061
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=115
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-81
AC CVCL_A998
SY chHES81
DR ISCR; 1062
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=116
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-82
AC CVCL_A999
SY chHES82
DR ISCR; 1063
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=117
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-83
AC CVCL_B000
SY chHES83
DR ISCR; 1064
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=118
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-84
AC CVCL_B001
SY chHES84
DR ISCR; 1065
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=119
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-85
AC CVCL_B002
SY chHES85
DR ISCR; 1066
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=120
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-86
AC CVCL_B003
SY chHES86
DR ISCR; 1067
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=121
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-87
AC CVCL_B004
SY chHES87
DR ISCR; 1068
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=122
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-88
AC CVCL_B005
SY chHES88
DR ISCR; 1069
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=123
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-89
AC CVCL_B006
SY chHES89
DR ISCR; 1070
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=124
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-9
AC CVCL_B007
SY chHES9
DR ISCR; 880
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=40
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-90
AC CVCL_B008
SY chHES90
DR ISCR; 1071
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=125
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-91
AC CVCL_B009
SY chHES91
DR ISCR; 1072
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=126
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-92
AC CVCL_B010
SY chHES92
DR ISCR; 1073
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=127
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-93
AC CVCL_B011
SY chHES93
DR ISCR; 1074
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=128
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID chHES-94
AC CVCL_B012
SY chHES94
DR ISCR; 1075
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=129
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-95
AC CVCL_B013
SY chHES95
DR ISCR; 1076
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=130
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-96
AC CVCL_B014
SY chHES96
DR ISCR; 1077
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=131
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Embryonic stem cell
//
ID chHES-97
AC CVCL_B015
SY chHES97
DR ISCR; 1078
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=132
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID chHES-98
AC CVCL_B016
SY chHES98
DR ISCR; 1079
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=133
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID chHES-99
AC CVCL_B017
SY chHES99
DR ISCR; 1080
RX PubMed=19896436;
WW http://www.hescbank.cn/ew/show.asp?id=134
CC From: National Engineering Research Center of Human Stem Cells; Changsha; Hunan; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHI007
AC CVCL_E524
SY CHI 007
DR dbMHC; 48723
DR ECACC; 94082291
DR IHW; IHW9191
DR IMGT/HLA; 11733
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl191.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHI013
AC CVCL_E525
SY CHI 013
DR dbMHC; 48724
DR ECACC; 94082220
DR IHW; IHW9121
DR IMGT/HLA; 11665
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl121.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHI034
AC CVCL_E526
SY CHI 034
DR dbMHC; 48725
DR ECACC; 940822104
DR IHW; IHW9200
DR IMGT/HLA; 11741
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl200.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CHI037
AC CVCL_F347
DR CLO; CLO_0051129
DR RCB; HSC0085
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHI05
AC CVCL_F348
DR CLO; CLO_0051150
DR RCB; HSC0114
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI059
AC CVCL_F349
DR CLO; CLO_0051082
DR RCB; HSC0051
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI08
AC CVCL_F350
DR CLO; CLO_0051078
DR RCB; HSC0047
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHI101
AC CVCL_F351
DR CLO; CLO_0051183
DR RCB; HSC0146
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI139
AC CVCL_F352
DR CLO; CLO_0051088
DR RCB; HSC0058
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI142
AC CVCL_F353
DR CLO; CLO_0051200
DR RCB; HSC0153
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHI144
AC CVCL_F354
DR CLO; CLO_0051201
DR RCB; HSC0154
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI146
AC CVCL_F355
DR CLO; CLO_0051182
DR RCB; HSC0144
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHI147
AC CVCL_F356
DR CLO; CLO_0051202
DR RCB; HSC0157
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI212
AC CVCL_F357
DR CLO; CLO_0051098
DR RCB; HSC0071
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CHI214
AC CVCL_F358
DR CLO; CLO_0051092
DR RCB; HSC0064
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI215
AC CVCL_F359
DR CLO; CLO_0051189
DR RCB; HSC0158
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CHI217
AC CVCL_F360
DR CLO; CLO_0051187
DR RCB; HSC0155
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CHI220
AC CVCL_F361
DR CLO; CLO_0051188
DR RCB; HSC0156
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CHI232
AC CVCL_F362
DR CLO; CLO_0051077
DR RCB; HSC0045
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI233
AC CVCL_F363
DR CLO; CLO_0051171
DR RCB; HSC0135
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI236
AC CVCL_F364
DR CLO; CLO_0051163
DR RCB; HSC0127
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI244
AC CVCL_F365
DR CLO; CLO_0051151
DR RCB; HSC0115
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI3
AC CVCL_F366
DR CLO; CLO_0051177
DR RCB; HSC0145
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CHI52
AC CVCL_A061
SY CHI-52
DR Cosmic; 688094
DR Cosmic; 1609541
RX PubMed=12068308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CHI60
AC CVCL_F367
DR CLO; CLO_0051081
DR RCB; HSC0050
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI76
AC CVCL_F368
DR CLO; CLO_0051185
DR RCB; HSC0151
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHI84
AC CVCL_F369
DR CLO; CLO_0051172
DR RCB; HSC0137
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHI85
AC CVCL_F370
DR CLO; CLO_0051178
DR RCB; HSC0143
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI88
AC CVCL_F371
DR CLO; CLO_0051184
DR RCB; HSC0148
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI89
AC CVCL_F372
DR CLO; CLO_0051203
DR RCB; HSC0159
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHI90
AC CVCL_F373
DR CLO; CLO_0051176
DR RCB; HSC0142
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI91
AC CVCL_F374
DR CLO; CLO_0051162
DR RCB; HSC0126
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHI94
AC CVCL_F375
DR CLO; CLO_0051181
DR RCB; HSC0149
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHI99
AC CVCL_F376
DR CLO; CLO_0051186
DR RCB; HSC0152
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Chile.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHIE
AC CVCL_R885
SY Cloned HIrame Embryo; Clone HIrame Embryo
RX CelloPub=CLPUB00030;
CC Group: Fish cell line.
OX NCBI_TaxID=8255; ! Paralichthys olivaceus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Chironomus tentans epithelial cell line
AC CVCL_0A36
SY Epithelial cell line from Chironomus tentans; C. tentans epithelial cell line; C. tentans embryonic epithelial cell line
RX PubMed=7044809;
RX PubMed=16313569;
RX PubMed=25261295;
CC Group: Insect cell line.
CC Omics: ESTs sequenced.
CC Omics: Genome sequenced.
OX NCBI_TaxID=7153; ! Chironomus tentans
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CHKS-1
AC CVCL_FA17
RX PubMed=16678911;
CC Breed/subspecies: Pomeranian.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_FA18 ! CHKS-2
OI CVCL_FA19 ! CHKS-3
OI CVCL_FA20 ! CHKS-4
SX Male
CA Cancer cell line
//
ID CHKS-2
AC CVCL_FA18
RX PubMed=16678911;
CC Breed/subspecies: Pomeranian.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_FA17 ! CHKS-1
OI CVCL_FA19 ! CHKS-3
OI CVCL_FA20 ! CHKS-4
SX Male
CA Cancer cell line
//
ID CHKS-3
AC CVCL_FA19
RX PubMed=16678911;
CC Breed/subspecies: Pomeranian.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_FA17 ! CHKS-1
OI CVCL_FA18 ! CHKS-2
OI CVCL_FA20 ! CHKS-4
SX Male
CA Cancer cell line
//
ID CHKS-4
AC CVCL_FA20
RX PubMed=16678911;
CC Breed/subspecies: Pomeranian.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_FA17 ! CHKS-1
OI CVCL_FA18 ! CHKS-2
OI CVCL_FA19 ! CHKS-3
SX Male
CA Cancer cell line
//
ID CHL
AC CVCL_0212
SY Chinese Hamster Lung
DR CLO; CLO_0002418
DR CLO; CLO_0051575
DR MCCL; MCC:0000101
DR CLDB; cl720
DR CCRID; 3131C0001000100002
DR CCRID; 3153C0001000000027
DR ECACC; 87111906
DR KCB; KCB 200811YJ
DR RCB; RCB0097
RX PubMed=3558490;
RX PubMed=5452405;
OX NCBI_TaxID=10029; ! Cricetulus griseus
SX Female
CA Spontaneously immortalized cell line
//
ID CHL-1
AC CVCL_1122
SY CHL1
DR BTO; BTO:0004061
DR CLO; CLO_0002420
DR EFO; EFO_0002132
DR ATCC; CRL-9446
DR BioSample; SAMN03470897
DR CCLE; CHL1_SKIN
DR ChEMBL-Cells; CHEMBL3308722
DR ChEMBL-Targets; CHEMBL1075422
DR Cosmic; 706115
DR Cosmic; 897494
DR Cosmic; 910853
DR Cosmic; 1459665
DR Cosmic; 1477418
DR Cosmic; 1995367
DR Cosmic-CLP; 910853
DR GDSC; 910853
DR GEO; GSM886928
DR GEO; GSM887994
DR GEO; GSM1669675
DR IGRhCellID; CHL1
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,11
ST D16S539: 13
ST D18S51: 11,12
ST D19S433: 13,15
ST D21S11: 29,30
ST D2S1338: 18
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 10,13
ST FGA: 23,25
ST Penta D: 12,14
ST Penta E: 10,13
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2713 ! RPMI-7932
SX Female
CA Cancer cell line
//
ID CHL-2
AC CVCL_V643
DR ATCC; CRL-9451
RX Patent=US5017478;
CC Transfected with: HGNC; 9051; PLAT.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,11
ST D16S539: 13
ST D5S818: 11,12
ST D7S820: 11,13
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1122 ! CHL-1
SX Female
CA Cancer cell line
//
ID CHL-3A4
AC CVCL_J390
RX PubMed=10322772;
CC Transfected with: HGNC; 2637; CYP3A4.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID CHL-CYP2C18
AC CVCL_0U07
RX PubMed=12378636;
CC Transfected with: HGNC; 2620; CYP2C18.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID CHL/IU
AC CVCL_4585
SY CHL-IU; CHL-CL-11; CHL-11
DR CLO; CLO_0002419
DR ATCC; CRL-1935
RX DOI=10.1016/j.mrgentox.2016.08.001;
RX PubMed=9118971;
RX PubMed=10320750;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID CHL/IU (IVGT)
AC CVCL_GP67
SY CHL/IU(IVGT)
DR ECACC; 14100201
DR JCRB; JCRB0030
RX DOI=10.1016/j.mrgentox.2016.08.001;
CC Part of: In Vitro Genetic Toxicity (IVGT) cell line panel.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4585 ! CHL/IU
SX Female
CA Spontaneously immortalized cell line
//
ID CHLA-01-MED
AC CVCL_B044
DR ATCC; CRL-3021
DR BioSample; SAMN03471712
RX PubMed=24300787;
RX PubMed=25211508;
RX PubMed=26380221;
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,14
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 6,9.3
ST TPOX: 9,12
ST vWA: 16,17
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N534 ! CHLA-01R-MED
SX Male
CA Cancer cell line
//
ID CHLA-01R-MED
AC CVCL_N534
DR ATCC; CRL-3034
RX PubMed=24300787;
RX PubMed=25211508;
RX PubMed=26380221;
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,14
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 6,9.3
ST TPOX: 9,12
ST vWA: 16
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B044 ! CHLA-01-MED
SX Male
CA Cancer cell line
//
ID CHLA-02-ATRT
AC CVCL_B045
DR ATCC; CRL-3020
DR BioSample; SAMN03471711
RX PubMed=25211508;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 13
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 10,12
ST vWA: 16,18
DI NCIt; C6906; Atypical teratoid/rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-03-AA
AC CVCL_U616
DR ATCC; CRL-3035
RX PubMed=25211508;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CHLA-04-ATRT
AC CVCL_0F38
DR ATCC; CRL-3036
RX PubMed=25211508;
RX PubMed=25246426;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C6906; Atypical teratoid/rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-05-ATRT
AC CVCL_AQ41
RX PubMed=24300787;
RX PubMed=25211508;
RX PubMed=25246426;
DI NCIt; C6906; Atypical teratoid/rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-06-ATRT
AC CVCL_AQ42
RX PubMed=24300787;
RX PubMed=25211508;
RX PubMed=25246426;
DI NCIt; C6906; Atypical teratoid/rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CHLA-07-BSGBM
AC CVCL_AQ43
RX PubMed=24300787;
RX PubMed=25211508;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CHLA-10
AC CVCL_6583
SY CHLA10
DR Cosmic; 930038
DR GEO; GSM1676328
DR GEO; GSM1701625
RX PubMed=11212268;
RX PubMed=15289350;
RX PubMed=24312454;
RX PubMed=26351324;
RX PubMed=28196595;
WW http://www.cogcell.org/dl/EFT_Lines_DataSheets/CHLA-10_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Doubling time: 32 hours (COG).
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): COG; PubMed=24312454
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 12,14
ST D19S433: 12,13
ST D21S11: 28,29
ST D2S1338: 20
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 10,13
ST FGA: 23
ST TH01: 7
ST TPOX: 11
ST vWA: 16
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M150 ! CHLA-9
SX Female
CA Cancer cell line
//
ID CHLA-101
AC CVCL_6584
DR Cosmic; 930032
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-103
AC CVCL_6585
DR Cosmic; 930048
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-108
AC CVCL_6586
DR Cosmic; 930049
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-11
AC CVCL_AQ10
RX PubMed=24792489;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-119
AC CVCL_A055
DR Cosmic; 1161984
RX PubMed=11507071;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 9,12
ST D18S51: 13,17
ST D19S433: 14
ST D21S11: 29,30
ST D2S1338: 19,24
ST D3S1358: 16,17
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 11
ST FGA: 23,25
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 14,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-12
AC CVCL_AQ11
RX PubMed=24792489;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-122
AC CVCL_A054
RX PubMed=11507071;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/CHLA-122_Cell_Line_Data_Sheet_COGcell_org.pdf
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 9
ST D18S51: 12,18
ST D19S433: 13,14
ST D21S11: 31.2,32.2
ST D2S1338: 23,25
ST D3S1358: 15,18
ST D5S818: 9,12
ST D7S820: 8
ST D8S1179: 10,13
ST FGA: 23,25
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6590 ! CHLA-136
SX Female
CA Cancer cell line
//
ID CHLA-123
AC CVCL_A060
DR Cosmic; 930050
DR Cosmic; 1019952
DR Cosmic; 1109361
RX PubMed=11212268;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 11,12
ST D18S51: 12,19
ST D19S433: 13,15
ST D21S11: 32.2
ST D2S1338: 17
ST D3S1358: 15,18
ST D5S818: 9
ST D7S820: 8,10
ST D8S1179: 12,13
ST FGA: 24,25
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 14,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-124
AC CVCL_6587
DR Cosmic; 930051
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-132
AC CVCL_6588
DR Cosmic; 930052
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-134
AC CVCL_6589
RX PubMed=9850071;
RX PubMed=11507071;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11
ST D16S539: 9,12
ST D18S51: 13,14
ST D19S433: 12.2,14
ST D21S11: 31.2,33.2
ST D2S1338: 17,24
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 12,13
ST D8S1179: 13,14
ST FGA: 20,23
ST TH01: 7
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-136
AC CVCL_6590
SY CHLA_136
DR Cosmic; 930053
DR Cosmic; 1890103
RX PubMed=11507071;
RX PubMed=11212268;
RX PubMed=23202128;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/CHLA-136_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Doubling time: 44 hours (COG).
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 9,12
ST D18S51: 12,18
ST D19S433: 13,14
ST D21S11: 31.2,32.2
ST D2S1338: 23,25
ST D3S1358: 15,18
ST D5S818: 9,12
ST D7S820: 8
ST D8S1179: 10,13
ST FGA: 23,25
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A054 ! CHLA-122
SX Female
CA Cancer cell line
//
ID CHLA-138
AC CVCL_6591
DR Cosmic; 930054
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-140
AC CVCL_6592
DR Cosmic; 930055
RX PubMed=11212268;
WW http://www.cogcell.org/dl/NB_Data_Sheets/CHLA-140_Cell_Line_Data_Sheet_COGcell_org.pdf
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,13
ST D16S539: 10,11
ST D18S51: 15
ST D19S433: 13.2,15
ST D21S11: 30,32
ST D2S1338: 17,19
ST D3S1358: 15,17
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 25,26
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-143
AC CVCL_6593
DR Cosmic; 930056
RX PubMed=11212268;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,13
ST D16S539: 9,11
ST D18S51: 15,17
ST D19S433: 14,15
ST D21S11: 29,30
ST D2S1338: 18,23
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 9,11
ST D8S1179: 12,13
ST FGA: 22,25
ST TH01: 7,9
ST TPOX: 11
ST vWA: 18,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-144
AC CVCL_AQ12
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 9,11
ST D18S51: 17,20
ST D19S433: 12,14.2
ST D21S11: 28,31
ST D2S1338: 17,18
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 9,11
ST D8S1179: 14
ST FGA: 19
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AQ13 ! CHLA-145
CA Cancer cell line
//
ID CHLA-145
AC CVCL_AQ13
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 9,11
ST D18S51: 17,20
ST D19S433: 12,14.2
ST D21S11: 28,31
ST D2S1338: 17,18
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 9,11
ST D8S1179: 14
ST FGA: 19
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AQ12 ! CHLA-144
CA Cancer cell line
//
ID CHLA-15
AC CVCL_6594
SY CHLA_15
DR Cosmic; 1890116
RX PubMed=9850071;
RX PubMed=23202128;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/CHLA-15_Cell_Line_Data_Sheet_COGcell_org.pdf
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 11,13
ST D18S51: 15,19
ST D19S433: 14,15
ST D21S11: 30,31.2
ST D2S1338: 17,26
ST D3S1358: 16
ST D5S818: 12,15
ST D7S820: 9,11
ST D8S1179: 13
ST FGA: 23,24
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6602 ! CHLA-20
SX Female
CA Cancer cell line
//
ID CHLA-150
AC CVCL_A059
DR Cosmic; 930057
DR Cosmic; 1019936
DR Cosmic; 1161985
RX PubMed=11212268;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,13
ST D16S539: 9
ST D18S51: 13,14
ST D19S433: 15
ST D21S11: 30.2,31
ST D2S1338: 23,25
ST D3S1358: 14,17
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 13,16
ST FGA: 20,23
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-151
AC CVCL_AX41
SY CHLA_151
DR Cosmic; 1890124
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 9,12
ST D18S51: 13,17
ST D19S433: 14,14.2
ST D21S11: 32.2,33.2
ST D2S1338: 19,22
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 9,13
ST D8S1179: 12,15
ST FGA: 23
ST TH01: 8
ST TPOX: 8,10,11
ST vWA: 16,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-152
AC CVCL_6595
DR Cosmic; 930058
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-153
AC CVCL_6596
DR Cosmic; 930059
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-171
AC CVCL_6597
DR Cosmic; 930060
DR Cosmic; 1019949
RX PubMed=11212268;
RX PubMed=11507071;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/CHLA-171_Cell_Line_Data_Sheet_COGcell_org.pdf
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 11,12
ST D18S51: 17,19
ST D19S433: 14
ST D21S11: 29,34.2
ST D2S1338: 21,24
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 12,13
ST D8S1179: 10,14
ST FGA: 20,26
ST TH01: 7,8.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-172
AC CVCL_A056
RX PubMed=11507071;
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 12,13
ST D16S539: 9
ST D18S51: 14,17
ST D19S433: 14.2,15
ST D21S11: 30,31
ST D2S1338: 18,28
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 12,14
ST FGA: 18,24
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-174
AC CVCL_6598
DR Cosmic; 930034
RX PubMed=11212268;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 12,13
ST D18S51: 12,14
ST D19S433: 13
ST D21S11: 31.2,32.2
ST D2S1338: 19,23
ST D3S1358: 14,15
ST D5S818: 9,13
ST D7S820: 10,11
ST D8S1179: 10,14
ST FGA: 20,21
ST TH01: 9.3,10
ST TPOX: 11,12
ST vWA: 15,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-178
AC CVCL_6599
DR Cosmic; 930061
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-179
AC CVCL_6600
DR Cosmic; 930036
RX PubMed=11212268;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 9,10
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 14,16
ST D19S433: 13,15
ST D21S11: 31.2,32.2
ST D2S1338: 19,22
ST D3S1358: 14,17
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 13
ST FGA: 23,25
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-185
AC CVCL_6601
DR Cosmic; 930062
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-192
AC CVCL_AQ34
RX CelloPub=CLPUB00315;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11
ST D18S51: 13,17
ST D19S433: 14,18
ST D21S11: 29,32.2
ST D2S1338: 19,23
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 11
ST FGA: 23,25
ST TH01: 7,9.3
ST TPOX: 8,12
ST vWA: 15,16
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-194
AC CVCL_AQ35
RX CelloPub=CLPUB00315;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 10,11
ST D18S51: 12,13
ST D19S433: 14
ST D21S11: 29,33.2
ST D2S1338: 19,20
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 10,12
ST D8S1179: 15
ST FGA: 19,23
ST TH01: 7,9.3
ST TPOX: 10,11
ST vWA: 14,17
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
** -----------------------------------------------------------------------
** CALIPHO group at the SIB - Swiss Institute of Bioinformatics
** Geneva, Switzerland
** -----------------------------------------------------------------------
**
** Description: References file for the Cellosaurus
** Version: 24.0
** Last update: 15-November-2017
**
** -----------------------------------------------------------------------
您正在向 biovector.net 发送关于产品 细胞株Cell Lines 9-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
